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Abstract
Caregiver status is a known risk factor for morbidity and mortality. In the time period immediately after a
stroke, high levels of uncertainty about the family member's recovery and the sudden assumption of a
new caregiver role may be acutely stressful. Little is known, however, about caregivers' experiences in the
very early period of caregiving or how caregiver stress may contribute subsequently to health. The
purpose of this study was to examine the effect of uncertainty on caregiver perceived and physiological
stress and psychological outcomes (burden, health-related quality of life [HRQOL] and depressive
symptoms) within 2 weeks poststroke (baseline) and at 6 weeks poststroke. In addition, the mediator
effect of stress on the relationship between uncertainty and psychological outcomes was explored. A
prospective, longitudinal observational study was conducted using a convenience sample of 63
caregivers and their stroke-survivor relatives recruited from acute-care settings in two academic healthscience centers. Multivariate stepwise regression was used to achieve the overall aim of this study.
Additionally, multivariate regression was used to explore the mediator effect of stress on the relationship
between uncertainty and psychological outcomes. Level of uncertainty at baseline was higher than
reported in several other caregiver populations and it remained so at 6 weeks poststroke. Greater level of
uncertainty was associated with higher perceived stress at baseline (p < 0.001) and at 6 weeks
poststroke (p < 0.001). Uncertainty, however, was not a significant predictor of physiological stress at
either time point. Overall, greater uncertainty was associated with greater burden (p < 0.001 at baseline
and p = 0.031 at 6 weeks poststroke), poorer HRQOL (p < 0.001 at baseline and p = 0.023 only in
univariate analysis at 6 weeks poststroke) and greater depressive symptoms (p = 0.002 at both
observations). By 6 weeks poststroke, perceived stress fully mediated the relationship between
uncertainty and depressive symptoms. Healthcare providers in neuroscience must become sensitized to
caregiver uncertainty in the early period of caregiving. Using uncertainty as a predictor may help identify
caregivers at risk for stress, burden, poor HRQOL or depressive symptoms, that is, those in need of
additional support. Further research exploring uncertainty and the development and testing of target
interventions for it may reduce the early uncertainty and stress of caregivers of stroke survivors and
prevent negative longer term health outcomes.
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ABSTRACT

EFFECTS OF UNCERTAINTY ON PERCEIVED AND PHYSIOLOGICAL STRESS
AND PSYCHOLOGICAL OUTCOMES IN STROKE-SURVIVOR CAREGIVERS
Eeeseung Byun
Lois K. Evans
Barbara J. Riegel
Caregiver status is a known risk factor for morbidity and mortality. In the time period
immediately after a stroke, high levels of uncertainty about the family member’s recovery
and the sudden assumption of a new caregiver role may be acutely stressful. Little is
known, however, about caregivers’ experiences in the very early period of caregiving or
how caregiver stress may contribute subsequently to health. The purpose of this study
was to examine the effect of uncertainty on caregiver perceived and physiological stress
and psychological outcomes (burden, health-related quality of life [HRQOL] and
depressive symptoms) within 2 weeks poststroke (baseline) and at 6 weeks poststroke. In
addition, the mediator effect of stress on the relationship between uncertainty and
psychological outcomes was explored. A prospective, longitudinal observational study
was conducted using a convenience sample of 63 caregivers and their stroke-survivor
relatives recruited from acute-care settings in two academic health-science centers.
Multivariate stepwise regression was used to achieve the overall aim of this study.
Additionally, multivariate regression was used to explore the mediator effect of stress on
the relationship between uncertainty and psychological outcomes. Level of uncertainty at
baseline was higher than reported in several other caregiver populations and it remained
vi

so at 6 weeks poststroke. Greater level of uncertainty was associated with higher
perceived stress at baseline (p < 0.001) and at 6 weeks poststroke (p < 0.001).
Uncertainty, however, was not a significant predictor of physiological stress at either time
point. Overall, greater uncertainty was associated with greater burden (p < 0.001 at
baseline and p = 0.031 at 6 weeks poststroke), poorer HRQOL (p < 0.001 at baseline and
p = 0.023 only in univariate analysis at 6 weeks poststroke) and greater depressive
symptoms (p = 0.002 at both observations). By 6 weeks poststroke, perceived stress fully
mediated the relationship between uncertainty and depressive symptoms. Healthcare
providers in neuroscience must become sensitized to caregiver uncertainty in the early
period of caregiving. Using uncertainty as a predictor may help identify caregivers at risk
for stress, burden, poor HRQOL or depressive symptoms, that is, those in need of
additional support. Further research exploring uncertainty and the development and
testing of target interventions for it may reduce the early uncertainty and stress of
caregivers of stroke survivors and prevent negative longer term health outcomes.
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CHAPTER 1: INTRODUCTION
In the United States, approximately 66 million people serve as informal caregivers
of family members or friends who are older, chronically ill or disabled (National Alliance
for Caregiving and AARP, 2009). Caregiver status is a known risk factor for morbidity
and mortality (Haley, Roth, Howard, & Safford, 2010; Schulz & Beach, 1999). Further,
immune-system suppression in caregivers is quite common (Bauer et al., 2000) and a
meta-analysis reports that stress hormones such as cortisol are elevated in caregivers
(Vitaliano, Zhang, & Scanlan, 2003). Although the literature on the long-term effects of
caregiving is well developed, little is known about either the immediate period (within
the first 2 weeks) when a family or friend initially assumes the caregiver role, or the longterm consequences for caregivers of their experiences during this period. To better
understand what occurs during this early period, which may impact caregiver outcomes, I
studied stroke-survivor caregivers. This population exemplifies those who encounter the
uncertainties and other stressors associated with a family member’s sudden, serious
health event (Brereton & Nolan, 2002; Burman, 2001; Forsberg-Warleby, Moller, &
Blomstrand, 2001; Hunt & Smith, 2004; O’Connell, Baker, & Prosser, 2003) and
subsequent caregiver-role assumption. Caregiving in this population is associated with
stressors related to both physical and psychological health as well as related morbidities
and illness-related symptoms, such as depression (Anderson, Linto, & Stewart-Wynne,
1995; Bauer et al., 2000; Berg, Palomaki, Lonnqvist, Lehtihalmes, & Kaste, 2005; Blake,
Lincoln, & Clarke, 2003; Burman, 2001; Forsberg-Warleby, Moller, & Blomstrand,
2002; McCullagh, Brigstocke, Donaldson, & Kalra, 2005; Pierce, Steiner, Hicks, &
Holzaepfel, 2006; White, Mayo, Hanley, & Wood-Dauphinee, 2003), hypertension and
1

angina (White et al., 2003).
Background
Stroke is a common global phenomenon, with more than 15 million stroke cases
annually worldwide (Mackay & Mensah, 2004). Stroke caregiving is also an important
public health problem in the United States where approximately 795,000 new or
recurring strokes occur each year. Of these, a large proportion—65%—occurs among
adults aged 65 and older (Lloyd-Jones et al., 2009). More than 7 million stroke survivors
live with poststroke effects in the United States (National Stroke Association, 2013), and
40% have permanent moderate-to-severe impairments (National Stroke Association,
2013). Because of these impairments and associated functional deficits (ForsbergWarleby et al., 2001, 2002; Visser-Meily et al., 2009), stroke survivors often require
assistance from caregivers in performing activities of daily living. Because stroke is
usually a sudden event, family members must abruptly assume the role of informal
caregiver without an opportunity to adjust. In contrast, family members of persons with a
chronic illness can more gradually adapt to the caregiver role. These differences in
caregiver populations warrant further investigation.
In the United States, the length of stay in the hospital after stroke averages 5.7
days; within 30 days, all stroke survivors will have been discharged to home (31%),
home with home-health services (15%), rehabilitation hospitals (20%) and/or skilled
nursing facilities or other long-term care (34%; Kind, Smith, Frytak, & Finch, 2007).
Given that caregivers need to assume their new role as informal caregivers in a relatively
short period of time, they may experience uncertainty, stress and early signs of burden
associated with these new caregiving experiences. A beginning literature review
2

suggested that burden may be present as early as 10 days to 30 days poststroke (Bugge,
Alexander, & Hagen, 1999; Forsberg-Warleby et al., 2001, 2002). Not surprisingly,
caregivers report physical and physiological health problems when measured months to
years after their relative’s stroke event (Anderson et al., 1995; Berg, Palomaki,
Lehtihalmes, Lonnqvist, & Kaste, 2003; Berg et al., 2005; White, Lauzon, Yaffe, &
Wood-Dauphinee, 2004).
Informal caregivers contribute “activities and experiences that provide help and
assistance to relatives or friends who are unable to provide for themselves” (Pearlin,
Mullan, Semple, & Skaff, 1990, p. 583). The general literature on caregiving
demonstrates several stress-related outcomes including higher mortality rates in those
with greater emotional strain (Schulz & Beach, 1999), increased risk for stroke in spousal
caregivers reporting higher strain (Haley et al., 2010) and increased coronary heart
disease in female spousal caregivers (S. Lee, Colditz, Berkman, & Kawachi, 2003).
Perceived stress (self-reported) is typically reflected in physiological stress,
including elevated neuroendocrine mediators such as cortisol and norepinephrine
(Morgan et al., 2002). Acute stress is associated with a disruption in circadian rhythms
(Feve-Montange et al., 1981) and, after exposure to acute stress, elevated levels of
plasma and salivary cortisol (Morgan et al., 2002). In a laboratory study of caregivers
whose spouses suffered from dementia, Cacioppo et al. (2000) found that when
caregivers were exposed to a stressor, they had higher blood pressures and heart rates
than noncaregivers. These results signify higher sympathetic activation (Cacioppo et al.,
2000), which is indicative of acute stress response. It is not known, however, whether
stress hormones are elevated in caregivers experiencing acute stress in a natural or
3

clinical environment (vs. the laboratory) or in those caring for persons with disorders
other than dementia, a question explored in the present study.
Among psychological outcomes for stroke-survivor caregivers, prevalence of
depression is known to be high (23% to 33%; Berg et al., 2005; Blake et al., 2003) and
longer term outcomes include caregiver burden (Blake et al., 2003; Bugge et al., 1999;
Forsberg-Warleby et al., 2001; Tooth, McKenna, Barnett, Prescott, & Murphy, 2005) and
decreased health-related quality of life (HRQOL; White et al., 2004).
A study of caregivers’ responses in the early poststroke period is critical to
understanding the role of uncertainty and stress as potentially modifiable factors affecting
caregiver health outcomes. There is currently little information that addresses the
relationship between caregiver uncertainty and psychological outcomes. This study adds
to the body of knowledge about the early period of caregiving by including, at two
distinct time points, measures of uncertainty as well as perceived and physiological stress
and caregiver psychological outcomes.
Purpose
The high levels of uncertainty about both the family member’s recovery following
a stroke and the sudden assumption of a new caregiver role may be acutely stressful, and
yet little is known about the caregivers’ experience in the first 2 to 6 weeks of caregiving
or how it may contribute subsequently to caregivers’ health. Thus, the overall purpose of
this study was to examine the effect of uncertainty on caregiver perceived and
physiological stress and psychological outcomes (burden, HRQOL and depressive
symptoms) within the first 6 weeks of caregiving following a sudden, serious health event
in a family member: stroke.
4

Aims and Hypotheses
I implemented a prospective, longitudinal observational study design during the
time period immediately poststroke (within 2 weeks, T1) and 4 weeks later (when stroke
survivors were at home, in rehabilitation hospitals or in nursing facilities, T2) to study the
following aims:
Aim 1: Determine at each time point if uncertainty (regarding stroke survivors’
health outcomes and new caregiver role) predicts levels of caregivers’ perceived stress.
H1: At each time point, greater uncertainty scores will be positively associated
with higher levels of perceived stress.
Aim 2: Determine at each time point if uncertainty predicts levels of caregivers’
physiological stress (salivary cortisol).
H2: At each time point, greater uncertainty scores will be positively associated
with elevated levels of salivary cortisol.
Aim 3: Examine at each time point the relationship of uncertainty to
psychological outcomes (burden, HRQOL and depressive symptoms).
At each time point, greater uncertainty scores will be positively associated with
H3: greater burden,
H4: poorer HRQOL and
H5: greater depressive symptoms.
Aim 4: Explore at each time point the mediator effect of stress (perceived stress
and physiological stress) on the relationship between uncertainty and psychological
outcomes (burden, HRQOL and depressive symptoms).

5

At each time point, perceived stress and salivary cortisol will mediate the
relationship between uncertainty and
H6: burden,
H7: HRQOL and
H8: depressive symptoms.
Significance of the Study
The uncertainty associated with the early caregiving experience (within the first 6
weeks of the sentinel event) may predict the caregiver’s experience and its consequences
over time. If uncertainty during this period is found to contribute significantly to stress, it
may be possible to develop interventions to reduce uncertainty and thereby contribute to
healthier outcomes for caregivers over time. For example, persons with higher levels of
baseline uncertainty had higher levels of anxiety and depression and lower levels of
perceived control and HRQOL 1 year after angiography compared to those with lower
levels of baseline uncertainty (Eastwood, Doering, Roper, & Hays, 2008). Thus, the study
results could inform early interventions that may have long-term impact. Further, the
study contributes important information regarding perceived and physiological stress
during the early caregiving experience and its association with uncertainty and with
psychological outcomes of caregiving.
In addition, it is not known whether stress hormones are elevated in caregivers of
stroke survivors or, indeed, among any caregivers experiencing new, acute stress. By
including direct measures of salivary cortisol as well as measures of caregiver
psychological, behavioral and environmental factors that influence hypothalamicpituitary-adrenal reactivity (HPA) in the brain, any change that occurs in the early period
6

of caregiving can be further illuminated (Pearlin et al., 1990) and, perhaps, suggest areas
for further intervention. For example, a stress-management program targeting areas
related to stress revealed in this study may reduce caregiver perceived stress and elevated
cortisol levels and prevent stress-related illnesses.
Understanding the impact of caregiver uncertainty on perceived stress,
physiological stress and psychological outcomes in the early weeks of caregiving is
essential in designing a future intervention study aimed at preventing related morbidities
in caregivers. Further, timely intervention resolving uncertainty and reducing caregiver
stress may help family members better cope in their role as informal caregivers and result
in better health outcomes for themselves and the stroke survivor.
Given the high prevalence of stroke, efforts to shore up the informal-caregiving
system, which may reduce healthcare costs by protecting the health of family caregivers,
are vital to public health. These findings also may be salient in a variety of other
caregiving situations when care recipients experience a sudden or serious health event,
such as brain injury or myocardial infarction.

7

CHAPTER 2: REVIEW OF LITERATURE
This chapter comprises a synthesis and evaluation of the existing literature on
family caregivers of stroke survivors and suggests fruitful areas for confirmation or
further exploration. The chapter is organized into four sections. Section one is the
conceptual framework for this study. Section two is a discussion of each of the main
variables in the study described from the perspective of existing literature: (a) uncertainty
and its relationship to perceived and physiological stress and psychological outcomes
including caregiver burden, health-related quality of life (HRQOL) and
depression/depressive symptoms; (b) stress including perceived and physiological stress;
(c) psychological outcomes including caregiver burden and HRQOL and
depression/depressive symptoms; and (d) relevant caregiver and stroke-survivor
characteristics. Section three provides a summary of known factors affecting caregiver
outcomes. Finally, a summary of gaps in the literature and the current study solutions are
presented.
Conceptual Framework
Mishel’s uncertainty-in-illness model (Mishel, 1988) and Schulz’s caregivercoping model (Schulz, Tompkins, & Rau, 1988) informed the conceptual framework
proposed to explore how uncertainty may influence caregiver perceived stress,
physiological stress and longer term psychological outcomes including burden, HRQOL
and depressive symptoms. Mishel’s model explains that uncertainty occurs when decision
makers cannot define meaning for illness-related events, predict what will happen next or
predict the consequences from the event (Mishel, 1981). Uncertainty is a neutral concept
that can be perceived either as danger or opportunity (Mishel, 1981, 1988). When
8

perceived as danger, people cope by trying to adapt to the situation and thereby resolve
uncertainty (Mishel, 1997a).
In addition to Mishel’s uncertainty-in-illness model (Mishel, 1988), Schulz’
caregiver-coping model, used with caregivers for stroke survivors (Schulz et al., 1988),
suggested the majority of variables used in this study. Schulz’ caregiver-coping model
identifies patient characteristics (e.g., functional status including independence in
activities of daily living, patient affective state, manifestations of disability and
prognosis) and caregiver characteristics (e.g., health, income, social support, satisfaction
with social contacts and coping strategies) affecting both caregiver perceived stress and
caregiver outcomes (psychological well-being, life satisfaction, depression and physical
well-being) as responses to that stress.
The resulting proposed conceptual framework (see Figure 1) specifies the
relationships among the main variables of interest: uncertainty, caregiver stress
(perceived and physiological stress) and psychological outcomes (burden, HRQOL and
depressive symptoms). Uncertainty is directly associated with caregiver stress (perceived
and physiological [salivary cortisol]). In addition, uncertainty is believed to directly
affect psychological outcomes and also to have an indirect impact on these outcomes
through their effects on caregiver stress, adjusting for covariates. Caregiver stress
(perceived and physiological [salivary cortisol]) is also directly associated with
psychological outcomes (burden, HRQOL and depressive symptoms), adjusting for
covariates. Known covariates affecting stroke-survivor caregiver outcomes include
caregiver characteristics (comorbidity, coping capacity, social support and
sociodemographics) and stroke-survivor characteristics (severity of stroke, functional
9

status, comorbidity and sociodemographics).

Stress
Psychological Outcomes
Uncertainty

Perceived
Physiological

Burden
Health-Related Quality of Life
Depressive Symptoms

Figure 1. Conceptual framework.
Note. Derived from Mishel’s Uncertainty-in-Illness Model (Mishel, 1988) and Schulz’s Caregiver-Coping
Model (Schulz et al., 1988).

Uncertainty
According to the uncertainty-in-illness model, uncertainty is defined as the
“inability to determine the meaning of illness-related events” (Mishel, 1988, p. 225) and
includes four dimensions: (a) ambiguity about the illness state; (b) complexity regarding
available information, treatment, the healthcare system and relationship with healthcare
providers; (c) lack of information about the diagnosis, seriousness of the illness,
treatment and symptoms; and (d) unpredictability of the illness course and prognosis
(Mishel, 1988). When people perceive uncertainty as danger, they try to cope with the
situation and resolve uncertainty, for example, by seeking knowledge or information or
adopting health-promoting behavior (Mishel, 1997a). Caregivers of stroke survivors are
not certain what to expect either in the disease trajectory or how fully the stroke survivor
will recover (Brereton & Nolan, 2002; Forsberg-Warleby et al., 2001; Hunt & Smith,
2004; O’Connell et al., 2003). Uncertainty arises when the decision maker cannot
anticipate outcomes because of lack of resources or information (Mishel, 1997a).
Caregivers’ uncertainty about stroke survivors’ outcomes from lack of information or
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knowledge may be heightened because of the very real difficulty in the early poststroke
period to predict just how much physical or cognitive impairment will remain (ForsbergWarleby et al., 2001; O’Connell et al., 2003). In contrast, by 1 year poststroke, recovery
is relatively stable (Anderson et al., 1995). Because stroke has a sudden onset, family
members need to adjust to a new relationship with stroke survivors and take on new
responsibilities as informal caregivers, potentially without adequate support or
knowledge (Coombs, 2007). Thus, in this study, uncertainty is defined as caregivers’
inability to determine the meaning of stroke survivors’ health outcomes and the new
caregiver role.
The concept of uncertainty in adults with chronic disease or cancer is well
established and parents’ uncertainty about the prognosis of children with cancer has also
been documented in the current literature. Few researchers, however, have systematically
studied uncertainty in caregivers for persons with acute or chronic disorders. Northouse,
Laten, and Reddy (1995) reported that caregivers of persons with breast cancer had
greater uncertainty about the patients’ illness than did the patients themselves and also
had difficulty adjusting to their new role. In another study, uncertainty in caregivers for
persons with breast cancer was correlated with caregiver emotional distress and caregiver
role adjustment (Northouse, Dorris, & Charron-Moore, 1995). Mitchell and Courtney
(2004) reported that uncertainty in family caregivers around transfer from intensive care
was significantly related to anxiety. As previously noted, persons with higher uncertainty
at baseline had poorer health outcomes (e.g., higher levels of anxiety and depression and
lower levels of perceived control and HRQOL) 1 year after angiography than those with
lower uncertainty at baseline (Eastwood et al., 2008). Regardless, caregivers’ uncertainty
11

in the early weeks of caregiving, not only for stroke survivors, but also for patients with
other disorders, has not been well explicated.
Uncertainty and stress.
Uncertainty and perceived stress. The impact of uncertainty on caregiver
perceived stress has not yet been made clear. One study reported that a mother’s
uncertainty about her infant’s HIV serostatus was related to the mother’s perceived stress
(Shannon & Lee, 2008). Uncertainty in illness was also correlated with posttraumatic
stress symptoms in young-adult childhood cancer survivors (Santacroce & Lee, 2006).
This study did not control for other covariates that may affect posttraumatic-stress
symptoms; the results, however, indicate that uncertainty may be a potential factor that
influences perceived stress in caregivers and is, thus, a target for intervention. Further,
the results of this study regarding posttraumatic-stress symptoms as mediators between
uncertainty and health-promotion behavior support one of the proposed hypotheses in this
study, i.e., that perceived stress will mediate the relationship between uncertainty and
psychological outcomes (burden, HRQOL and depressive symptoms).
Uncertainty and physiological stress. The relationship between uncertainty and
physiological stress has not been investigated in the current literature. Mishel (1990)
noted that chronically ill persons who are uncertain can develop symptoms related to
pathological response to stressors. Caregivers for stroke survivors may have struggled
with new responsibilities in their role as informal caregivers in the early poststroke period.
Uncertainty regarding stroke survivors’ outcomes as well as the new caregiver role is
likely to be stressful. Understanding the relationship between uncertainty and
physiological stress will expand knowledge in the current literature and contribute to
12

development of a biobehavioral model to guide a future intervention study.
Uncertainty and psychological outcomes.
Uncertainty and burden. The impact of uncertainty on caregiver burden has not
been documented in the current literature. In a related study, 30% of 44 caregivers for
patients with Parkinson’s disease reported psychological distress, and uncertainty was a
significant determinant for it (Sanders-Dewey, Mullins, & Chaney, 2001). In the existing
literature, caregivers for stroke survivors conveyed caregiver burden beginning at least 1
month poststroke (Bugge et al., 1999). Whether early uncertainty influences later
caregiver burden is not clear, and a study in the early weeks of caregiving is, thus,
required to reveal this relationship. If found, relieving some of this early uncertainty may
be important to decreasing later caregiver morbidity and mortality associated with burden.
Uncertainty and health-related quality of life. The relationship between
uncertainty and HRQOL in caregivers for persons with recurrent breast cancer was
studied by Northouse et al. (2002). Compared with estimated norms, caregivers for
persons with breast cancer had lower (poorer) mean scores (mean 48.4, p = 0.03) in
mental health dimensions of HRQOL, as measured by the Medical Outcomes Study SF36. Mean scores in physical health dimensions of HRQOL, however, were similar to
norm values. In their study, caregiver uncertainty was associated with mental health
dimensions of HRQOL, adjusting for caregiver characteristics (age, education, selfefficacy, current concerns, family hardiness, social support and symptoms) as well as
patient characteristics (symptom distress, stage of disease and length of the disease-free
interval between stage of disease and recurrence). Eastwood et al. (2008) found worse
HRQOL 1 year later in coronary angiography patients with high baseline uncertainty.
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The influence of uncertainty on HRQOL in caregivers of stroke survivors, however, has
not been documented in the current literature.
Uncertainty and depression or depressive symptoms. Depression or depressive
symptoms are common in caregivers of stroke survivors, but, there is little research
linking caregiver uncertainty and depression. Sanders-Dewey et al. (2001) reported that
uncertainty in caregivers for individuals with Parkinson’s disease was correlated with
their depression, but no further predictive analysis was reported. Caregiver uncertainty
about a family member’s transfer from intensive care was significantly associated with
anxiety (Mitchell & Courtney, 2004). Patients with higher levels of uncertainty than those
with lower levels of uncertainty had more anxiety and depression at 1 year after coronary
angiography (Eastwood et al., 2008). Further study is required to identify the impact of
uncertainty on caregiver depression while controlling for known risk factors for
depression in caregivers of stroke survivors, including the survivors’ stroke severity and
older age (Berg et al., 2005) and caregivers’ social support (Grant et al., 2006).
Stress
Perceived stress. Caregivers’ perceived stress includes “domestic upset, negative
feelings toward the patient and personal distress in relation to the patient” (Draper et al.,
2007, p. 124). Caregivers experience higher perceived stress than do noncaregivers
(Bauer et al., 2000) due to exposure to complex stressors (Pearlin et al., 1990). The
literature on caregiving reported (Pearlin et al., 1990) that caregiving stressors can be
broadly divided into two categories: primary (i.e., patient characteristics and caregivers’
perspectives on these characteristics including cognitive status, behavioral symptoms and
activities of daily living) and secondary (i.e., family conflict, job–caregiving conflict,
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economic problems and constriction of social life).
Stress from caregiving has been associated with effects on health and risk factors
for mortality. Caregivers with greater emotional strain have 63% higher mortality rates
than do noncaregivers (Schulz & Beach, 1999). Spousal caregivers with higher strain
have increased risk for stroke (Haley et al., 2010) and female spousal caregivers are at
higher risk for coronary heart disease (S. Lee et al., 2003). In caregivers of stroke
survivors, significant stress was reported within the first year poststroke and one of its
significant predictors was the functional status of the stroke survivor. Related caregiver
factors include caregiver gender, age, caregiver health, time since providing care for
stroke survivors, coping strategy/capacity, social support and preparedness for caregiving
(Ostwald, Bernal, Cron, & Godwin, 2009). With stroke’s sudden onset, the early
poststroke period may especially be acutely stressful for caregivers, but acute stress in
caregivers during the early poststroke period has not yet been described.
After stroke, caregivers need to address and become accustomed to patients’
functional deficits (Visser-Meily et al., 2009). In the acute stage of stroke, providers
cannot anticipate exactly how much physical or cognitive impairment will remain
(O’Connell et al., 2003), and the process of recovery from stroke is gradual. In the
literature on family caregivers of stroke survivors, the concept of stress has been
integrated with the explanation of caregiver burden. Little has been reported on perceived
stress in the early weeks of caregiving.
Physiological stress. Perceived stress is correlated with physiologic response,
including elevated neuroendocrine mediators such as norepinephrine or cortisol (Morgan
et al., 2002). As an allostatic response, that is, the ability to achieve stability during
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change (McEwen, 1998), stress stimulates the sympathetic nervous system as well as
activates the hypothalamic-pituitary-adrenal (HPA) axis. Sympathetic nervous-system
stimulation results in norepinephrine (catecholamine neurotransmitter) release from
sympathetic nerves into target tissues and epinephrine release from adrenal medulla into
circulation. The activation of the HPA axis causes the adrenal cortex to release
glucocorticoids, principally cortisol in humans. Salivary cortisol has often been measured
to assess stress in caregivers, especially those caring for dementia patients; these
caregivers have an increase in cortisol levels (Bauer et al., 2000; Da Roza Davis &
Cowen, 2001; de Vugt et al., 2005; Vedhara et al., 1999). Receptor-mediated actions of
cortisol cause immunosuppressive and anti-inflammatory effects on target immune
tissues and cells (Elenkov, Webster, Torpy, & Chrousos, 1999), and the immune system
is known to be suppressed in caregivers of dementia patients (Vitaliano et al., 2003). One
study reported diurnal salivary-cortisol patterns in caregivers of stroke survivors; levels
of salivary cortisol were lower across the day in caregivers with greater depressive
symptoms than in those with less (Saban, Mathews, Bryant, O’Brien, & Janusek, 2012).
This study found that younger age was associated with lower levels of cortisol on waking
and 30 minutes postwaking.
In the case of acute stress, a significant association with disrupted circadian
rhythms, defined as a 24-hour cycle of physiological, biochemical and behavioral
processes, was reported (Feve-Montange et al., 1981). After exposure to acute stress,
levels of plasma and salivary cortisol and their ratios were significantly increased
(Morgan et al., 2002) and acute stress also had long-term health implications (McEwen,
1998). The activation of the sympathetic nervous system releases catecholamines
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resulting in a broad physiologic response (Seeman, Singer, Rowe, Horwitz, & McEwen,
1997): increased blood pressure, heart rate, breathing rate and blood-glucose level and
intensifies muscle tension (Preville, Zarit, Susman, Boulenger, & Lehoux, 2008). To date,
physiologic response from acute stress in caregivers has been measured only in
experimental settings. When caregivers of demented spouses were asked to provide care
for their spouses in the laboratory, they had higher blood pressure and heart rate than did
noncaregivers, indicating they were experiencing acute stress and higher sympathetic
activation (Cacioppo et al., 2000).
In contrast to dementia, which is a chronic progressive disorder, stroke has a
sudden onset and, thus, in the early poststroke period stroke-survivor caregivers are likely
to experience acute stress. One study reported that levels of salivary cortisol were
decreased across the day in caregivers with greater depressive symptoms compared with
those with fewer depressive symptoms (Saban et al., 2012). It is not well known whether
stress hormones are elevated, decreased or affected at all in caregivers of stroke survivors
when they first confront their new role as a caregiver in a natural environment.
Caregivers may also experience stress due to their own personal problems in addition or
unrelated to their family members’ sudden onset of stroke or their new caregiving
situation. Thus, in this study I attempted to capture these other precipitants by asking
caregivers about their other potentially stressful life events in the past 3 months (e.g.,
death, moving, retirement and marriage).
Salivary cortisol. Salivary cortisol has often been used as a biomarker of
psychological stress. The salivary-cortisol level is reliable in assessing the variation in
endocrine activity and response to acute stress (Feve-Montange et al., 1981). One
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advantage of salivary cortisol is that one can measure the free unbound fraction of
cortisol because it is the last output of the HPA axis that remains high in acute stress with
its disruption of circadian rhythms (Feve-Montange et al., 1981; Hellhammer, Wust, &
Kudielka, 2009). In addition, salivary cortisol acts independently of competition with
other steroid hormones to bind cortisol globulin (Woods et al., 2008). Salivary cortisol is
correlated with serum cortisol (Kirschbaum & Hellhammer, 1994; Shimada, Takahashi,
Ohkawa, Segawa, & Higurashi, 1995) and contains up to 10% of serum cortisol (Woods
et al., 2008). Assessing salivary-cortisol levels in caregivers of stroke survivors can
contribute to a better understanding of caregiver stress.
Psychological Outcomes
Burden. Caregiver burden for stroke survivors refers to family members’ feelings
of being overwhelmed and strained in assisting their care recipients (Elmstahl, Malmberg,
& Annerstedt, 1996). The general concept of caregiver burden itself is dynamic. Zarit,
Todd, and Zarit (1986) defined caregiver burden as “the extent to which caregivers
perceived their emotional or physical health, social life and financial status as suffering as
a result of caring for their relative” (p. 261). Although in the current literature the term
“demand” has been recently used to describe caregiver burden, the majority of the
literature on caregiving in stroke survivors continues to use the term “burden.” Thus,
“caregiver burden” was used in this study.
Objective burden is defined as “caregiving situations” such as “the caregiving
tasks that are performed, like assistance with self-care, mobility, instrumental activities
and financial management and the time spent on each task” (van Exel, Koopmanschap,
van den Berg, Brouwer, & van den Bos, 2005, p. 12). One third of caregivers for stroke
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survivors reported they were burdened by household responsibilities and caregiving
(Thommessen, Wyller, Bautz-Holter, & Laake, 2001).
Subjective burden is defined as “the psychological, social or emotional impact
caregivers experience from the objective burden of caregiving” (van Exel et al., 2005,
p. 12) or “the distress experienced” (Thommessen et al., 2002, p. 79). Few studies
distinguish between objective burden and subjective burden, rather reporting on burden in
general.
As demonstrated in existing literature, caregivers reported a sense of burden from
at least 1 month to 1 year poststroke (Blake et al., 2003; Bugge et al., 1999; ForsbergWarleby et al., 2001; Tooth et al., 2005). Of spousal caregivers of stroke patients, 34%
reported burden at 3 months poststroke and 40% had burden at 6 months poststroke
(Blake et al., 2003). Significant burden was reported in the first 12 months poststroke
(Tooth et al., 2005). Some studies reported that burden of caregivers decreased over time,
that is, baseline to 6 months (McCullagh et al., 2005; Vincent, Desrosiers, Landreville,
Demers, & BRAD group, 2009), whereas others revealed that caregiver burden continued
from 2 months to 6 months (Ilse, Feys, de Wit, Putman, & de Weerdt, 2008) or from 1
month to 6 months (Blake et al., 2003; Bugge et al., 1999).
Several caregiver sociodemographic factors are known predictors for burden:
relationship to stroke survivors (Van Puymbroeck & Rittman, 2005), gender (Bugge et al.,
1999), age (Periard & Ames, 1993; Schulz et al., 1988; van Exel et al., 2005), time spent
helping the survivors (Bugge et al., 1999) and coping capacity (Cameron & Gignac,
2008; Forsberg-Warleby et al., 2001; Van Puymbroeck & Rittman, 2005; Visser-Meily et
al., 2009). Stroke-survivor characteristics affecting burden include functional status (Ilse
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et al., 2008), cognitive impairment (Thommessen et al., 2001) and communication
loss/aphasia (Vincent et al., 2009). HRQOL of caregivers at 6 months poststroke is also
strongly related to caregiver burden (van Exel et al., 2005). The effect of uncertainty on
caregiver burden, however, has not yet been studied.
Health-related quality of life. Quality of life is a broad concept that includes
HRQOL. Quality of life can reference personal well-being or satisfaction with life.
HRQOL focuses aspects on perceived health or illness. General caregiving literature
reports that quality of life of caregivers is lower than that of noncaregivers (Roth, Perkins,
Wadley, Temple, & Haley, 2009). Caregivers of stroke survivors also experienced
decreased HRQOL from 1 month to several months poststroke (White et al., 2004).
Increased caregiver burden was associated with decreased caregiver HRQOL (Larson et
al., 2005; van Exel et al., 2005; Van Puymbroeck & Rittman, 2005), especially in the area
of mental health (Morimoto et al., 2003). Caregiver HRQOL was predicted by caregiver
age and gender (McCullagh et al., 2005). New caregivers of stroke survivors must
confront issues of independence and managing comorbid conditions in stroke survivors,
balance roles (e.g., caregiver, spouse and employee) and participate in physical therapy
(Pierce et al., 2006). They must also deal with a number of factors affecting themselves
and stroke survivors: emotions such as depression or anger, living with physical
limitations and sleep problems (Pierce et al., 2006). These factors may affect their
HRQOL. Uncertainty was associated with the mental health dimensions of HRQOL in
caregivers for persons with recurrent breast cancer (Northouse et al., 2002). Whether
uncertainty affects HRQOL in caregivers of stroke survivors, however, has not been
studied.
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Depression/depressive symptoms. Prevalence of depression is high among
caregivers of stroke survivors; as many as 23% to 33% of caregivers experience
depression during the 18-month follow-up period poststroke (Berg et al., 2005; Blake et
al., 2003). Bakas, Kroenke, Plue, Perkins, and Williams (2006) reported that 18% of
caregivers for stroke survivors had moderate depressive symptoms. In their study, an
additional 18% of caregivers who were taking antidepressant medications showed no
depressive symptoms, suggesting that approximately 36% of caregivers of stroke
survivors may have symptoms of depression (Bakas, Kroenke, et al., 2006). Predictors
for depression in caregivers include severity of stroke and older age of stroke survivors
(Berg et al., 2005), caregiver social support (Grant et al., 2006), race, gender, hours spent
providing care per day (Van Puymbroeck, Hinojosa, & Rittman, 2008) and younger age
(Saban et al., 2012). Positive aspects of caregiving that protect against depression in
caregivers of stroke survivors were also reported: a high sense of coherence at 1 month
poststroke was associated with less depressive symptoms at 12 months poststroke (Van
Puymbroeck et al., 2008). A longitudinal study reported moderate caregiver depression in
2% of participants at baseline, 6% at 6 months poststroke and 9% at 18 months poststroke
(Berg et al., 2005). Whether caregiver uncertainty influences depression, after adjusting
for other known factors, has not been studied.
Relevant Caregiver and Stroke-Survivor Characteristics
Caregiver characteristics.
Comorbidity and health status. Comorbidity is defined as the presence of
coexisting diseases or conditions with reference to an initial diagnosis or the index
condition that is the subject of study (Webster’s Online Dictionary, 2011). Caregivers of
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stroke survivors have comorbidities (Hodgson, Wood, & Langton-Hewer, 1996) and
confront new physical-health issues, comorbid issues and high numbers of illness-related
symptoms including depression (Anderson et al., 1995; Bauer et al., 2000; Berg et al.,
2005; Blake et al., 2003; Burman, 2001; Cameron & Gignac, 2008; Forsberg-Warleby et
al., 2002; McCullagh et al., 2005; Pierce et al., 2006; White et al., 2003). Of caregivers of
stroke survivors, 54% already had preexisting medical conditions, including arthritis,
vertigo or back problems that can influence their caregiving for stroke survivors over
time (Hodgson et al., 1996). Caregivers studied during the first and second year
poststroke reported a range of disorders including hypertension, arthritis, cataracts,
bronchitis, angina, history of myocardial infarction, diabetes, asthma and ulcer disease
(White et al., 2003). Reported psychological symptoms included depression, fear,
frustration, resentment, impatience, guilt (Anderson et al., 1995), anxiety (Anderson et al.,
1995; McCullagh et al., 2005), worry, concern (Cameron & Gignac, 2008), anger (Pierce
et al., 2006) and fear about the recurrence of stroke or other medical complications in
their family members (Forsberg-Warleby et al., 2002).
In addition to comorbidities, caregivers’ own perceived health status also affects
their experience of burden (Bugge et al., 1999) and HRQOL (Morimoto et al., 2003).
Comorbidity of caregivers is believed to influence the relationship between uncertainty,
perceived stress and caregiver outcomes. Thus, in this study, the effect of comorbidity on
outcomes was controlled.
Coping capacity. Coping is defined as “one’s ability to respond to stressors by the
appropriate use of adaptive coping resources” (Chumbler, Rittman, Van Puymbroeck,
Vogel, & Qin, 2004, p. 944). When individuals confront stressful life events, they use
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strategies to cope and adapt to the situation to decrease harmful effects that may arise
from stress or to reduce emotional distress as a response to the event (Visser-Meily et al.,
2009). Coping capacity has been highly associated with burden (Cameron & Gignac,
2008; Forsberg-Warleby et al., 2001; Van Puymbroeck & Rittman, 2005; Visser-Meily et
al., 2009), quality of life (Visser-Meily et al., 2009) and depression (Visser-Meily et al.,
2009) in caregivers of stroke survivors. Thus, the effects of coping capacity on caregiver
perceived and physiological stress and psychological outcomes (burden, HRQOL and
depressive symptoms) in the early poststroke period were examined.
Social support. Social support is defined as caregivers’ perceptions about the
availability of relationships that provide help or support them and prevent negative
outcomes from the stressful event (Sherbourne & Stewart, 1991). Less perceived
availability of social support predicted depression in caregivers of stroke survivors (Grant,
Bartolucci, Elliot, & Giger, 2000), whereas caregivers of stroke survivors who reported
more perceived social support had less depression (Grant et al., 2006). Caregivers who
reported greater satisfaction with social support had less caregiver strain (van den Heuvel,
de Witte, Schure, Sanderman, & Meyboom-de Jong, 2001). Furthermore, social support
was a significant determinant of better well-being and general health in caregivers (Grant
et al., 2006).
Sociodemographics. Caregivers’ burden has been shown to be associated with
their sociodemographic characteristics. The relationship to patients with stroke was a
predictor of caregiver burden: spousal caregivers at 1 month poststroke report higher
levels of burden than nonspousal caregivers (Van Puymbroeck & Rittman, 2005). Gender
also appeared to be important: the majority of caregivers are women, and female
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caregivers experience greater caregiver burden than do male caregivers (Bugge et al.,
1999). Caregivers of stroke survivors spend significant time assisting patients with daily
activities (Tooth et al., 2005): approximately 4.6 hours per day at 6 months poststroke
and approximately 3.6 hours per day at 12 months poststroke (Tooth et al., 2005). The
time spent helping stroke survivors was associated with caregiver strain at 1, 3 and 6
months poststroke (Bugge et al., 1999). Age was also one of the predictors of caregiver
burden at 6 (van Exel et al., 2005), 7 or 9 months after stroke (Schulz et al., 1988). In
contrast, in at least one study, the caregiver-burden score decreased as the age of
participants increased (Periard & Ames, 1993). Predictors of caregiver quality of life at 3
months and 1 year poststroke have also been shown to include age and gender
(McCullagh et al., 2005). Women caregivers had lower psychological well-being, which
in turn, was related to lower quality of life (Larson et al., 2008).
Stroke-survivor characteristics.
Severity of stroke. Severity of stroke or resulting level of impairment also affects
caregiver outcomes. In a study of 212 caregivers for stroke survivors, severity of stroke
was found to be related to caregiver strain (van den Heuvel et al., 2001). Moderate
impairment from stroke, together with a number of other factors, explained 56% of the
variance in caregiver HRQOL (Berg et al., 2005; White et al., 2003). Berg et al. (2005)
found that caregiver depression was predicted by severity of stroke in stroke survivors,
whereas no such relationship was found in another study (Davis et al., 2009). Additional
work to explore the association between severity of stroke and caregiver outcomes,
including depressive symptoms, is required; these associations are clarified in the present
study.
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Functional status. In this study, functional status is defined as a stroke survivor’s
motor and cognitive ability to perform activities of daily living. Stroke occurs when
blood flow in the brain is interrupted by obstruction or hemorrhage of blood vessels
(Nestler, Hyman, & Malenka, 2009). The specific lesions caused by stroke may predict
the resulting types of neurological impairments. Broadly, physical performance,
including motor or sensory performance, is affected by impairment of the sensorimotor
cortex (Kunesch, Binkofski, Steinmetz, & Freund, 1995). Both location and size of
damage as a result of stroke are related to resultant motor function (Chen, Tang, Chen,
Chung, & Wong, 2000). Because of these neurological impairments and related impaired
functional status, stroke survivors often require assistance from caregivers to perform
activities of daily living (Forsberg-Warleby et al., 2002; Visser-Meily et al., 2009). Some
investigators have reported that stroke survivors’ functional status predicts caregiver
stress (Ostwald et al., 2009), burden (Ilse et al., 2008) and time spent providing care
(Tooth et al., 2005), whereas others reported no such association with caregiver burden
(Morimoto et al., 2003), emotional illness (Anderson et al., 1995) or quality of life (White
et al., 2003).
The prevalence of cognitive impairment after stroke ranges from 30% to 40% (del
Ser et al., 2005; Nestler et al., 2009; Patel, Coshall, Rudd, & Wolfe, 2002; Tatemichi et
al., 1994). When patients’ stroke is located in the cerebellar region, more than 80% of
survivors have cognitive deficits (Kalashnikova, Zueva, Pugacheva, Korsakova, & Zueva,
2005). Stroke in the prefrontal cortex mainly affects cognitive function, emotion, decision
making or behavior, but is not involved in motor, sensory or language function (Nestler et
al., 2009). Poststroke cognitive impairment was associated with low functional status in
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stroke survivors (Patel et al., 2002; Tatemichi et al., 1994) and, for their caregivers, with
low quality of life (White et al., 2003) and higher burden (Thommessen et al., 2001).
Communication. Of stroke survivors, 21 to 38% experience aphasia (loss of
communicative ability), including impaired language understanding or expression
(Berthier, 2005). Aphasia was associated with caregiver burden (Vincent et al., 2009) and
decreased quality of life (White et al., 2003). Caregivers for stroke survivors with aphasia
rated communication as the most upsetting factor to them (Bakas, Kroenke, et al., 2006).
They also reported having more difficulty with caregiving tasks than did caregivers for
stroke survivors without aphasia (Bakas, Kroenke, et al., 2006). Although communication
is essential to overall functional status, it is not necessarily included as a specific item in
functional-status assessment. Thus, I addressed communication separately in this study.
Comorbidity. Comorbidity is defined as the presence of coexisting diseases with
reference to an initial diagnosis or with reference to the index condition that is the subject
of study (Webster’s Online Dictionary, 2011). Stroke survivors themselves often have
comorbid diseases, as the major risk factors of stroke include hypertension, dyslipidemia,
cigarette smoking, diabetes mellitus, carotid stenosis, arterial fibrillation and valvular
heart disease (Hankey, 2006). Additionally, 95% of ischemic stroke survivors have
medical complications (Johnston et al., 1998). Although few studies have reported any
association between stroke-survivor comorbidity and caregiver outcomes, one recent
investigation found that stroke survivors’ chronic medical conditions (as measured by the
Charlson Index, a tool that does not include depression screening measures) were not
significant factors influencing caregiver depression; however, stroke-survivor depression
was highly associated with caregiver depression (Davis et al., 2009).
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Sociodemographics. Caregivers experience more strain when stroke survivors are
older (Berg et al., 2005). The present study focused exclusively on caregivers of stroke
survivors aged 65 or older in an effort to reveal the impact of age (e.g., the oldest old,
such as those 85 years of age or older) on caregiver outcomes. Other stroke-survivor
sociodemographics have not been found to be significant factors affecting caregiver
outcomes. This study further clarifies the relationship between stroke-survivor
sociodemographics and caregiver outcomes.
Summary of Known Factors Affecting Caregiver Outcomes
Table 1 summarizes known factors affecting caregiver stress, burden, HRQOL
and depression or depressive symptoms in caregivers of stroke survivors. (To my
knowledge, with the exception of one study by Saban et al. (2012), direct measurement of
physiological stress in caregivers of stroke survivors has not been studied.) What is not
well known, however, is whether these same characteristics affect caregiver stress in the
early poststroke period, nor is the role of uncertainty in caregiver perceived or
physiological stress and these same psychological outcomes known.
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Table 1
Summary of Known Factors Influencing Caregiver Stress and Psychological Outcomes
(Burden, Health-Related Quality of Life and Depressive Symptoms) in Caregivers of
Stroke Survivors
Outcomes

Factors influencing Outcomes

Stress
Perceived

Caregiver gender, age, caregiver health, time since providing care
for stroke survivors, coping strategy/capacity, social support,
preparedness for caregiving and number of close friends and
relatives; stroke-survivor function (Ostwald et al., 2009)

Physiological

Caregiver younger age (Saban et al., 2012)

Psychological Outcomes
Burden

Caregiver relationship to the stroke survivor (Van Puymbroeck &
Rittman, 2005), age (Periard & Ames, 1993; Schulz et al., 1988;
van Exel et al., 2005), gender, time spent helping the stroke
survivor, health status (Bugge et al., 1999) and coping capacity
(Cameron & Gignac, 2008; Forsberg-Warleby et al., 2001; Van
Puymbroeck & Rittman, 2005; Visser-Meily et al., 2009); strokesurvivor functional status (Ilse et al., 2008), cognitive impairment
(Thommessen et al., 2001) and communication loss/aphasia
(Vincent et al., 2009)

Health-Related Quality of Life

Caregiver age, gender (McCullagh et al., 2005), health status
(Morimoto et al., 2003) and coping capacity (Visser-Meily et al.,
2009)

Depression/Depressive
Symptoms

Caregiver social support (Grant et al., 2006), race, gender, hours
spent providing care per day (Van Puymbroeck et al., 2008) and
younger age (Saban et al., 2012); severity of stroke and older age of
stroke survivors (Berg et al., 2005)
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Gaps in the Literature and Current Study Solutions
Although the literature on the long-term effects of caregiving is well developed,
little is known about the immediate, early period after an acute event that precipitates
assumption of the caregiver role by a family member or friend. Thus, this study
incorporated prospective and longitudinal aspects to explore whether the level of
uncertainty about stroke survivor’s health outcomes as well as uncertainty about
assuming a new role predict caregiver perceived stress, physiological stress and
psychological outcomes (burden, HRQOL and depressive symptoms) in the early
poststroke period.
The literature review confirmed that the effect of uncertainty on perceived stress
has not been clearly differentiated. Researchers have studied mothers’ uncertainty about
infant HIV serostatus (Shannon & Lee, 2008) and uncertainty in young-adult childhoodcancer survivors (Y. L. Lee, 2006; Santacroce & Lee, 2006), and revealed the correlation
between uncertainty and stress. These investigators failed, however, to control for other
factors that may influence perceived stress. Further, to my knowledge, the relationship
between uncertainty and perceived stress in caregivers of stroke survivors has not been
documented. Thus, a study of caregivers’ responses in the early poststroke period is
critical to understanding the role of uncertainty and stress as potential factors affecting
caregiver outcomes.
No studies regarding the influence of uncertainty on caregivers’ physiological
stress have been found in the current literature. In studies of caregivers of stroke
survivors, the concept of stress has more often been integrated with the operational
definitions of caregiver burden or HRQOL, rather than treated as a separate concept, or
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measured solely as perceived stress. Only one study was found that included direct
measurement of physiological stress in caregivers of stroke survivors. The present study
contributes to filling important gaps in the current literature.
This study is innovative not only in measuring immediate physiological stress, but
also by assessing the association of uncertainty with psychological outcomes (burden,
HRQOL and depressive symptoms) 1 month after the first interview (around 6 weeks
poststroke). There is limited information that addresses the relationship between
uncertainty and caregiver psychological outcomes. Examining the mediating effect of
caregiver stress (perceived and physiological [salivary cortisol]) on the relationship
between uncertainty and psychological outcomes (burden, HRQOL and depressive
symptoms) at each of these two time points is essential to begin to fill in these gaps.
The robust biological and behavioral data collected are critical to prevention of
untoward sequelae, resulting in better long-term health outcomes for caregivers. The
findings may inform the development of a biobehavioral theoretical model that can serve
as a foundation for future intervention studies. These intervention studies may result in
supporting care-related decisions, preventing disease and promoting long-term health in
caregivers.
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CHAPTER 3: RESEARCH DESIGN AND METHODS
Research Design and Study Overview
A prospective, longitudinal observational study was conducted using a
convenience sample of caregivers and their stroke-survivor relatives recruited from acutecare settings in two Philadelphia academic health-science centers. Caregivers were
enrolled and entered in the study within the first 2 weeks following their relatives’ stroke
(T1) and revisited 4 weeks later (T2; ~ 6 weeks post stroke). This design enabled me to
gain comprehensive information about the influence of uncertainty at two separate time
periods during the early poststroke period. The study involved quantitative measures of
caregiver and stroke-survivor characteristics and outcomes to allow the testing of
hypotheses about relationships among the variables of interest (Burns & Grove, 1997).
Participant enrollment and data collection for the entire study were completed over an 8month period; each participant was actively involved for approximately 4 weeks. Overall
data analysis of study aims was conducted at the University of Pennsylvania School of
Nursing. Salivary-cortisol assays were analyzed at the University of Pennsylvania
Pearlman School of Medicine Clinical and Translational Research Center. The specific
aims for the study were:
Aim 1: Determine at each time point if uncertainty (regarding stroke survivors’
health outcomes and new caregiver role) predicts levels of caregivers’ perceived stress.
Aim 2: Determine at each time point if uncertainty predicts levels of caregivers’
physiological stress (salivary cortisol).
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Aim 3: Examine at each time point the relationship of uncertainty to
psychological outcomes (burden, health-related quality of life [HRQOL] and depressive
symptoms).
Aim 4: Explore at each time point the mediator effect of stress (perceived stress
and physiological stress) on the relationship between uncertainty and psychological
outcomes (burden, HRQOL and depressive symptoms).
Sample and Settings
The convenience sample of caregivers, the primary participants for this study, and
their stroke survivors were recruited from the large neurology and neurosurgery services
at the Hospital of the University of Pennsylvania and the Thomas Jefferson University
Hospital/Jefferson Hospital for Neurosciences in Philadelphia, PA. Caregivers’ relatives
with stroke were also enrolled in order to collect relevant medical information from their
medical records.
To be included in the study, caregivers had to (a) self-identify as a family member,
(b) self-identify as the expected primary caregiver for an older adult (age 65 or older)
who was diagnosed within the past 2 weeks with new or recurrent ischemic or
hemorrhagic stroke, (c) communicate in English, (d) demonstrate capacity for informed
consent (see the consent capacity guide in Appendix N) and (e) be 21 years old or older.
Given the higher incidence of stroke in older adults, this study enrolled only
caregivers whose relatives were age 65 or older. In addition, all stroke survivors (a) had a
family caregiver participating in the study, (b) had been diagnosed with new or recurrent
stroke, (c) were within the first 2 weeks of stroke onset and (d) agreed (either self or
surrogate) to a medical-chart review.
32

Power Analysis
Because this study spans only 1 month per participant, I did not expect significant
attrition. Originally, I proposed to enroll a total of 115 subjects to account for an attrition
rate of 15% for a sample size of 100. In 2009, the Hospital of the University of
Pennsylvania admitted approximately 1,000 adults over age 65 with stroke (ICD9 code
range 430–438); thus, I expected little difficulty in enrolling 115 subjects. Power
estimation was based on a sample size of 100 with the assumed ability to accrue 115
caregivers and satisfy Aim 1, regressing caregiver perceived stress on uncertainty using
multiple regression. Ostwald et al. (2009) published that predictors for caregiver
perceived stress (perceived stress scale) were caregiver gender, caregiver age, caregiver
health, time since providing care for stroke survivors, stroke-survivor function, coping
strategy, social support, preparedness for caregiving and number of close friends and
relatives. I ran a power analysis based on findings from a published study of uncertainty
and distress in family caregivers for persons with Parkinson’s disease (Sanders-Dewey et
al., 2001) and a series of values corresponding to variance in perceived stress in strokesurvivor caregivers, explained by nine covariates (caregiver gender, caregiver age,
caregiver health, time since providing care for stroke survivors, stroke-survivor function,
coping strategy, social support, preparedness for caregiving and number of close friends
and relatives). Using an F-test with 0.05 significance level, a sample size of 100 would
achieve 98% power to detect an R-squared of 0.11 attributed to one independent variable,
namely uncertainty, accounting for 20% of variance explained by the nine control
variables in caregiver perceived stress.
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I enrolled a total of 63 participants at T1, however, and 40 of these remained and
completed the study at T2. Thus, I recalculated power, based on sample size 40 and
revealed R-Squared of uncertainty as well as covariates for Aim 1 at T2, regressing
caregiver perceived stress on uncertainty using multiple regression. Using an F-test with
a significance level of 0.05, the achieved sample of 40 participants had 99.6% power to
detect an R-squared of 0.26 attributed to one independent variable, namely uncertainty.
The variables tested were adjusted for an additional two independent variables associated
with perceived stress at T2 (social support and stroke-survivor income), with an Rsquared of 0.28.
Study Variables and Instruments
A paper and pencil survey was constructed that included instruments and items
(see Appendices A–M) to measure each of the study variables. These are summarized in
Tables 2 and 3. Additionally, participants self-collected and submitted samples of
caregiver saliva at each time point. A chart abstraction form was used to obtain medicalrecord information about each stroke patient. The study variables and their measures are
described here.
Uncertainty. The 31-item Perception of Uncertainty in Illness Scale for Family
Members (Mishel, 1997b; see Appendix B) was used to measure caregivers’ degree of
uncertainty (inability to determine the meaning of illness-related events) regarding stroke
survivors’ health outcomes and the new caregiver role. Each of 31 items was scored on a
scale of 1 (strongly disagree) to 5 (strongly agree). Total sum scores range from 31 to
155; high scores indicate greater uncertainty. In the present study, total sum score
measured on a continuum was used for statistical analysis. Construct validity of the
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Parent Perception of Uncertainty Scale (the original scale used to measure parents’
perceptions of uncertainty by using the word child instead of him/her) is supported by
correlation between factors and total scale (r = 0.50–0.89) as well as correlation between
total score and the judged seriousness of their child’s illness (r = 0.16, p < 0.004; Mishel,
1983). Internal consistency for the total scale is from 0.81 to 0.92 (Cronbach’s alpha) for
family caregivers (Mishel, 1997b). In the present study, Cronbach’s alpha for the 31
items was 0.92 at T1 and 0.95 at T2.
Stress.
Perceived stress. The Perceived Stress Scale (PSS) includes 14 items designed to
assess symptoms of stress and global measures of the degree of stress experienced in the
last month including today (see Appendix C). In the present study, the time parameter
was modified to ask about stress experienced in the past day (24 hours). This
modification was made because the period of “the last month” would actually precede the
occurrence of the serious health event in the family member: stroke; the value of interest
is the stress that participants have experienced since the event. The same language was
used for the T2 interview (4 weeks later), as the more recent experience of stress was
viewed as most relevant to the study outcomes and also most comparable to the T1
measure. Items are related to how unpredictable, uncontrollable and overloaded
respondents find their lives. Each item is scored from 0 (never) to 4 (very often) with total
sum scores ranging from 0 to 56; higher scores indicate higher perceived stress. Total
sum score measured on a continuum was used for statistical analysis in this study. One
advantage of this instrument is that it has a normative value per age group (B. Cohen &
Williamson, 1988) and the scale has been validated and correlated with depressive
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(r = 0.65 – 0.76, p < 0.001) and physical symptomatology (r = 0.52 – 0.65, p < 0.001)
and social anxiety (r = 0.37 – 0.46, p < 0.001) in college students (S. Cohen, Kamarck, &
Mermelstein, 1983). Cronbach’s alpha of the PSS ranges from 0.84 to 0.86 (S. Cohen et
al., 1983), and 0.91 in older African American and European American females
(McCallum, Sorocco, & Fritsch, 2006), which represents the majority of participants in
this study. Cronbach’s alpha for the PSS in the present study was 0.86 at T1 and 0.88 at
T2, indicating good internal consistency at each time point.
Physiological stress. Salivary-cortisol level is a reliable way to assess the
variation in endocrine activity and response to acute stress (Feve-Montange et al., 1981).
Salivary cortisol is highly correlated with serum cortisol: correlation coefficients range
from 0.71 in patients with alpha-cholinergic medication to 0.96 in healthy older adults
(Kirschbaum & Hellhammer, 1994). Sample collection was noninvasive, which can
reduce the stress-inducing effects on cortisol levels by venipuncture (Stone et al., 2001)
or burdensome 24-hour urine-specimen collection.
Cortisol levels follow a circadian rhythm (Preville et al., 2008); levels normally
reach their peak in the early morning, and the concentration is lower at night (Chernow et
al., 1987). Woods et al. (2008) reported that cortisol levels measured in the morning
(09:00) and afternoon (16:00) in some samples did not coincide with a normal circadian
rhythm pattern, whereas peak levels on waking and lower levels in the evening were
generally consistent across samples. Cortisol dysregulation is more likely to be detected
in the evening (Woods et al., 2008). Thus, it is also important to observe for higher
cortisol levels in the evening by comparing the findings with normal levels in the evening.
To capture diurnal variations in cortisol concentration in this study, caregivers collected
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saliva using Salimetrics oral swabs on waking and again at 2100 h (see Appendix D;
McCallum et al., 2006).
The Salimetrics salivary-cortisol kit is immunoassay designed and validated for
detecting salivary-cortisol levels from .003 to 3.0 µg/dL using 25 µL of saliva per sample
(Woods et al., 2008). The Salimetrics Kits’ sensitivity is < 0.003 μg/dL (Salimetrics,
2011). Salivary cortisol using a Salimetrics enzyme immunoassay kit is highly correlated
with serum (r = 0.91, p < 0.0001; Salimetrics, 2011). An inter-assay coefficient of
variation is 6.41% across 12 runs and an intra-assay coefficient of variation is 3.65%
(Woods et al., 2008). In the present study, an inter-assay coefficient of variation was
6.56% and intra-assay coefficient of variation was 4.61%. The minimum detectable limit
was 0.010 μg/dL.
Psychological outcomes.
Burden. The Zarit Burden Interview scale includes 22 items related to “problems
including caregivers’ health, psychological well-being, finances, social life and the
relationship between the caregiver and the impaired person” (Zarit, Reever, & BachPeterson, 1980, p. 651; see Appendix E). The original Zarit Burden Interview had 25
items (Zarit et al., 1980), but the revised version with 22 questions is more widely used
(Whitlatch, Zarit, & von Eye, 1991). Each item is scored from 0 (never) to 4 (nearly
always). Total scores range from 0 to 88 (severe burden 61–88; moderate to severe
burden 41–60; mild to moderate burden 21–40 and little or no burden 0–21; Zarit & Zarit,
1987). The sum score for two subscales—personal strain (six items) and role strain (12
items)—together with four items not included in any factor are commonly used as an
overall measure of burden (Whitlatch et al., 1991). Thus, the total score measured on a
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continuum was used for statistical analysis. Construct validity for the Zarit Burden
Interview score is high (Seng et al., 2010); the Zarit Burden Interview score is highly
correlated with the Burden Assessment Scale score (r = 0.73, p < 0.0001), General Health
Questionnaire score (r = 0.62, p < 0.0001), Dementia Management-Strategies Scale score
(r = 0.53, p < 0.0001) and Revised Memory and Behavior Problems Checklist score
(r = 0.53, p < 0.0001). Cronbach’s alpha ranges from 0.87 to 0.93 for caregivers of stroke
survivors (Visser-Meily, Post, Riphagen, & Lindeman, 2004) and 0.89 for older
caregivers of stroke survivors (Hartke & King, 2002). The test–retest reliability (Kappa)
carries a value of 0.71 (Vitaliano, Young, & Russo, 1991). In the present study,
Cronbach’s alpha ranged from 0.92 at T1 to 0.94 at T2.
Health-related quality of life. The EQ5D of the EuroQol is a generic HRQOL
measure that consists of five descriptive items (see Appendix F). Each question of the
EQ5D investigates one of five concepts: mobility, self-care, usual activities,
pain/discomfort and anxiety/depression, with scoring from 1 (no problems or symptoms)
to 3 (serious problems or symptoms). Total score measured on a continuum was used for
statistical analysis. The EuroQol has been demonstrated to be a valid and reliable
measure of HRQOL in various populations (Dorman, Slattery, Farrell, Dennis, &
Sandercock, 1998; Fransen & Edmonds, 1999; Hurst, Kind, Ruta, Hunter, & Stubbings,
1997; Schweikert, Hahmann, & Leidl, 2006). The validity correlation coefficients with
the 36-item short-form health-survey subscales and EQ5D index score range from 0.57 to
0.74 in patients with acute coronary syndromes (Schweikert et al., 2006). The intraclass
correlation coefficient is 0.70 (Fransen & Edmonds, 1999). Cronbach’s alpha in an
evaluation of HRQOL in patients with cancer was 0.68 (Pickard, Neary, & Cella, 2007).
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In the present study, Cronbach’s alpha was 0.48 at T1 and 0.59 at T2, which was
minimally acceptable.
Depressive symptoms. The Patient Health Questionnaire (PHQ-9) is a 9-item
scale used as a diagnostic screening measure for major and minor depression (see
Appendix G). The items in the PHQ-9 correspond with the full range of symptoms listed
in the Diagnostic and Statistical Manual of Mental Disorders major depressive-disorder
category (Kroenke & Spitzer, 2002). This scale assesses the frequency of symptoms such
as disinterest, low mood, sleep disruption or tiredness over the last 2 weeks, and each
item is scored from 0 (Not at all) to 3 (Nearly every day). Total score ranges between 0
and 24 and severity of depression can be described as none (score 1 to 4), mild (5 to 9),
moderate (10 to 14), moderately severe (15 to 19) and severe (20 to 27; Kroenke &
Spitzer, 2002). Total sum score measured on a continuum was used for statistical analysis.
This scale has demonstrated excellent internal consistency reliability (α = 0.86 to 0.89),
test–retest reliability (r = 0.84) and construct validity (correlation coefficients range from
0.33 to 0.73 between depression severity scores and worsening function with the subscale
of the 20-item Short-Form General Health Survey; Kroenke, Spitzer, & Williams, 2001).
Internal consistency reliability for caregivers of stroke survivors ranges from 0.80 to 0.86
(Bakas, Champion, Perkins, Farran, & Williams, 2006; Bakas, Kroenke, et al., 2006). In
the present study, reliability was demonstrated by Cronbach’s alpha of 0.84 at T1 and
0.86 at T2.
Caregiver characteristics: Covariates.
Comorbidity. A modified version of the Cumulative Illness Rating Scale (CIRS;
Miller et al., 1992) was used to measure comorbidity, that is, the presence of coexisting
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diseases in caregivers (see Appendix H). The CIRS total scores (Miller et al., 1992) range
from 0 (no impairment) to 56 (maximal impairment) across 14 systems. Scoring of each
system followed the guidelines proposed by Hudon, Fortin, and Vanasse (2005). The
total sum score measured on a continuum was used for statistical analysis. The CIRS is
valid and reliable in measuring multimorbidity, a condition with more than one chronic
disease, in a family practice (Hudon et al., 2005). There is correlation (r = 0.58, p < 0.02)
between the CIRS scores and the Older American Activities of Daily Living Scale scores
(Miller et al., 1992). The intraclass correlation coefficients to evaluate multimorbidity by
interviewing patients in a family practice ranges from 0.70 to 0.89 (Hudon et al., 2005).
In the present study, Cronbach’s alpha was not calculated because items (i.e., heart vs.
lower gastrointestinal) are not necessarily closely related to others in the group.
Health status. A single index on the EuroQol, a visual-analog scale (VAS), was
used to measure health status (see Appendix F). The VAS evaluates current perceived
health status on a scale of 0 to 100, with 100 indicating the best imaginable health status.
In the present study, the self-rated score measured on a continuum was used for statistical
analysis. The validity correlation coefficients with the 36-item Short form Health Survey
subscales and the VAS score range from 0.21 to 0.72 in patients with acute coronary
syndromes (Schweikert et al., 2006). See the previous HRQOL section for validity and
reliability of the overall EuroQol.
Coping capacity. A 13-item short-form version of the Sense of Coherence (SOC)
tool (Antonovsky, 1987) was used to measure how well caregivers coped with stress
associated with caregiving (see Appendix I). The SOC refers to “one’s ability to respond
to stressors by the appropriate use of adaptive coping resources” (Chumbler et al., 2004,
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p. 944). Each item is scored from 1 (never) to 7 (very often), with total scores ranging
from 13 to 91 where higher scores indicate greater coping. Total score measured on a
continuum was used for statistical analysis. Construct-validity correlations between the
SOC scale and the Self-Esteem Scale, the Mastery Scale (used to measure perception of
control) and the Life Orientation Test (used to measure dispositional optimism) are 0.61,
0.54 and 0.53, respectively (Pallant & Lae, 2002). Internal consistency is 0.86
(Cronbach’s alpha) for caregivers of stroke survivors (Chumbler et al., 2004). In the
present study, Cronbach’s alpha was 0.81 at T1 and 0.83 at T2.
Social support. Social support was measured using the Multidimensional Scale of
Perceived Social Support (MSPSS; Zimet, Dahlem, Zimet, & Farley, 1988; see Appendix
J). The MSPSS is a 12-item scale that assesses perceptions about support from family,
friends and a significant other. Responses range from 1 (very strongly disagree) to
7 (very strongly agree) and higher scores indicate better levels of perceived social
support. Total score measured on a continuum was used for statistical analysis. This scale
shows excellent internal consistency (α = 0.92), good test–retest reliability (r = 0.85) and
moderate construct validity (r = –0.13 – –0.25 with anxiety and depression subscales of
the Hopkins Symptom Checklist; Zimet et al., 1988). Internal consistency for caregivers
of persons with traumatic brain injury is excellent (α = 0.95; Davis et al., 2009). In the
present study, Cronbach’s alpha reliability scores were 0.94 at both T1 and T2.
Sociodemographics. Sociodemographics were assessed using a standard set of
investigator-developed items (see Appendix A). The items included age, gender,
race/ethnicity, native language, relationship to the stroke survivor (e.g., spouse or child),
perceived quality of relationship with the stroke survivor (on a scale of 1 = excellent to
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4 = poor), duration of caregiving role for the stroke survivor (prior to as well as since
stroke), hours spent caring each day (prior to and since stroke), length of time since the
stroke survivor was diagnosed with stroke, perceived level of preparedness for caregiving
(on a scale of 1 = well prepared to 4 = not at all prepared), insurance type including
Medicare/Medicaid, number of close friends and relatives, distance between site of care
(e.g., hospital) and caregiver’s home, education, employment status, income and other
life events (e.g., death, moving, retirement or marriage) in the past 3 months (at T1). At
T2, selected items including perceived quality of relationship with the stroke survivor,
duration of caregiving role for the stroke survivor since stroke, hours spent caring each
day since stroke, length of time since the stroke survivor was diagnosed with stroke,
perceived level of preparedness for caregiving, distance between site of care and home
and other life events since the first interview were assessed.
Stroke-survivor characteristics: Covariates.
Severity and description of stroke. Severity of stroke was operationalized by the
National Institute of Health (NIH) Stroke Scale, a standard neurological examination tool
that measures consciousness, language, neglect, visual-field loss, extraocular movements,
motor strength, ataxia, dysarthria and sensory loss (see Appendix L). This scale has 13
items and total scores range from 0 (not impaired) to 42 (fully impaired). Total score
measured on a continuum was used for statistical analysis. This tool has been shown to be
reliable overall (Cronbach’s alpha > 0.5) and highly validated (Brott et al., 1989;
Goldstein, Bertels, & Davis, 1989; Lyden et al., 1994). The validity correlations between
NIH Stroke Scale scores and stroke-lesion size and patient outcome are 0.68 and 0.79,
respectively (Brott et al., 1989). The stroke survivor’s medical chart was reviewed to
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assess severity of stroke; the intraclass correlation coefficient was 0.82 in assessing
neurological impairment by medical-chart review (Kasner et al., 1999). In the present
study, Cronbach’s alpha was 0.88. In addition, a chart-abstraction form was used to
describe the type of stroke, area of the stroke, communication disability (yes/no) and time
poststroke in days.
Functional status. Caregiver perception of the survivor’s ability to perform
activities of daily living was measured using the Barthel Index (Mahoney & Barthel,
1965; see Appendix M). The Barthel Index has 10 items that assess activities of daily
living: self-care, continence of bowel and bladder and mobility. Each is scored from 0 to
15. Total scores range from 0 to 100 where higher scores indicate independence from any
help. Total sum score measured on a continuum was used for statistical analysis. The
Barthel Index has well-established validity and reliability in measuring the functional
status of stroke patients (Wade & Hewer, 1987; White et al., 2003). The validity
correlations between the Barthel Index and the Motricity Index arm, leg, and total scores
range from 0.73 to 0.77 on stroke patients (Wade & Hewer, 1987). Cronbach’s alpha with
patients with stroke is 0.93 (White et al., 2003). Internal consistency in patients with
stroke ranges from 0.87 to 0.92 (Shah, Vanclay, & Cooper, 1989). The intraclass
correlation for caregiver proxy measure is excellent: 0.71 (Saban et al., 2012). In the
present study, Cronbach’s alpha was 0.94 at both T1 and T2.
Comorbidity. The modified version of the CIRS (Miller et al., 1992, see
Comorbidity section in Caregiver Characteristics: Covariates) was used to evaluate the
stroke survivor’s comorbidity (the presence of coexisting or additional diseases) with
reference to an initial diagnosis or with reference to the index condition, that is, stroke,
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which is the subject of study (see Appendix H). Data were obtained by medical chart
review. The scores of the CIRS (Miller et al., 1992), relative to its 14 systems, range from
0 (no impairment) to 56 (maximal impairment). This scale has been shown to be valid
and reliable in evaluating comorbidity among geriatric populations (Hudon et al., 2005)
and in institutionalized older adults (Parmelee, Thuras, Katz, & Lawton, 1995). There is a
correlation (r = 0.58, p < 0.02) between the CIRS scores and the Older American
Activities of Daily Living Scale scores (Miller et al., 1992). The intraclass correlation
coefficients range from 0.66 to 0.87 and interrater reliability ranges from 0.80 to 0.89 in
assessing comorbidity by medical-chart review in a family practice (Hudon et al., 2005).
Total score measured on a continuum was used for statistical analysis. In the present
study, Cronbach’s alpha for the CIRS was not calculated because items (i.e., heart vs.
lower gastrointestinal) are not necessarily closely related to others in the group.
Sociodemographics. Sociodemographic data were collected in the caregiver
interview using a standard investigator-developed form (see Appendix K). At T1,
caregivers provided stroke-survivor data: age, gender, race/ethnicity, education,
employment status, income, insurance including Medicare/Medicaid and time in days
since admission to the hospital. At T2, I obtained location (e.g., rehabilitation hospital,
nursing facility or home) to which a stroke survivor was initially transferred after hospital
discharge, site of current placement and time since admission to any facility or discharge
to home. In addition, I assessed duration of rehabilitation including inpatient or outpatient,
if relevant.
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Table 2
Summary of Main Variables and Measures

Research
variable
Uncertainty

Theoretical definition
Inability to determine the
meaning of illness-related
events (i.e., stroke survivors’
health outcomes and the new
caregiver role)

Instrument/
items (source)
Perception of
Uncertainty in
Illness Scale/
31 items
(Mishel, 1997b)

Total score
range/
data type
Total Score
(31 to 155)/
Continuous

Validity/reliability
Correlation coefficient: 0.50–0.89 between
factors and total scale/ 0.16 between total score
and the judged seriousness of their child’s
illness in the Parent Perception of Uncertainty
Scale (Mishel, 1983)

Source for
data
collection
Caregiver
Interview
T1, T2
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Cronbach’s alpha: 0.81–0.92 for family
caregivers (Mishel, 1997b);
Cronbach’s alpha in the present study: 0.92 to
0.95
Perceived
Stress

Domestic upset, negative
feelings toward the patient
and personal distress in
relation to the patient

Perceived Stress
Scale/
14 items
(S. Cohen et al.,
1983)

Total Score
(0 to 56)/
Continuous

Correlation coefficient: 0.65–0.76 with
depressive and 0.52–0.65 with physical
symptomatology and 0.37–0.46 with social
anxiety in college students (S. Cohen et al.,
1983)

Caregiver
Interview
T1, T2

Cronbach’s alpha: 0.84–0.86 (S. Cohen et al.,
1983) and 0.91 in older African American and
European American females (McCallum et al.,
2006); Cronbach’s alpha in the present study:
0.86–0.88
Table continues

Research
variable
Physiological
Stress

Theoretical definition
Variation in endocrine
activity and response to
stressor

Instrument/
items (source)
Salivary Cortisol
level; collection
at awaking to
capture peak
levels and at
2100h to capture
lower levels using
Salimetrics oral
swabs
(McCallum et al.,
2006)

Total score
range/
data type
Cortisol in
units: μg/dL/
Continuous

Validity/reliability
Salivary cortisol reflects the variation in
endocrine activity and response to acute stress
(Feve-Montange et al., 1981) and is a reliable
and valid reflection of cortisol in blood (Woods
et al., 2008).

Source for
data
collection
Caregiver
Self
Collection
T1, T2

Collecting salivary cortisol at awaking and in
the evening can capture the circadian rhythm
(Woods et al., 2008).
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Correlation between salivary cortisol using a
Salimetrics Kit and serum cortisol: 0.91
(Salimetrics, 2011)
Salimetrics Kits’ Sensitivity: < 0.003 μg/dL;
Inter-assay coefficient of variation (CV)
across 12 runs: 6.41% (Woods et al., 2008)
Intra-assay CV: 3.65% (Woods et al., 2008)
Inter-assay CV in the present study: 6.56%
Intra-assay CV in the present study: 4.61%
Minimum detectable limit in the present study :
0.010 μg/dL
Table continues

Research
variable
Burden

Theoretical definition
Caregivers’ feelings of being
overwhelmed and strained in
assisting their care recipients

Instrument/
items (source)
Zarit Burden
Interview/
22 items
(Zarit & Zarit,
1987)

Total score
range/
data type
Total Score
(0 to 88)/
Continuous

Validity/reliability
Correlation coefficient: 0.73 with the Burden
Assessment Scale score, 0.62 with the General
Health Questionnaire score, 0.53 with the
Dementia Management Strategies Scale score
and 0.53 with the Revised Memory and
Behavior Problems Checklist score (Seng et
al., 2010)

Source for
data
collection
Caregiver
Interview
T1, T2
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Cronbach’s alpha: 0.87–0.93 for caregivers of
stroke survivors (Visser-Meily et al., 2004);
0.89 for older caregivers of stroke survivors
(Hartke & King, 2002); Test–retest reliability
(Kappa): 0.71 (Vitaliano et al., 1991);
Cronbach’s alpha in the present study: 0.92–
0.94
HealthRelated
Quality of
Life

Personal well-being or
satisfaction focusing on
aspects of health or illness

EuroQol:
EQ5D/
5 items
(EuroQol Group)

Total Score
(5 to 15)/
Continuous

Valid and reliable to measure health-related
quality of life in various populations (Dorman
et al., 1998; Fransen & Edmonds, 1999; Hurst
et al., 1997; Schweikert et al., 2006)

Caregiver
Interview
T1, T2

Correlation coefficient: 0.57–0.74 with the 36item short-form health-survey subscales in
patients with acute coronary syndromes
(Schweikert et al., 2006)
Intraclass correlation coefficient: 0.70 (Fransen
& Edmonds, 1999);
Cronbach’s alpha in the present study: 0.48–
0.59
Table continues

Research
variable
Depressive
Symptoms

Theoretical definition
Symptoms listed in the
Diagnostic and Statistical
Manual of Mental Disorders
major depressive-disorder
category such as disinterest,
low mood, sleep disruption or
tiredness

Instrument/
items (source)
Patient Health
Questionnaire/
9 items
(Kroenke &
Spitzer, 2002)

Total score
range/
data type
Total score
(0 to 27)
Continuous

Validity/reliability
Correlation coefficient: 0.33–0.73 with
depression severity scores and worsening
function with the subscale of the 20-item
Short-Form General Health Survey (Kroenke et
al., 2001)
Excellent internal consistency reliability (α =
0.86–0.89), test-retest reliability (r =0.84) and
validity (Kroenke et al., 2001); Internal
consistency reliability for caregivers of stroke
survivors: 0.80–0.86 (Bakas, Champion, et al.,
2006; Bakas, Kroenke, et al., 2006);
Cronbach’s alpha in the present study: 0.84–
0.86

Source for
data
collection
Caregiver
Interview
T1, T2
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Table 3
Summary of Covariates and Measures
Caregiver covariates

Research variable
Comorbidity

Health status
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Coping capacity

Theoretical definition
Presence of coexisting diseases

Instrument/
items (source)

Total score
range/
data type

Cumulative Illness Rating Total Score
Scale/
(0–56)/
14 systems
Continuous
(Miller et al., 1992)

Source for
data
collection

Validity/reliability

Correlation coefficient: 0.58 with the
Caregiver
Older American Activities of Daily
Interview
Living Scale scores (Miller et al., 1992) T1, T2
Intraclass correlation: 0.70–0.89 (Hudon
et al., 2005)

Self-perceived level of overall wellness EuroQol:
in the individual
VAS/
1 item visual analogue
scale
(EuroQol Group)

Self-rated
Score
VAS
(0–100)/
Continuous

Correlation coefficient: 0.21–0.72 with Caregiver
the 36-item Short-Form Health-Survey Interview
subscales in patients with acute coronary T1, T2
syndromes (Schweikert et al., 2006).

One’s ability to respond to stressors by Sense of Coherence/
the appropriate use of adaptive
13 items
resources
(Chumbler et al., 2004)

Total score
(13–91)/
Continuous

Correlation coefficient: 0.61 with the
Self-Esteem Scale, 0.54 with the
Mastery Scale (used to measure
perception of control), 0.53 with the
Life Orientation Test (used to measure
dispositional optimism; Pallant & Lae,
2002)

Intraclass correlation coefficient: 0.70
(Fransen & Edmonds, 1999)
Caregiver
Interview
T1, T2

Internal consistency; alpha = 0.9
(Chumbler et al., 2004);
Cronbach’s alpha in the present study:
0.81–0.83
Table continues

Caregiver covariates

Research variable
Social
support

Theoretical definition
Perceptions about the availability of
relationships that provide help and
prevent negative outcomes from the
stressful event

Instrument/
items (source)
Multidimensional Scale
of Perceived Social
Support/
12 items
(Zimet et al., 1988)
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Sociodemographics At T1, age, duration of caregiving in
Investigator Developed
days (prior to and since stroke), hours Form
spent caring each day (prior to and
since stroke), days since stroke,
number of close friends and relatives,
distance between site of care and home
in miles, perceived quality of
relationship with the stroke survivor,
perceived level of preparedness for
caregiving, other life events in the past
3 months, gender, race/ethnicity, native
language, relationship to the stroke
survivor, health insurance, education,
employment status and income

Total score
range/
data type
Total score
(7–84)/
Continuous

Source for
data
collection

Validity/reliability
Correlation coefficient: –0.13 – –0.25
with the anxiety and depression
subscales of the Hopkins Symptom
Checklist (Zimet et al., 1988)

Caregiver
Interview
T1, T2

Excellent high internal consistency
(α = 0.92) and good test–retest
reliability (r = 0.85), correlated with the
full version (Zimet et al., 1988); Internal
consistency for caregivers of persons
with traumatic brain injury: α = 0.95
(Davis et al., 2009);
Cronbach’s alpha in the present study:
0.94–0.94
Continuous N/A
Ordinal
Dichotomous
or
Categorical

Caregiver
Interview
T1, T2

Table continues

Caregiver covariates

Research variable

Theoretical definition

Instrument/
items (source)

Total score
range/
data type

Validity/reliability

Source for
data
collection

Validity/reliability

Source for
data
collection

At T2, hours spent caring each day
since stroke, duration of caregiving
role for the stroke survivor since stroke
in days, days since stroke, distance
between site of care and home in miles,
perceived quality of relationship with
the stroke survivor, perceived level of
preparedness for caregiving and other
life events occurring since the 1st
interview
Stroke-survivor covariates
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Research variable
Severity of stroke

Theoretical definition
Measures of consciousness, language,
neglect, visual-field loss, extra-ocular
movements, motor strength, ataxia,
dysarthria and sensory loss

Instrument/
items (source)
National Institutes of
Health Stroke Scale/
13 items
(Know Stroke, 2010)

Total score
range/
data type
Total score
(0–42)/
Continuous

Correlation coefficient: 0.68 with
stroke-lesion size and 0.79 with patient
outcome (Brott et al., 1989)

Chart
Review
T1

The intraclass correlation coefficient:
0.82 by medical-chart review (Kasner et
al., 1999);
Cronbach’s alpha in the present study:
0.88
Description of
stroke

Measures of communication disability Investigator-developed
(yes/no),type of stroke, area of stroke form
and time poststroke

Dichotomous N/A
or
Categorical

Chart
Review
T1
Table continues

Stroke-survivor covariates

Research variable
Functional
status

Theoretical definition
Ability to perform activities of daily
living

Instrument/
items (source)
Barthel Index/
10 items
(Mahoney & Barthel,
1965)

Total score
range/
data type
Total score
(0 to 15)/
Continuous

Source for
data
collection

Validity/reliability
Correlation coefficient: 0.73–0.77 with
the Motricity Index arm, leg and total
scores range from on stroke patients
(Wade & Hewer, 1987).

Caregiver
Interview
T1, T2
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Cronbach’s alpha: 0.93 (White et al.,
2003);
Internal consistency: 0.87–0.92 (Shah et
al., 1989) in stroke patients);
Intraclass correlation for caregiver
proxy measure: 0.71 (Saban et al.,
2012);
Cronbach’s alpha in the present study:
0.94–0.94
Comorbidity

Presence of coexisting diseases

Cumulative illness
rating scale/
14 systems
(Miller et al., 1992)

Total Score
(0 to 56)/
Continuous

Correlation coefficient: 0.58 with the
Chart
Older American Activities of Daily
review
Living Scale scores (Miller et al., 1992) T1
Intraclass correlation coefficients; 0.66–
0.87;
Interrater reliability; 0.80–0.89 in
assessing comorbidity by medical-chart
review
Table continues

Stroke-survivor covariates

Research variable

Theoretical definition

Instrument/
items (source)

Sociodemographics At T1, age, days since admission to the Investigator-developed
hospital, gender, race/ethnicity,
form
education, employment status, income
and health insurance
At T2, duration of rehabilitation in
days, if relevant, location to which a
stroke survivor initially placed after
hospital discharge and/or now currently
placed and days since admission to any
facility or discharge to home

Total score
range/
data type
Continuous
or
Categorical

Validity/reliability
N/A

Source for
data
collection
Caregiver
interview
T1, T2
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Procedures
Participant recruitment, screening and informed consent. Approval for the
proposed study was obtained from the Institutional Review Boards (IRBs) at the
University of Pennsylvania and Thomas Jefferson University. A member of the research
team, either a research assistant or I (hereafter referred to as “research team member”),
trained in the study protocol, visited each unit during weekdays and/or on weekends to
identify, screen and enroll eligible participants. The research team member first inspected
a daily list from the electronic medical records to identify patients admitted with stroke.
Stroke survivors’ paper charts as well as electronic medical records were then reviewed
by the research team member to identify eligible potential participants. In addition,
nursing leaders on the units helped identify potential caregiver participants. As a
recruitment strategy at the Hospital of the University of Pennsylvania, we posted IRBapproved recruitment flyers in the units and added them to patient-education brochures
that are routinely distributed to patients and caregivers by nursing staff when patients are
admitted to the hospital (see Appendix X). At Thomas Jefferson University, IRBapproved recruitment flyers were distributed to potential participants by a research team
member.
Ideally, a research team member tried to make first contact with caregivers for
enrollment and T1 data collection while caregivers were visiting on the unit following
their introduction by the nursing staff (See Appendix V). Alternatively, the research team
member telephoned caregivers to explain the study and arrange a convenient meeting at
the hospital or at their homes (See Appendix W). The research team member then talked
with caregivers and determined their interest in study participation.
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If caregivers met all of the inclusion criteria and expressed an interest in
participating, a research team member obtained written informed consent. An effort was
made to recruit caregivers within the first week of their relatives’ stroke since it was
expected that this period would best capture caregivers’ acute stress in the natural
environment. For caregivers who initially expressed being too overwhelmed to
participate in an interview, the research team member sought their permission to
approach them again up to 2 weeks poststroke.
Informed consent. A research team member informed potential participants in
lay language that participation was voluntary and the purpose of the study, potential risks,
and what they would need to do if they chose to participate. The research team member
also encouraged potential participants to discuss participation with their family, friends
and/or healthcare providers. The research team member judged the decision-making
capacity of caregivers to consent, based on the person’s ability to “understand, appreciate,
compare and choose” (Ulrich & Karlawish, 2006, p. 57). The consent capacity guide used
is found in Appendix N.
After recruitment and obtaining informed consent from caregivers, the research
team member also obtained from stroke survivors or their surrogates informed consent
and Health Insurance Portability and Accountability Act of 1996 (HIPPA) authorization
to access the stroke survivor’s medical record (see Appendices P, Q, S, T and U). Some
stroke survivors who are cognitively impaired may or may not be able to demonstrate
capacity for informed consent. For those lacking decision-making capacity, federal
regulations require researchers to obtain written informed consent from their legally
authorized representatives. For this study, we used the MacArthur Competency
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Assessment for Clinical Research (MacCAT-CR; Appelbaum & Grisso, 2000) for
situations in which it was not clear whether the stroke survivor did or did not demonstrate
capacity for informed consent. The MacCAT-CR is a semistructured interview with
open-ended questions and has been used to test capacity for decision making for consent
in patients with Alzheimer’s disease (Kim, Caine, Currier, Leibovici, & Ryan, 2001; Kim,
& Karlawish, 2003; Ulrich & Karlawish, 2006). The original MAcCAT-CR tool was
developed for a clinical trial and some questions did not fit our study design. Thus, we
modified relevant questions and a new cut-off point: 13 was used to determine capacity
for informed consent in the group of stroke survivors with unclear capacity (see
Appendix O). In cases when it was still unclear whether care recipients (stroke survivors)
had the capacity to consent to the study, we used the “dual consent process” (see
Appendix R), based on the recommendations of Barron, Duffey, Byrd, Campbell, and
Ferrucci (2004, p. 82).
Data collection. Data collection from caregiver participants occurred at two time
points: within 2 weeks poststroke (T1) while stroke survivors were still in the hospital
and then 4 weeks after the first interview (T2) (hereafter referred to as “6 weeks
poststroke”). At each time point, participants completed a quantitative survey instrument
and provided salivary specimens. Data from the stroke survivor’s medical record were
collected only at T1; selected items were repeated with the proxy at T2.
Survey instrument administration. After recruiting participants and obtaining
informed consent, a research team member interviewed consenting caregivers in a quiet
place at the hospital or in caregivers’ homes to provide privacy and protect
confidentiality. With a few exceptions at T2, according to protocol, caregiver participants
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were interviewed in person at each time point. The interviews required as much as 40–50
minutes (including enrollment procedures) at T1 and as much as 30–40 minutes at T2.
The research team member gave caregivers the option to stop the interview or take a
break if needed. Quantitative paper and pencil survey instruments were administered by
reading questions to participants and recording their answers. The participant was given a
large print copy of the instrument to follow along to help overcome potential barriers in
reading level or literacy in the study population. Alternatively, participants read and filled
out the survey questions first and the research team member reviewed their answers for
clarity and completeness. For T2 data collection (4 weeks after the first interview), the
research team member contacted the caregiver participant by telephone to arrange to meet
at a place convenient to them. For caregiver participants who were not available to meet
in person at T2, we provided a copy of the survey instruments in advance, arranged a
telephone interview and read questions aloud as necessary to enable participants to
answer the survey questions by phone. Alternatively, some participants filled out the
survey questions and collected the second saliva sample by themselves and mailed both
to us. The research team member subsequently called the participants to review the
survey answers for clarity and completeness.
The research team member tried to minimize missing data by providing a quiet
room for privacy, if the interview was conducted in a hospital or other healthcare setting.
Missing data due to interviewer error was corrected in one of two ways. The research
team member carefully reviewed the survey form for completeness before concluding
each interview, or we telephoned participants to ask about any missing data and to
confirm responses.
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Chart review for stroke survivors. After having obtained informed consent and
HIPAA authorization from patients or surrogates, a research team member reviewed the
medical record of consenting stroke survivors at T1 to obtain information about their
stroke severity, description of stroke and comorbidities. These data were subsequently
reviewed for completeness and charts revisited to supply any missing data.
Saliva-specimen collection. Caregivers were taught self-collection of saliva in an
in-person demonstration at T1. On a day following the interview at T1 and before the
interview at T2, caregivers were asked to collect their saliva samples. They were
instructed to collect saliva at home at T1 and T2 using the same procedure. Written and
diagrammatic instructions along with the collection kits were sent home with the
caregiver and instructions were reviewed by telephone prior to the day they were to
collect the samples at each time point. To capture diurnal variations in cortisol
concentration, caregivers collected saliva on waking and again at 2100 h (McCallum et
al., 2006). Caregivers were instructed not to eat food, drink liquid or brush teeth for 30
minutes before collecting saliva and not to smoke for 60 minutes before collecting saliva.
Caregivers put the Salimetrics oral swab under their tongue for 1 minute to collect saliva.
They then inserted the oral swab into the tube, replaced the cap and filled out and placed
the label on the storage tube. Saliva collection and labeling took up to 5 minutes each
time. For each data collection (on waking and 2100 h), they placed the tube in a sealed
plastic bag and placed the bag in the freezer overnight as instructed. The research team
member picked up the samples and transported them in a cooler bag to the School of
Nursing Biobehavioral Laboratory for storage. Alternatively (for those few caregivers
living at extreme distance), caregivers placed the bags of tubes in a prepaid post office
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envelope and mailed it to us. In either case, the sample was delivered, placed in a projectlabeled container and stored in a freezer at –80° C for later analysis.
Retention. To avoid losing contact with participants, the research team member
requested two telephone numbers (home phone and cellular phone) as well as street and
e-mail addresses and an alternative contact for each participant. Every attempt was made
to locate and contact the participant for the T2 data collection using this information. For
participants who did not respond to our telephone calls, the research team member sent
e-mail messages as well as letters via the U.S. Postal Service.
As an additional strategy for retention, thank-you notes with a $10 gift card per
participant were given after data collection was completed at each time point for a total
maximum value of $20. The participant received the gift card in person or by U.S. mail
upon completion of the quantitative interview and saliva data collection for each T1 and
T2. If they withdrew from the study before T2, they kept the T1 gift card they had
already received. If stroke survivors died following T1 data collection, an attempt to
retain their caregiver participant for T2 data collection was made.
Data Management
All data were kept anonymous to protect the confidentiality of participants;
identification numbers rather than names were assigned sequentially and were used on all
paper and electronic materials that referenced participants. Paper forms were locked in a
cabinet in a locked data-repository room at the University of Pennsylvania School of
Nursing, separate from signed consent forms and lists of participants with code numbers.
All data were entered into an electronic file. Double data entry was used and any
discrepancy between the two data sets was compared and cleaned. Electronic data and
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results of all analyses were stored and managed using a secure research server at the
University of Pennsylvania School Nursing.
The salivary-cortisol samples were kept in freezer storage at the Biobehavioral
Laboratory at the University of Pennsylvania School of Nursing until data collection was
complete, and then transported to the University of Pennsylvania Pearlman School of
Medicine Clinical and Translational Research Center where the assays were completed
all at one time by the trained laboratory staff. This updated 2,000-square-foot laboratory
for biological research provides optimal –80° C freezer space and an established protocol
for the assay of salivary cortisol using enzyme-linked immuno sorbent assay.
Statistical Analysis
Overall analysis. All data were analyzed using SPSS 20.0 for Windows and
STATA 12. All variables were described using descriptive statistics and bivariate
analysis. In addition, for participants with complete data at both time points, a paired
t-test (for continuous variables) and Fisher’s exact test (for categorical variables) were
used to explore any changes over time. For the development of multivariable models,
multivariate stepwise regression was conducted to evaluate study hypotheses while
adjusting for important covariates related to study outcomes for Aims 1, 2 and 3. For Aim
4, univariate or multivariate regression in each Baron and Kenny (1986) step was used in
establishing the mediator effect of perceived stress and salivary cortisol on the
relationship between uncertainty and psychological outcomes (burden, HRQOL and
depressive symptoms). The robust standard error was used to protect against violations in
the homoscedasticity assumption in all regression analyses.
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Preliminary analysis. Descriptive estimates of all measures were generated:
frequencies and percents for categorical variables and estimates of central tendency
(means and medians), measures of variability (standard deviations, interquartile ranges
and ranges) and derived moments of skewness and kurtosis for continuous variables. An
analysis of distributional properties using histograms and Shapiro-Wilk tests were
performed to determine if variance stabilizing should be applied. Outliers were accessed
via visual inspection of distributions and checked for accuracy.
Comparison of study variables at T1 and T2. A paired t-test (for continuous
variables) and Fisher’s exact test (for categorical variables) were used to examine
differences in study variables measured at both time points in participants with complete
datasets.
Bivariate analysis.
Correlations. I estimated correlations among caregiver or stroke-survivor
characteristics and the main study variables—uncertainty, perceived stress, salivary
cortisol, burden, HRQOL and depressive symptoms. I calculated Pearson’s correlation
coefficient when two variables were normally distributed and Spearman’s correlation
coefficient when one of the variables was not normally distributed or was ordinal.
Differences in continuous variables by categories of caregiver and strokesurvivor characteristics. Two-sample t-tests (for dichotomous variables) and one-way
analysis of variance (ANOVA; for categorical variables having more than two levels)
were used when comparing with continuous variables. For the positively skewed and not
normally distributed variables, Mann-Whitney U test (for dichotomous variables) and the
Kruskal-Wallis test (for categorical variables on more than two levels) were used to
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examine differences in continuous variables between categories of caregiver and strokesurvivor characteristics.
Multivariate analysis. Multivariate stepwise regression and a p-value cut off
point of 0.05 were used to determine the effect of uncertainty on perceived stress,
salivary cortisol, burden, HRQOL and depressive symptoms (Aims 1, 2 and 3),
controlling for covariates. Given the large number of covariates available and the limited
sample size, only caregiver and stroke-survivor characteristics that were identified from
bivariate analysis on the basis of a p-value less than or equal to 0.05 were entered in the
multivariate stepwise regression models to test Aims 1, 2 and 3. Univariate or
multivariate regression in each Baron and Kenny step (1986) was used in establishing the
mediator effect of perceived stress and salivary cortisol on the relationship between
uncertainty and psychological outcomes (burden, HRQOL and depressive symptoms;
Aim 4). Covariates, which remained in the final stepwise models for each Aim 1, 2 and 3,
were entered in the models to test Aim 4. The robust standard error was used to protect
against violations in the homoscedasticity assumption in all analyses. For all analyses, a
p-value of less than 0.05 in a two-sided test was considered statistically significant.
Aim 1. Determine at each time point if uncertainty (regarding stroke survivors’
health outcomes and new caregiver role) predicts levels of caregivers’ perceived stress.
The level of uncertainty measured continuously was modeled as an independent
predictor of the dependent variable, perceived stress (total score measured on a
continuum). Separate models were estimated for the dependent variable at T1 and at T2.
Multivariate stepwise regression and a p-value cut off point of 0.05 were used to
individually model the dependent variable as a function of the predictor of interest
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(uncertainty) at T1 and at T2, while controlling for potential confounders or precision
variables identified from bivariate analysis on the basis of a p-value less or equal to 0.05.
To test the linearity assumption, a scatterplot matrix of all independent variables against
the dependent measure in a pairwise manner was used. A bivariate correlation matrix of
the independent variables combined with the computation of auxiliary R-squared values,
tolerance and variance inflation factor were used to check for multicollinearity. Finally,
the Huber-White robust sandwich variance estimator was used to protect against
violations in the homoscedasticity assumption.
Aim 2. Determine at each time point if uncertainty predicts levels of caregivers’
physiological stress (salivary cortisol).
The level of uncertainty measured continuously was modeled as an independent
predictor of the dependent variable, salivary cortisol. A multivariate stepwise regressionanalysis approach similar to that used for Aim 1 was used for Aim 2. Model assumptions
were assessed as described for Aim 1.
Aim 3. Examine at each time point the relationship of uncertainty to
psychological outcomes (burden, HRQOL and depressive symptoms).
Separate models were estimated for each dependent variable (burden, HRQOL
and depressive symptoms) at T1 and at T2. Multivariate stepwise regression and a pvalue cut off point of 0.05 was used to individually model the dependent variable as a
function of the predictor of interest (uncertainty) at T1 and at T2, while controlling for
potential confounders or precision variables identified from bivariate analysis on the
basis of a p-value less or equal to 0.05. Model assumptions were assessed as described
for Aim 1.
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Aim 4. Explore at each time point the mediator effect of stress (perceived stress
and physiological stress) on the relationship between uncertainty and psychological
outcomes (burden, HRQOL and depressive symptoms).
To test the hypothesis of stress (perceived or salivary cortisol) as a mediator in the
relationship between uncertainty and psychological outcomes (burden, HRQOL and
depressive symptoms) at T1 and at T2, separate models were estimated for each mediator
(perceived stress and salivary cortisol) and each dependent variable (burden, HRQOL and
depressive symptoms) at T1 and at T2. According to Baron and Kenny (1986) and Judd
and Kenny (1981), the following must hold to establish a mediational effect: (a)
uncertainty must be significantly associated with each mediator (perceived stress or
salivary cortisol); (b) each mediator (perceived stress or salivary cortisol) must reliably
predict each psychological outcome (burden, HRQOL or depressive symptoms); and (c)
the significant relationship between uncertainty and each psychological outcome should
be attenuated when the mediator is added to the model.
First, multiple regression analysis was used to assess the association between
uncertainty and each potential mediator (perceived stress or salivary cortisol). Second,
multiple regression analysis was used to assess the association between each dependent
variable and each potential mediator. Third, uncertainty and the specific covariate were
entered into a model estimated for each dependent variable, followed by the addition of
the specific mediator. To demonstrate mediation, we observed a change in the
relationship between uncertainty and the dependent variable from significant to
nonsignificant or attenuated, after adjusting for perceived stress or salivary cortisol.
Model assumptions were assessed as described in Aim 1.
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Sensitivity analyses.
Comparison of study completers and dropouts. A sensitivity analysis was
conducted to compare baseline caregiver and stroke-survivor sociodemographics and
stroke-related characteristics between participants who completed the study and those
who were excluded in the data analysis at T2.
Repeated-measures analysis for Aims 1, 2 and 3. Separate bivariate linear mixed
models with repeated measures of each dependent variable were computed to additionally
explore the overall effects of uncertainty or covariates on repeated measures of each
dependent variable (perceived stress, salivary cortisol, burden, HRQOL and depressive
symptoms). Restricted maximum likelihood was used. Restricted maximum likelihood
“chooses as estimates those values that, if true, would maximize the probability of
observing what has, in fact, been observed” (Allison, 2002, p. 13). Because restricted
maximum likelihood compensates for missing data, all participants who were recruited at
T1 were included in the analysis. For participants whose stroke survivor died after T1
data collection, predeath recall of measures of uncertainty, burden or stroke-survivor
functional status, as well as current (T2, postdeath) measures for perceived stress,
salivary cortisol, HRQOL or depressive symptoms were included as data at T2, because
these data are more likely to be similar to real than missing data. For participants who
were lost to follow up or withdrew from the study, there were no available data at T2.
First, separate bivariate linear mixed models with repeated measures of each
dependent variable (perceived stress, salivary cortisol, burden, HRQOL and depressive
symptoms) were computed to assess the overall effects of repeated measures of
uncertainty on each dependent variable. The initial model included uncertainty, time and
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the interaction between uncertainty and time to determine which factors were significant
predictors of each dependent variable. If the interaction variable between uncertainty and
time was not significant, this interaction variable was excluded in the final model.
Second, separate bivariate linear mixed models with repeated measures of each
dependent variable (perceived stress, salivary cortisol, burden, HRQOL and depressive
symptoms) were computed to assess the overall effects of each covariate (that remained
in the final stepwise regression model) on each dependent variable for Aims 1, 2 and 3.
The initial model included each covariate, time and interaction between covariate and
time to determine which factors were significant predictors of each dependent variable. If
the interaction between covariate and time was not significant, the interaction variable
was excluded from the final model.
Third, the effects of time on repeated measures of each dependent variable
(perceived stress, salivary cortisol, burden, HRQOL and depressive symptoms) were
visually compared to the results from the paired t-test that was used to examine any
differences in continuous variables measured at both time points for participants with
complete datasets.

66

CHAPTER 4: RESULTS
Introduction
A total of 63 caregivers and stroke survivors agreed to participate in the study. At
T1, all 63 caregivers were interviewed using a survey questionnaire; there were no
missing data. Fifty seven of these caregivers provided saliva samples on waking and 56
provided saliva samples in the evening. Of the evening samples, however, one lacked
sufficient volume of saliva to detect cortisol and another was an extreme outlier when
assayed, suggesting contamination; these two samples were excluded from data analysis.
Thus, at T1, 57 saliva samples on waking and 54 evening saliva samples were included in
the data analysis. Also at T1, the medical records of the 63 stroke survivors were
reviewed to obtain information about severity of stroke, description of stroke and
comorbidity with no missing data. At T2, 13 stroke survivors had died and their
caregivers’ data were not included in the analyses of aims at T2; an additional seven
caregivers were lost to follow up because we were unable to contact them, despite
multiple attempts, and three caregivers withdrew from the study. The participants who
withdrew from the study expressed that they could no longer participate due to their
caregiving situation and/or personal problems.
Thus, a total of 40 caregivers were included for data analysis at T2. There were no
missing survey data for these 40 caregivers; 38 of them provided saliva samples on
waking and in the evening, and all of these samples were available for assay. Comparing
baseline characteristics of participants who completed the study (N = 40) and those who
were not included in the data analysis at T2 (N = 23), there were no differences in values
for caregiver or stroke-survivor characteristics with these exceptions: those who were not
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included in data analysis at T2 had more social support at baseline (p = 0.036) and they
and their stroke survivors were more likely of the non-Hispanic White race (p = 0.018
for caregivers, p = 0.009 for stroke survivors).
Descriptive Analysis for Sample Characteristics and Main Variables
Caregiver characteristics. The sociodemographic characteristics of the
caregivers are reported in Tables 4 and 5. The majority were female (67%) and largely
non-Hispanic White (73%) or African American (22%). Caregivers’ ages ranged from 30
to 89 years (Mean [M] ± Standard Deviation [SD]: 56.92 ± 13.81; median: 56.00, mode:
41), and 30% were aged 65 years or older. Of caregivers, 60% were adult children and
35% were spouses of stroke survivors. All caregivers had completed at least high school;
most had either private, Medicare, or Medicare + supplemental health insurance plans
(87%) and worked either full-time (43%) or part-time (11%). Just under half (48%) of
caregivers felt comfortable financially and had more than enough funds to make ends
meet. They reported an average of 18.37 (± 17.34) close friends and relatives.
Table 5 shows caregiver characteristics measured at both T1 (N = 63) and T2
(N = 40). In the year prior to the stroke, caregivers had provided help to their family
member for an average of 201.75 (± 646.24) days, and time per day spent caring prior to
the stroke was 2.90 (± 6.37) hours. At the T1 interview, the duration of caregiving for
stroke survivors following the stroke was 4.19 (± 3.37) days and at T2, 36.03 (± 6.96)
days. Time spent per day in caregiving since the stroke was 8.59 (± 6.64) hours at T1 and
7.60 (± 6.59) hours at T2. Perceived quality of the relationship with the stroke survivor,
on a scale of 1 (excellent) to 4 (poor), averaged 1.25 (± 0.60) at T1 and 1.5 (± 0.75) at T2.
Perceived level of preparedness for caregiving on a scale of 1 (excellent) to 4 (poor) was
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2.21 (1.11) at T1 and 2.25 (± 1.01) at T2. At T1, 40% of the caregivers had experienced
other significant life events (e.g., a death, moving, retirement or marriage) in the 3
months prior to the stroke in their family member and at T2, 23% reported similar life
events that had occurred subsequent to the first interview. Distance between home and
site of care was 39.35 miles (± 123.28) at T1 when stroke survivors were still
hospitalized and 10.95 miles (± 20.26) at T2 when stroke survivors were at a
rehabilitation hospital, a nursing facility or home.
The average caregiver comorbidity score as measured by the Cumulative Illness
Rating Scale (CIRS; higher score reflects greater severity) was 4.90 (± 4.20) at T1
(N = 63) and 6.20 (± 4.69) at T2 (N = 40). Caregivers’ self-reported health status was also
poorer at T2 (N = 40) with a mean EQ-Visual-Analog Scale (VAS) score of 74.68
(± 15.68) compared to 80.57 (± 12.44) at T1 (N = 63). The mean coping capacity score as
measured by the short-form version of the Sense of Coherence Scale (SOC; higher score
reflects better coping) was 65.75 (± 11.71) at T1 (N = 63) and 67.25 (± 15.46) at T2
(N = 40). On average, caregivers reported social-support scores of 73.57 (± 12.16) at T1
(N = 63) and 63.88 (± 18.18) at T2 (N = 40) on the Multidimensional Scale of Perceived
Social Support (MSPSS; higher score represents better social support).
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Table 4
Caregiver Sociodemographic Characteristics (N = 63)
Variable

M ± SD or N (%)

Age (years)

56.92 ± 13.81

Gender
Female

42 (67%)

Male

21 (33%)

Race/Ethnicity
Non-Hispanic White

46 (73%)

African American

14 (22%)

Asian

1 (< 2%)

Hispanic

1 (< 2%)

Other

1 (< 2%)

Native Language
English

60 (95%)

Other

3 (5%)

Relationship to the Stroke Survivor
Spouse

22 (35%)

Child

38 (60%)

Grandchild

1 (2%)

Sibling

2 (3%)

Caregiver Insurance
Private/Medicare/Medicare + Supplemental Health
Insurance Plans

55 (87%)

Medicare + Medicaid/Medicaid/No insurance

8 (13%)

Number of close friends and relatives

18.37 ± 17.34

Education
Less than High School

0

High School

20 (32%)

Vocational Training

6 (9.5%)

College

23 (36.5%)

Postgraduate

14 (22%)
Table continues
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Variable

M ± SD or N (%)

Employment
Full Time

27 (43%)

Part Tim

7 (11%)

Homemaker

2 (3%)

Unemployed

5 (8%)

Retired

18 (29%)

Leave of Absence

4 (6%)

Income
Comfortable

30 (48%)

Adequate

26 (41%)

Insufficient

7 (11%)

Note. M = mean; SD = standard deviation; This information was collected only at T1.
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Table 5
Caregiver Characteristics Measured at T1 and T2
M ± SD or N (%)
Variable
Distance between site of care and home (miles)

T1 (N = 63)

T2 (N = 40)

39.35 ± 123.28

10.95 ± 20.26

Duration of Caregiving (days)
Prior to Stroke

201.75 ± 646.24

Since Stroke
Days Since Stroke

4.19 ± 3.37

36.03 ± 6.96

4.25 ± 3.36

36.45 ± 6.50

Time Spent Caring per Day (hours)
Prior to Stroke

2.90 ± 6.37

Since Stroke

8.59 ± 6.64

7.60 ± 6.59

25 (40%)

9 (23%)

Perceived Quality of Relationship with the
Stroke Survivor
[1=Excellent, 4=Poor]

1.25 ± 0.60

1.50 ± 0.75

Perceived Level of Preparedness for Caregiving
[1=Excellent, 4=Poor]

2.21 ± 1.11

2.25 ± 1.01

Comorbidity Score

4.90 ± 4.20

6.20 ± 4.69

Health Status

80.57 ± 12.44

74.68 ± 15.68

Coping Capacity

65.75 ± 11.71

67.25 ± 15.46

Social Support

73.57 ± 12.16

63.88 ± 18.18

Other significant life events in the past 3 months
at T1 or since stroke at T2 (Yes)

Note. M = mean; SD = standard deviation; Higher scores = poorer perceived quality of relationship with the
stroke survivor, poorer perceived level of preparedness for caregiving, more comorbidities, better health
status, better coping capacity and better social support.

72

Stroke-survivor characteristics. Table 6 summarizes stroke-survivor
sociodemographic characteristics obtained from the caregivers. Just over half of stroke
survivors were female (59%) and non-Hispanic White (71%), and most of the remainder
were African American (24%). Stroke survivors’ ages ranged from 65 to 95 years (75.92
± 7.82, median: 75.00, mode: 68), and 86% of them had completed high school or higher
education. The majority had either private, Medicare, or Medicare + supplemental health
insurance plans (84%). Most (75%) were retired, and their caregivers reported that only
43% of them felt generally financially comfortable or had more than enough funds to
make ends meet.
Stroke-related information was obtained from a review of medical records, which
was completed, on average, 4.22 (± 3.37) days poststroke (see Table 7). For the majority
of stroke survivors (81%), this was a first stroke, whereas for 19% this was a recurrence
(3% of 63 stroke survivors had a history of both stroke and transient ischemic attack) and
11% had a history of transient ischemic attack. The average length of time since
admission to the hospital at T1 was 4.49 (± 4.75) days at time of caregiver interview. The
majority had either ischemic (51%) or hemorrhagic stroke (33%). For 43%, the stroke
was located in the right hemisphere of the brain and for 44% in the left hemisphere. Of
stroke survivors, 43% were unable to communicate verbally. The mean severity of stroke
as measured by the National Institutes of Health (NIH) Stroke Scale was 12.98 (± 9.92;
range 0–40, with higher scores reflecting greater severity) and the stroke-survivor
comorbidity score, as measured by the CIRS, was 8.37 (± 4.37; higher scores represent
greater severity).
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Of the 40 stroke survivors remaining in the study at T2, 60% had been initially
discharged from the acute-care hospital to a rehabilitation hospital (vs. 10% to a nursing
facility; 22.5% to home and 7.5% to another place or remained in the same hospital). By
the time of the T2 interview, only 17 (42.5%) of all stroke survivors were at home (vs.
27.5% at a rehabilitation hospital, 12.5% at a nursing facility and 17.5% at another place).
With regard to their rehabilitation experience, 80% had received in-patient rehabilitative
therapy (in a rehabilitation hospital or skilled nursing facility) for a mean of 19.34 days
(± 9.00) and 38% had received out-patient rehabilitative therapy for a mean of 18.71 days
(± 10.80). Stroke-survivor functional status (see Table 7), as measured by the Barthel
Index (higher scores reflect better function), was 23.17 (± 28.71) at T1 (N = 63)
and 43.75 (36.56) at T2 (N = 40).
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Table 6
Stroke-Survivor Sociodemographic Characteristics (N = 63)
M ± SD or N (%)

Variable

75.92 ± 7.82

Age (years)
Gender
Female

37 (59%)

Male

26 (41%)

Race/Ethnicity
Non-Hispanic White

45 (71%)

African American

15 (24%)

Asian

2 (3%)

Hispanic

1 (2%)

Education
Less than High School

9 (14%)

High School

22 (35%)

Vocational Training

6 (10%)

College

19 (30%)

Postgraduate

7 (11%)

Employment
Full Time

6 (10%)

Part Time

1 (2%)

Homemaker

7 (11%)

Unemployed

2 (3%)

Retired

47 (75%)

Leave of Absence

0

Income
Comfortable

27 (43%)

Adequate

27 (43%)

Insufficient

9 (14%)

Insurance
Private/Medicare/Medicare + Supplemental Health
Insurance Plans

53 (84%)

Medicare + Medicaid/Medicaid/No insurance
10 (16%)
Note. M = mean; SD = standard deviation; This information was collected only at T1.
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Table 7
Stroke-Related Characteristics of Stroke Survivors (N = 63)
M ± SD or N (%)

Variable

4.22 ± 3.37
4.49 ± 4.75

Days poststroke
Days since admission to hospital
at time of caregiver interview
Type of Stroke
Ischemic
Intracerebral Hemorrhage
Subarachnoid Hemorrhage
Area of Stroke
Right
Left
Right and Left or Other
Communication Disability
Yes
No
Unclassified
Severity of Stroke
Comorbidity Score
Functional Status

32 (51%)
21 (33%)
10 (16%)
27 (43%)
28 (44%)
8 (13%)

27 (42.9%)
30 (47.6%)
6 (9.5%)
12.98 ± 9.92
8.37 ± 4.37
23.17 ± 28.71 at T1
43.75 ± 36.56 at T2 (N = 40)
Note. M = mean; SD = standard deviation; With the exception of functional status, this information was
collected only at T1; Higher scores = greater severity of stroke, more comorbidities and better functional
status.

Main study variables. Table 8 summarizes levels of caregiver uncertainty,
perceived stress, salivary cortisol on waking and in the evening, burden, health-related
quality of life (HRQOL) and depressive symptoms at T1 (N = 63) and T2 (N = 40).
Average uncertainty score on the Mishel Uncertainty in Illness Scale for Family
Members (higher scores reflect greater uncertainty) was 84.13 (± 19.93) at T1 and 85.23
(± 23.94) at T2. Their average score on the Perceived Stress Scale (PSS; higher scores
reflect higher perceived stress) was 24.21 (± 9.55) at T1 and 24.47 (± 10.74) at T2.
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The mean salivary-cortisol level on waking was 0.41 (± 0.37) µg/dL at T1 and
0.33 (± 0.21) µg/dL at T2 and the mean salivary-cortisol level in the evening was 0.13
(± 0.11) µg/dL at T1 and 0.12 (± 0.10) µg/dL at T2 (see Figures 2 & 3). The average time
of day participants collected waking saliva was 7.51 (±1.23) hours at T1 and 7.78 (±1.56)
hours at T2. In the evening, caregivers collected saliva on average around 21.23 (± 1.05)
hours at T1 and 21.20 (± 0.90) hours at T2.
Caregivers reported mild to moderate burden with a mean Zarit Burden score of
22.59 (± 16.56) at T1 and 26.90 (± 17.87) at T2. Caregivers reported reduced HRQOL at
T2 with a mean EQ5D score of 6.58 (± 1.48) compared to 5.90 (± 1.12) at T1. On
average, caregivers reported mild levels of depressive symptoms with a mean Patient
Health Questionnaires (PHQ)-9 score of 6.67 (± 5.55) at T1 and 6.60 (± 5.96) at T2. At
T1, 43% of caregivers and at T2 53% of caregivers reported no depressive symptoms.
Table 8
Summary of Main Study Variables at T1 and T2
T1 (N = 63)
Variable

T2 (N = 40)

Minimum –
Maximum

M ± SD

M ± SD

Minimum –
Maximum

Uncertainty

84.13 ± 19.93

33–137

85.23 ± 23.94

43–140

Perceived Stress

24.21 ± 9.55

0–43

24.47 ±10.74

5–46

Salivary Cortisol AM

0.41 ± 0.37
(N = 57)

0.03–2.30

0.33 ± 0.21
(N = 38)

0.06–1.07

Salivary Cortisol PM

0.13 ± 0.11
(N = 54)

0.02–0.58

0.12 ± 0.10
(N = 38)

0.03–0.46

22.59 ± 16.56

2–71

26.90 ± 17.87

0–68

Health-Related Quality of Life

5.90 ± 1.12

5–10

6.58 ± 1.48

5–9

Depressive Symptoms

6.67 ± 5.55

0–22

6.60 ± 5.96

0–20

Burden

Note. M = mean; SD = standard deviation; Higher scores = greater uncertainty, higher perceived stress,
greater burden, poorer health-related quality of life and greater depressive symptoms.
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Figure 2. Diurnal salivary cortisol pattern at T1.

Figure 3. Diurnal salivary cortisol pattern at T2.
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Comparisons of Study Variables at T1 and T2
Among the 40 participants with data at both T1 and T2, paired t-tests were used to
examine T1–T2 differences in main study continuous variables (uncertainty, perceived
stress, salivary cortisol, burden, HRQOL and depressive symptoms) and continuous
caregiver and stroke-survivor characteristics that were measured at both T1 and T2
(perceived quality of relationship with the stroke survivor, hours spent caring per day,
perceived level of preparedness for caregiving, caregiver comorbidity, coping capacity
and social support and stroke-survivor functional status). Fisher’s exact test was used to
examine differences in the only categorical variable, other life events, that was measured
at both time points.
Among the main study variables, salivary cortisol (at T1 and T2), burden (at T1),
HRQOL (at T1 and T2) and depressive symptoms (at T1 and T2) were positively skewed
due to variable floor effects. Thus, study variables at T1 and T2 were also compared
using a Wilcoxon Signed Ranks Test. The results using paired t-tests and Wilcoxon
Signed Ranks Test were similar; therefore, only the paired t-test results are reported.
Table 9 summarizes descriptive analysis and comparison of study variables
measured at both time points among 40 participants who completed the study. Compared
to T1, caregivers at T2 had poorer HRQOL (t = –2.636, p = 0.012), poorer health status
(t = 2.241, p = 0.031), higher comorbidity scores (t = –2.054, p = 0.047), better coping
capacity (t = –2.061, p = 0.046) and less social support (t = 2.560, p = 0.014). Functional
status of the stroke survivors improved from T1 to T2 (t = –3.266, p = 0.002). There were
no statistically significant differences between T1 and T2 for caregiver uncertainty,
perceived stress, salivary cortisol (on waking and evening), burden, depressive symptoms,
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perceived quality of relationship with the stroke survivor, hours spent caring per day,
perceived level of preparedness for caregiving or other life events.
Table 9
Comparison of Study Variables between T1 and T2 (N=40)
M ± SD or
N (%)
at T1

M ± SD or
N (%)
at T2

t statistic

p value

Uncertainty

83.73 ± 23.47

85.23 ± 23.94

–0.713

0.480

Perceived Stress

24.38 ± 10.15

24.48 ±10.74

–0.080

0.936

Salivary Cortisol AM (N = 38)

0.39 ± 0.23

0.33 ± 0.21

1.308

0.199

Salivary Cortisol PM (N = 37)

0.12 ± 0.10

0.12 ± 0.11

–0.061

0.952

Burden

23.0 ± 17.64

26.90 ± 17.87

–1.880

0.068

Health-Related Quality of Life

6.03 ± 1.25

6.58 ± 1.48

–2.636

0.012*

Depressive Symptoms

7.25 ± 5.84

6.60 ± 5.96

0.891

0.379

Perceived quality of relationship with
the stroke survivor

1.28 ± 0.64

1.50 ± 0.75

–1.940

0.060

Hours spent caring per day

8.7 ± 6.29

7.6 ± 6.59

0.954

0.346

Perceived level of preparedness for
caregiving

2.15 ± 0.98

2.25 ± 1.01

–0.561

0.578

Caregiver Comorbidity

5.65 ± 4.37

6.20 ± 4.69

–2.054

0.047*

Health Status

80.33 ± 12.68

74.68 ± 15.68

2.241

0.031*

Caregiver Coping Capacity

63.85 ± 12.52

67.25 ± 15.46

–2.061

0.046*

Caregiver Social Support

71.15 ± 13.14

63.88 ± 18.18

2.560

0.014*

Stroke-Survivor Functional Status

26.25 ± 28.83

43.75 ± 36.56

–3.266

0.002**

17 (43%)

9 (23%)

Variable

Other Life Event

0.134

Note. M = mean; SD = standard deviation; *p < 0.05, two-tailed, **p < 0.01, two-tailed; Paired t-test was
used for all variables except other life event for which Fisher’s exact test was calculated; Caregivers had
poorer health-related quality of life, more comorbidities, poorer health status, better coping capacity and
less social support at T2; Stroke-survivor functional status improved from T1 to T2.
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Bivariate Analysis
Correlations among the study variables. Correlations among caregiver or
stroke-survivor characteristics and the main study variables at T1 were estimated.
Pearson’s correlation coefficient was calculated when two variables were normally
distributed and Spearman’s correlation coefficient was calculated when one of the
variables was not normally distributed or was ordinal. Tables 10 and 11 report main study
variables and characteristics of any statistically significant correlations. Variable
correlations with each of the main variables are summarized here.
Uncertainty. At T1, greater uncertainty was significantly correlated with poorer
coping capacity (r = –0.424, p = 0.001), less social support (r = –0.307, p = 0.014),
poorer perceived quality of relationship with the stroke survivor (r = 0.289, p = 0.022),
poorer stroke-survivor functional status (r = –0.258, p = 0.041), higher perceived stress
(r = 0.545, p < 0.001), greater burden (r = 0.439, p < 0.001), poorer HRQOL (r = 0.475,
p < 0.001), poorer health status (r = –0.321, p = 0.01) and greater depressive symptoms
(r = 0.487, p < 0.001).
At T2, significant correlations persisted between greater uncertainty and the
following variables: poorer coping capacity (r = –0.560, p < 0.001), poorer perceived
quality of relationship with the stroke survivor (r = 0.359, p = 0.023), poorer strokesurvivor functional status (r = –0.398, p = 0.011), higher perceived stress (r = 0.512,
p = 0.001), greater burden (r = 0.586, p < 0.001), poorer HRQOL (r = 0.327, p = 0.039),
poorer health status (r = –0.372, p = 0.018) and greater depressive symptoms (r = 0.413,
p = 0.008). Greater uncertainty was also statistically correlated with caregiver older age
(r = 0.350, p = 0.027) and elevated salivary-cortisol level in the evening (r = 0.418,
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p = 0.009). The correlation between uncertainty and social support, however, was no
longer significant.
Perceived stress. At T1, higher perceived stress was significantly correlated with
greater uncertainty (r = 0.545, p < 0.001), poorer coping capacity (r = –0.543, p < 0.001),
greater burden (r = 0.479, p < 0.001), poorer HRQOL (r = 0.573, p < 0.001), poorer
health status (r = –0.421, p = 0.001), greater depressive symptoms (r = 0.590, p < 0.001)
and poorer stroke-survivor functional status (r = –0.278, p = 0.027). There was no
significant correlation between perceived stress and salivary cortisol, either on waking or
in the evening.
At T2, higher perceived stress remained significantly correlated with the
following variables: greater uncertainty (r = 0.512, p = 0.001), poorer coping capacity
(r = –0.755, p < 0.001), greater burden (r = 0.680, p < 0.001), poorer HRQOL (r = 0.510,
p = 0.001), poorer health status (r = –0.487, p = 0.001), greater depressive symptoms
(r = 0.744, p < 0.001) and poorer stroke-survivor functional status (r = –0.419, p = 0.007).
Higher perceived stress was also significantly correlated with elevated salivary-cortisol
level in the evening (r = 0.520, p = 0.001). The relationship of higher perceived stress
and lower social support approached significance (r = –0.310, p = 0.051). The
relationship of higher perceived stress and more caregiver comorbidities also approached
significance (r = 0.312, p = 0.050). There was no significant correlation between
perceived stress and salivary cortisol on waking.
Salivary cortisol. At T1, elevated salivary-cortisol level on waking was
significantly correlated with greater burden (r = 0.262, p = 0.049), older caregiver age
(r = 0.370, p = 0.005) and poorer perceived quality of relationship with the stroke
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survivor (r = 0.420, p = 0.001). Salivary-cortisol level in the evening at T1 was not
significantly correlated with any variable.
At T2, decreased salivary-cortisol level on waking was significantly correlated
with poorer HRQOL (r = –0.333, p = 0.041) and poorer health status (r = 0.383,
p = 0.017). The correlations between salivary-cortisol level on waking and burden,
caregiver age or poorer perceived quality of relationship with the stroke survivor were no
longer significant.
Elevated salivary-cortisol level in the evening at T2 was significantly correlated
with higher uncertainty (r = 0.418, p = 0.009), poorer coping capacity (r = –0.433,
p = 0.007), greater severity of stroke (r = 0.426, p = 0.008), higher perceived stress
(r = 0.520, p = 0.001), poorer health status (r = –0.370, p = 0.022) and greater depressive
symptoms (r = 0.502, p = 0.001). The relationship of elevated salivary-cortisol in the
evening with poorer stroke-survivor functional status approached significance (r = –0.319,
p = 0.051).
Burden. At T1, greater burden was significantly correlated with greater
uncertainty (r = 0.439, p < 0.001), poorer coping capacity (r = –0.427, p < 0.001), more
caregiver comorbidities (r = 0.271, p = 0.032), poorer perceived quality of relationship
with the stroke survivor (r = 0.403, p = 0.001), poorer perceived level of preparedness for
caregiving (r = 0.411, p = 0.001), higher perceived stress (r = 0.479, p < 0.001), elevated
salivary-cortisol level on waking (r = 0.262, p = 0.049), poorer HRQOL (r = 0.464, p <
0.001), poorer health status (r = –0.446, p < 0.001) and greater depressive symptoms
(r = 0.474, p < 0.001). There was no statistical correlation between burden and salivary
cortisol in the evening.
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At T2, greater burden was still significantly correlated with greater uncertainty
(r = 0.586, p < 0.001), poorer coping capacity (r = –0.650, p < 0.001), higher perceived
stress (r = 0.680, p < 0.001), poorer HRQOL (r = 0.447, p = 0.004), poorer health status
(r = –0.523, p = 0.001) and greater depressive symptoms (r = 0.558, p < 0.001). At T2,
however, burden failed to correlate significantly with caregiver comorbidity, perceived
quality of relationship with stroke survivor, perceived level of preparedness for
caregiving or salivary cortisol on waking.
Health-related quality of life. At T1, poorer HRQOL was significantly correlated
with greater uncertainty (r = 0.475, p < 0.001), poorer coping capacity (r = –0.470, p <
0.001), more caregiver comorbidities (r = 0.482, p < 0.001), higher perceived stress
(r = 0.573, p < 0.001), greater burden (r = 0.464, p < 0.001), poorer health status (r = –
0.646, p < 0.001) and greater depressive symptoms (r = 0.558, p < 0.001).
At T2, poor HRQOL remained significantly correlated with greater uncertainty
(r = 0.327, p = 0.039), poorer coping capacity (r = –0.556, p < 0.001), more caregiver
comorbidities (r = 0.586, p < 0.001), higher perceived stress (r = 0.510, p = 0.001),
greater burden (r = 0.447, p = 0.004), poorer health status (r = –0.564, p < 0.001) and
greater depressive symptoms (r = 0.489, p = 0.001). In addition, poor HRQOL at T2 was
statistically correlated with decreased salivary-cortisol level on waking (r = –0.333,
p = 0.041) and more stroke survivor comorbidities (r = 0.380, p = 0.016).
Depressive symptoms. At T1, greater depressive symptoms were significantly
correlated with greater uncertainty (r = 0.487, p < 0.001), poorer coping capacity (r = –
0.467, p < 0.001), less social support (r = –0.305, p = 0.015), higher perceived stress
(r = 0.590, p < 0.001), greater burden (r = 0.474, p < 0.001), poorer HRQOL (r = 0.558,
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p < 0.001), poorer health status (r = –0.447, p < 0.001), poorer stroke-survivor functional
status (r = –0.249, p = 0.049) and greater severity of stroke (r = 0.297, p = 0.018).
At T2, greater depressive symptoms were still significantly correlated with greater
uncertainty (r = 0.413, p = 0.008), poorer coping capacity (r = –0.744, p < 0.001), higher
perceived stress (r = 0.744, p < 0.001), greater burden (r = 0.558, p < 0.001), poorer
HRQOL (r = 0.489, p = 0.001), poorer health status (r = –0.409, p = 0.009) and poorer
stroke-survivor functional status (r = –0.464, p = 0.003). Greater depressive symptoms
were also significantly correlated with the following variables: fewer close friends and
relatives (r = –0.406, p = 0.007) and elevated salivary-cortisol level in the evening
(r = 0.502, p = 0.001). At T2, however, depressive symptoms were no longer
significantly correlated with social support or severity of stroke.
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Table 10
Main Study Variables and Characteristics with Any Statistically Significant Correlations at T1 (N = 63)
Variables

1

1. Uncertainty

2
0.545**

3

4

5

6

7

0.172

0.070

0.439**

0.475**

0.487**

0.131

–0.104

0.479**

0.573**

0.590**

0.113

0.262*
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2. Perceived Stress

0.545**

3. Salivary Cortisol AM (N = 57)

0.172

0.131

4. Salivary Cortisol PM (N = 54)

0.070

–0.104

5. Burden

0.439**

0.479**

6. Health-Related Quality of Life

0.475**

0.573**

–0.016

–0.027

0.464**

7. Depressive Symptoms

0.487**

0.590**

0.125

0.008

0.474**

0.558**

8. CG Comorbidity

0.119

0.124

0.064

0.066

0.271*

0.482**

0.147

9. CG Health Status

–0.321*

–0.421**

0.043

0.240

–0.446**

–0.646**

–0.447**

10. CG Coping Capacity

–0.424**

–0.543**

–0.173

0.201

–0.427**

–0.470**

–0.467**

11. CG Social Support

–0.307*

–0.205

–0.159

0.108

–0.202

–0.168

–0.305*

12. CG Age

0.195

–0.105

0.370**

0.250

0.076

0.088

–0.116

13. Perceived Quality of
Relationship with the SS

0.289*

0.176

0.420**

0.127

0.403**

0.185

0.125

14. Perceived Level of Preparedness
for Caregiving

0.202

0.166

0.241

0.102

0.411**

0.180

0.120

15. SS Severity of Stroke

0.201

0.224

–0.238

–0.057

0.224

0.297*

–0.157

0.113
0.262*

–0.157

–0.016

0.125

–0.027

0.008

0.464**

–0.014

0.474**
0.558**

16. SS Functional Status
–0.258*
–0.278*
0.219
0.042
–0.040
–0.181
–0.249*
Note. *p < 0.05, two-tailed, **p < 0.01, two-tailed; CG = caregiver; SS = stroke survivor. Higher scores = greater uncertainty, higher perceived stress,
greater burden, poorer health-related quality of life, greater depressive symptoms, more comorbidities, better health status, better coping capacity, better
social support, poorer perceived quality of relationship with the stroke survivor, poorer perceived level of preparedness for caregiving, greater severity of
stroke and better functional status.

Table 11
Main Study Variables and Characteristics with Any Statistically Significant Correlations at T2 (N = 40)
Variables

1

1. Uncertainty

2
0.512**

3

4

5

6

7

0.038

0.418**

0.586**

0.327*

0.413**

–0.212

0.520**

0.680**

0.510**

0.744**
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2. Perceived Stress

0.512**

3. Salivary Cortisol AM (N = 38)

0.038

4. Salivary Cortisol PM (N = 38)

0.418**

0.520**

0.072

5. Burden

0.586**

0.680**

–0.226

0.205

6. Health-Related Quality of Life

0.327*

0.510**

–0.333*

0.267

0.447**

7. Depressive Symptoms

0.413**

0.744**

–0.207

0.502**

0.558**

0.489**

8. CG Comorbidity

0.248

0.312

–0.113

0.274

0.243

0.586**

0.112

9. CG Health Status

–0.372*

–0.487**

0.383*

–0.370*

–0.523**

–0.564**

–0.409**

10. CG Coping Capacity

–0.560**

–0.755**

0.244

–0.433**

–0.650**

–0.556**

–0.744**

11. CG Social Support

–0.034

–0.310

0.149

–0.052

–0.190

–0.194

–0.257

–0.212

0.072

–0.226

–0.333*

–0.207

0.205

0.267

0.502**

0.447**

0.558**
0.489**

12. CG Age

0.350*

–0.088

0.135

–0.106

0.082

0.305

–0.102

13. Perceived Quality of
Relationship with the SS

0.359*

0.199

0.159

–0.031

0.257

–0.010

0.089

–0.056

–0.185

0.116

–0.106

–0.293

–0.162

–0.406**

15. SS Severity of Stroke

0.143

0.205

0.071

–0.173

–0.007

0.248

16. SS Functional Status

–0.398*

–0.419**

–0.066

–0.319

–0.224

–0.193

–0.464**

0.156

0.246

0.083

–0.083

0.005

14. Number of close friends and
relatives

17. SS Comorbidity

0.426**

0.380*

0.210

Note. *p < 0.05, two-tailed, **p < 0.01, two-tailed; CG = caregiver; SS = stroke survivor. Higher scores = greater uncertainty, higher perceived stress,
greater burden, poorer health-related quality of life, greater depressive symptoms, more comorbidities, better health status, better coping capacity, better
social support, poorer perceived quality of relationship with the stroke survivor, greater severity of stroke and better functional status.

Differences in main study variables by categories of caregiver and strokesurvivor characteristics. I explored differences in main study variables by category of
caregiver and stroke-survivor characteristics. Two sample t-tests (for dichotomous
variables) and one-way analysis of variance (ANOVA: for categorical variables having
more than two levels) were used to examine differences in uncertainty and perceived
stress between categories of caregiver and stroke-survivor characteristics. The variables
salivary cortisol (T1 and T2), burden (T1), HRQOL (T1 and T2) and depressive
symptoms were positively skewed, due to the floor effects. Thus, the Mann-Whitney U
test (for dichotomous variables) and the Kruskal-Wallis test (for categorical variables on
more than two levels) were used to compare differences in these characteristics.
Dichotomous/categorical variables and uncertainty. At T1, level of uncertainty
differed significantly depending on stroke-survivor health insurance type (t = 2.610,
p = 0.011; greater uncertainty found in those with private insurance/Medicare/Medicare +
supplemental health insurance plans). At T2, uncertainty differed significantly by
caregiver role (spouse vs. nonspouse; t = –2.343, p = 0.024), with greater uncertainty
found among spousal caregivers.
Dichotomous/categorical variables and perceived stress. At T1, degree of
perceived stress differed significantly, depending on stroke-survivor communicative
ability (t = –2.092, p = 0.041; higher stress, less communicative ability) and strokesurvivor health insurance type (t = 2.197, p = 0.032; higher stress, private
insurance/Medicare/Medicare + supplemental health insurance plans). At T2, perceived
stress differed significantly depending on stroke-survivor gender (t = 2.266, p = 0.029
with higher stress in men) and stroke-survivor income (F = 4.708, p = 0.015; higher
88

stress found in caregivers with adequate vs. comfortable income levels).
Dichotomous/categorical variables and salivary cortisol. At T1, level of salivary
cortisol on waking differed significantly depending on stroke-survivor health insurance
type (p = 0.040; elevated salivary-cortisol level found in those with private
insurance/Medicare/Medicare + supplemental health insurance plans) and other life
events (p = 0.015; elevated salivary-cortisol level found in caregivers with no other life
events). At T1, no statistically significant differences in salivary-cortisol level in the
evening were found among categories of caregiver or stroke-survivor characteristics. At
T1 and T2, the difference in level of salivary cortisol on waking among spousal and
nonspousal caregivers approached significance (p = 0.050; elevated salivary-cortisol level
in spouse at T1 and T2). At T2, salivary-cortisol level on waking differed significantly by
caregiver race (elevated salivary-cortisol level in non-Hispanic White than non-White
participants; p = 0.047) and salivary-cortisol level in the evening differed significantly by
caregiver income (p = 0.032; elevated salivary-cortisol level found in caregivers with
insufficient income compared with those reporting adequate or comfortable income).
Dichotomous/categorical variables and burden. At T1, level of burden differed
significantly depending on stroke-survivor health insurance type (p = 0.034; greater
burden found in those with private insurance/Medicare/Medicare + supplemental health
insurance plans). No statistically significant differences in burden were found among
categories of caregiver or stroke-survivor characteristics at T2.
Dichotomous/categorical variables and health-related quality of life. At T1 and
T2, HRQOL differed significantly by caregiver income (p = 0.029 at T1 and p = 0.011 at
T2; poorer HRQOL was found in caregivers with insufficient compared with comfortable
89

income).
Dichotomous/categorical variables and depressive symptoms. At T1, depressive
symptoms differed significantly by caregiver income (p = 0.014; greater depressive
symptoms in those with insufficient income compared with those reporting adequate or
comfortable income), stroke-survivor income (p = 0.041; greater depressive symptoms in
those with adequate income compared with those whose income is comfortable),
caregiver race (greater depressive symptoms in non-White; p = 0.015) and strokesurvivor race (greater depressive symptoms in non-White; p = 0.018). At T2, no
statistically significant differences in depressive symptoms were found among any
categories of caregiver and stroke-survivor characteristics.
Multivariate Analysis
As discussed in Chapter 3, multivariate stepwise regression and a p-value cut off
point of 0.05 were used to determine the effect of uncertainty on perceived stress,
salivary cortisol, burden, HRQOL and depressive symptoms at each time point (Aims 1,
2 and 3), controlling for covariates. Univariate or multivariate regression in each Baron
and Kenny (1986) step was used in establishing the mediator effect of each perceived
stress and salivary cortisol on the relationship between uncertainty and each
psychological outcome (burden, HRQOL and depressive symptoms; Aim 4). The robust
standard error was used to protect against violations in the homoscedasticity assumption
in all analyses. Given the large number of covariates available and the limited sample
size (N = 63 at T1 and N = 40 at T2), only caregiver and stroke-survivor characteristics
that were identified from bivariate analysis on the basis of a p-value less than or equal to
0.05 were entered in the multivariate stepwise regression models to test Aims 1, 2 and 3.
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Due to multicollinearity between caregiver comorbidity and health status, caregiver
comorbidity was used as a covariate and health status was excluded from the regression
models. For Aim 4, covariates, which remained in the final stepwise models for each Aim
1, 2 and 3, were entered in the multivariate regression models. For all analyses, a p-value
of less than 0.05 in a two-sided test was considered statistically significant.
Aim 1: Determine at each time point if uncertainty (regarding stroke survivors’
health outcomes and new caregiver role) predicts levels of caregivers’ perceived stress.
H1: At each time point, greater uncertainty scores will be positively associated
with higher levels of perceived stress.
At T1, uncertainty and the covariates—coping capacity, stroke-survivor
functional status, stroke-survivor health insurance type and stroke-survivor
communicative ability, as identified from bivariate analysis on the basis of a p-value less
than or equal to 0.05—were entered in the multivariate stepwise regression model. In the
final regression model, uncertainty and all covariates except stroke-survivor functional
status and health insurance remained. At T1, 48% of the variance in perceived stress was
explained by uncertainty, coping capacity and stroke survivor’s inability to communicate.
Greater uncertainty (p < 0.001), poorer coping capacity (p < 0.001) and stroke survivor’s
inability to communicate (p = 0.025) were associated with higher perceived stress (see
Table 12).
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Table 12
Multivariate Stepwise Regression of Perceived Stress at T1 (N = 63)
Predictors
Uncertainty
Coping Capacity
SS Communicative Ability

β

Robust SE

t statistic

p value

95% CI

0.163

0.042

3.89

< 0.001**

[0.079, 0.246]

–0.338

0.086

–3.94

< 0.001**

[–0.510, –0.166]

4.000

1.743

2.30

0.025*

[0.513, 7.487]

Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; SS = stroke
survivor; F(3, 59) = 29.98; Prob > F = 0.000; R-squared = 0.48; *p < 0.05, two-tailed, **p < 0.01, twotailed.

At T2, uncertainty and the covariates—caregiver comorbidity, social support,
stroke-survivor functional status, stroke-survivor gender and stroke-survivor income, as
identified from bivariate analysis on the basis of a p-value less than or equal to 0.05—
were entered in the multivariate stepwise regression model. Coping capacity mediated the
relationship between uncertainty and perceived stress; thus, coping capacity was
excluded from the model. In the final regression model, uncertainty and two covariates—
caregiver social support and stroke-survivor income—remained, explaining 49% of the
variance in perceived stress. Greater uncertainty (p < 0.001), lower social support
(p = 0.011) and stroke survivors’ adequate (compared to comfortable) income (p = 0.005)
were associated with higher perceived stress (see Table 13).
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Table 13
Multivariate Stepwise Regression of Perceived Stress at T2 (N = 40)
β

Robust SE

0.211

0.051

–0.170

SS Adequate Income#
SS Insufficient income#

Predictors
Uncertainty
Social Support

t statistic

p value

95% CI

4.14

< 0.001**

[0.107, 0.314]

0.063

–2.68

0.011*

[–0.299, –0.041]

8.000

2.681

2.98

0.005**

[2.554, 13.439]

9.080

6.163

1.47

0.150

[–3.432, 21.592]

Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; SS = stroke
survivor; F(4, 35) = 8.23; Prob > F = 0.0001; R-squared = 0.49; *p < 0.05, two-tailed, **p < 0.01, twotailed; #Reference category was stroke survivor comfortable income.

At T1 and T2, greater uncertainty scores were positively associated with higher
perceived stress, controlling for covariates (caregiver coping capacity and stroke
survivor’s inability to communicate at T1 and social support and stroke-survivor income
at T2). Thus, Hypothesis 1 was supported.
Aim 2: Determine at each time point if uncertainty predicts levels of caregivers’
physiological stress (salivary cortisol).
H2: At each time point, greater uncertainty scores will be positively associated
with elevated levels of salivary cortisol.
Uncertainty and salivary cortisol on waking. At T1, in univariate regression
analysis, uncertainty was not significantly associated with salivary cortisol on waking
(p = 0.103; see Table 14).
Table 14
Univariate Regression of Salivary Cortisol on Waking at T1 (N = 57)
Predictor
Uncertainty

β

Robust SE

t statistic

p value

95% CI

0.003

0.002

1.66

0.103

[–0.001, 0.006]

Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; F(1, 55) = 2.75;
Prob > F = 0.103; R-squared = 0.024.
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At T1, the variables identified from bivariate analysis on the basis of a p-value
less than or equal to 0.05—caregiver age, relationship to the stroke survivor (spousal vs.
nonspousal), perceived quality of relationship with the stroke survivor, other life events
and stroke-survivor health insurance type—were entered in the multivariate stepwise
regression model. In the final regression model, caregiver age and other life events
remained whereas relationship to the stroke survivor, perceived quality of relationship
with the stroke survivor and stroke-survivor health insurance were excluded. At T1, 10%
of the variance in salivary cortisol on waking was explained by caregiver age and other
life events. Older caregiver age (p = 0.043) and having no other events in the period since
the stroke (p = 0.048) were associated with elevated salivary-cortisol level on waking
(see Table 15).
Table 15
Multivariate Stepwise Regression of Salivary Cortisol on Waking at T1 (N = 57)
Predictors
CG Age
Other Life Events

β

Robust SE

t statistic

0.005

0.002

2.07

0.043*

[0.000, 0.009]

–0.176

0.087

–2.03

0.048*

[–0.351, –0.002]

p value

95% CI

Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; CG = caregiver;
F(2, 54) = 4.61; Prob > F = 0.01; R-squared = 0.10; *p < 0.05, two-tailed.

At T2, in univariate regression analysis, uncertainty was not significantly
associated with salivary cortisol on waking (p = 0.570; see Table 16).
Table 16
Univariate Regression of Salivary Cortisol on Waking at T2 (N = 38)
Predictor
Uncertainty

β

Robust SE

t statistic

p value

95% CI

0.001

0.002

0.57

0.570

[–0.002, 0.004]

Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; F(1, 36) = 0.33;
Prob > F = 0.57; R-squared = 0.012.
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At T2, the variables identified from bivariate analysis on the basis of a p-value
less than or equal to 0.05 were caregiver race (non-Hispanic White vs. non-White),
relationship to the stroke survivor (spousal vs. non-spousal). Caregiver race and
relationship to the stroke survivor were entered in the multivariate stepwise regression
model. In the final regression model, relationship to the stroke survivor remained. At T2,
15% of the variance in the salivary-cortisol level on waking was explained by the
relationship to the stroke survivor (see Table 17). A spousal relationship with the stroke
survivor was associated with elevated salivary-cortisol level on waking (p = 0.035).
Table 17
Multivariate Stepwise Regression of Salivary Cortisol on Waking at T2 (N = 38)
Predictors
Relationship to the SS

β

Robust SE

t statistic

0.17

0.077

2.19

p value
0.035*

95% CI
[0.012, 0.326]

Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; SS = stroke
survivor; F(1, 36) = 4.78; Prob > F = 0.036; R-squared = 0.15; *p < 0.05, two-tailed, **p < 0.01, two-tailed.

Uncertainty and salivary cortisol in the evening. At T1, uncertainty was not
significantly associated with salivary cortisol in the evening in univariate regression
analysis (p = 0.451; see Table 18). Salivary-cortisol level in the evening was not
significantly correlated with any variable. In addition, no statistically significant
differences in salivary-cortisol level in the evening were found among categories of
caregiver or stroke-survivor characteristics.
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Table 18
Univariate Regression of Salivary Cortisol in the Evening at T1 (N = 54)
Predictor
Uncertainty

β

Robust SE

t statistic

p value

95% CI

0.000

0.001

0.76

0.451

[–0.001, 0.002]

Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; F(1, 52) = 0.58;
Prob > F = 0.451; R-squared = 0.006.

In univariate regression analysis at T2, uncertainty was not significantly
associated with salivary cortisol in the evening (p = 0.055; see Table 19). Uncertainty and
the covariates—coping capacity, caregiver income, stroke-survivor functional status and
severity of stroke, which were identified from bivariate analysis on the basis of a p-value
less than or equal to 0.05—were entered in the multivariate regression model. No
variables that were significantly associated with salivary cortisol in the evening remained
in the final model.
Table 19
Univariate Regression of Salivary Cortisol in the Evening at T2 (N = 38)
Predictor
Uncertainty

β

Robust SE

t statistic

p value

95% CI

0.001

0.001

1.98

0.055

[–0.000, 0.002]

Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; F(1, 36) = 3.93;
Prob > F = 0.055; R-squared = 0.072.

At neither T1 nor T2 was uncertainty significantly associated with salivary
cortisol, either on waking or in the evening. Thus, Hypothesis 2 (which proposed that at
each time point, greater uncertainty scores would be positively associated with elevated
levels of salivary cortisol) was not supported.
Aim 3: Examine at each time point the relationship of uncertainty to
psychological outcomes (burden, HRQOL and depressive symptoms).
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At each time point, greater uncertainty scores will be positively associated with
H3: greater burden,
H4: poorer HRQOL and
H5: greater depressive symptoms.
Uncertainty and burden. At T1, uncertainty and the covariates—perceived
quality of relationship with the stroke survivor, perceived level of preparedness for
caregiving, coping capacity, caregiver comorbidity and stroke-survivor health insurance
type, as identified from bivariate analysis on the basis of a p-value less than or equal to
0.05—were entered into the multivariate regression model. In the final regression model,
uncertainty and the covariates perceived level of preparedness for caregiving and
caregiver comorbidity remained; however, perceived quality of relationship with the
stroke survivor, caregiver coping capacity and stroke-survivor health insurance were
excluded. Of the variance in burden, 43% was explained by uncertainty, perceived level
of preparedness for caregiving and caregiver comorbidity (see Table 20). Greater
uncertainty (p < 0.001), less preparedness for caregiving (p = 0.009) and more caregiver
comorbidities (p = 0.010) were associated with greater burden.
Table 20
Multivariate Stepwise Regression of Burden at T1 (N = 63)
Predictors

β

Robust SE

t statistic

p value

95% CI

Uncertainty

0.335

0.071

4.72

< 0.001**

[0.193, 0.477]

Preparedness for Caregiving

4.236

1.579

2.68

0.009**

[1.076, 7.395]

CG Comorbidity

1.026

0.384

2.67

0.010*

[0.258, 1.794]

Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; CG = caregiver;
F(3, 59) = 14.14; Prob > F = 0.000; R-squared = 0.43; *p < 0.05, two-tailed, **p < 0.01, two-tailed.
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At T2, uncertainty and the covariate coping capacity as identified from bivariate
analysis on the basis of a p-value less than or equal to 0.05 were entered into the
multivariate regression model. Both uncertainty and coping capacity remained in the final
model. Forty nine percent (49%) of the variance in burden was explained by uncertainty
and coping capacity (Table 21). Greater uncertainty (p = 0.031) and poorer coping
capacity (p = 0.006) were associated with greater burden.
Table 21
Multivariate Stepwise Regression of Burden at T2 (N = 40)
Predictors
Uncertainty
Coping Capacity

β

Robust SE

t statistic

0.242

0.108

2.24

0.031*

[0.023, 0.461]

–0.542

0.185

–2.93

0.006**

[–0.917, –0.167]

p value

95% CI

Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; F(2, 37) = 21.55;
Prob > F = 0.000; R-Squared = 0.49; *p < 0.05, two-tailed, **p < 0.01, two-tailed.

At T1 and T2, greater uncertainty scores were positively associated with greater
burden, controlling for covariates (perceived level of preparedness for caregiving and
caregiver comorbidity at T1 and caregiver coping capacity at T2). Thus, Hypothesis 3
was supported.
Uncertainty and health-related quality of life. At T1, uncertainty and the
covariates—caregiver coping capacity, comorbidity and income, as identified from
bivariate analysis on the basis of a p-value less than or equal to 0.05—were entered into
the multivariate stepwise regression model. In the final regression model, uncertainty and
covariates caregiver coping capacity and comorbidity remained; caregiver income,
however, was excluded. Of the variance in HRQOL, 54% was explained by uncertainty,
caregiver coping capacity and caregiver comorbidity (see Table 22). Greater uncertainty
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(p < 0.001), poorer coping capacity (p = 0.026) and more caregiver comorbidities
(p < 0.001) were associated with poorer HRQOL.
Table 22
Multivariate Stepwise Regression of Health-Related Quality of Life at T1 (N = 63)
β

Robust SE

t statistic

0.017

0.005

3.74

< 0.001**

[0.008, 0.026]

Coping Capacity

–0.019

0.008

–2.29

0.026*

[–0.036, –0.002]

CG Comorbidity

0.130

0.032

4.00

< 0.001**

[0.065, 0.195]

Predictors
Uncertainty

p value

95% CI

Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; F(3, 59) = 13.95;
Prob > F = 0.000; R-squared = 0.54; *p < 0.05, two-tailed, **p < 0.01, two-tailed.

In the univariate regression model at T2, 11% of the variance in HRQOL was
explained by uncertainty, and greater uncertainty (p = 0.023) was associated with poorer
HRQOL (see Table 23). It was noted that coping capacity mediated the relationship
between uncertainty and HRQOL. Thus, a multivariate stepwise regression model was
conducted, omitting coping capacity to determine the effect of uncertainty on HRQOL,
controlling for covariates (caregiver income, caregiver comorbidity and stroke-survivor
comorbidity) identified from bivariate analysis on the basis of a p-value less than or equal
to 0.05; uncertainty, however, failed to remain in the final model.
Table 23
Univariate Regression of Health-Related Quality of Life at T2 (N = 40)
Predictor
Uncertainty

β

Robust SE

t statistic

p value

95% CI

0.020

0.009

2.37

0.023*

[0.003, 0.038]

Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; F(1, 38) = 5.61;
Prob > F = 0.023; R-squared = 0.11; *p < 0.05, two-tailed, **p < 0.01, two-tailed.
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To further explore significant variables that might explain HRQOL at T2,
HRQOL at T2 was regressed on the independent variables coping capacity, caregiver
income, caregiver comorbidity and stroke-survivor comorbidity, as identified from
bivariate analysis on the basis of a p-value less than or equal to 0.05 while omitting
uncertainty. In the final regression model, all independent variables remained except
stroke-survivor comorbidity. Of the variance in HRQOL, 57% was explained by coping
capacity, caregiver comorbidity and caregiver income (see Table 24). Poorer coping
capacity (p = 0.004), more caregiver comorbidities (p < 0.001) and caregivers’ income
(p = 0.001; insufficient rather than comfortable) were associated with poorer HRQOL.
Table 24
Multivariate Stepwise Regression of Health-Related Quality of Life at T2 (N = 40)
β

Robust SE

t statistic

Coping Capacity

–0.036

0.011

–3.12

0.004**

CG Comorbidity

0.129

0.028

4.68

< 0.001**

[0.073, 0.185]

CG Adequate Income#

0.636

0.392

1.62

0.114

[–0.160, 1.431]

CG Insufficient Income#

1.389

0.378

3.67

0.001**

[0.622, 2.157]

Predictors

p value

95% CI
[–0.055, –0.012]

Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; F(4, 35) = 27.29;
Prob > F = 0.0000; R-squared = 0.57; *p < 0.05, two-tailed, **p < 0.01, two-tailed ; #Reference category
was caregiver comfortable income.

At T1, greater uncertainty scores were positively associated with poorer HRQOL,
controlling for the covariates caregiver coping capacity and comorbidity. At T2, greater
uncertainty scores were positively associated with poorer HRQOL only in the univariate
regression model. Thus, Hypothesis 4 (that at each time point, greater uncertainty scores
would be positively associated with poor HRQOL) was partially supported.
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Uncertainty and depressive symptoms. At T1, uncertainty and the covariates—
caregiver race, caregiver income, coping capacity, social support, stroke-survivor
functional status and severity of stroke, as identified from bivariate analysis on the basis
of a p-value less than or equal to 0.05—were entered in the multivariate stepwise
regression model. In the bivariate analysis, depressive symptoms statistically differed
depending on stroke-survivor race and stroke-survivor income. These variables, however,
were excluded from the regression model due to multicollinearity between caregiver race
and stroke-survivor race, as well as caregiver income and stroke-survivor income. In the
final regression model, uncertainty and the covariates caregiver race and coping capacity
remained, whereas caregiver income, social support, stroke-survivor functional status and
severity of stroke were excluded. Of the variance in depressive symptoms, 40% was
explained by uncertainty, coping capacity and caregiver race (see Table 25). Greater
uncertainty (p = 0.002), poorer coping capacity (p = 0.042) and caregivers’ race (nonWhite, p = 0.009) were associated with greater depressive symptoms.
Table 25
Multivariate Stepwise Regression of Depressive Symptoms at T1 (N = 63)
Predictors
Uncertainty
Coping Capacity
CG Race

β

Robust SE

t statistic

0.111

0.033

3.31

0.002**

[0.044, 0.178]

–0.112

0.054

–2.08

0.042*

[–0.220, –0.004]

3.454

1.271

2.72

0.009**

[0.911, 5.997]

p value

95% CI

Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; CG = caregiver;
F(3, 59) = 15.59; Prob > F = 0.000; R-squared = 0.40; *p < 0.05, two-tailed, **p < 0.01, two-tailed.

At T2, uncertainty and the covariate number of close friends and relatives, as
identified from bivariate analysis on the basis of a p-value less than or equal to 0.05, were
entered in the multivariate stepwise regression model. Depressive symptoms were also
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statistically correlated with caregiver coping capacity and stroke-survivor functional
status in bivariate analysis. Coping capacity, however, mediated the relationship between
uncertainty and depressive symptoms when controlling for number of close friends and
relatives, whereas uncertainty mediated the relationship between stroke-survivor
functional status and depressive symptoms when controlling for number of close friends
and relatives. Thus, coping capacity and stroke-survivor functional status were omitted
from the regression model.
Of the variance in depressive symptoms, 22% was explained by uncertainty (see
Table 26), and greater uncertainty was associated with greater depressive symptoms
(p = 0.002). The number of close friends and relatives did not remain in the final model.
Table 26
Multivariate Stepwise Regression of Depressive Symptoms at T2 (N = 40)
Predictor
Uncertainty

β

Robust SE

t statistic

0.116

0.036

3.25

p value
0.002**

95% CI
[0.044, 0.189]

Note. β = unstandardized slope coefficient; SE = standard error; CI = confidence interval; F(1, 38) = 10.59;
Prob > F = 0.002; R-squared = 0.22; *p < 0.05, two-tailed, **p < 0.01, two-tailed.

At T1, greater uncertainty scores were positively associated with greater
depressive symptoms, controlling for caregiver coping capacity and race. At T2, greater
uncertainty scores were positively associated with greater depressive symptoms, whereas
the covariate, number of close friends and relatives, did not remain in the final regression
model. Thus, Hypothesis 5 (that at each time point, greater uncertainty scores would be
positively associated with greater depressive symptoms) was supported.
Table 27 summarizes significant associations between uncertainty and perceived
stress, salivary cortisol, burden, HRQOL and depressive symptoms at T1 and T2.
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Table 27
Significant Associations between Uncertainty and Perceived Stress, Salivary Cortisol,
Burden, Health-Related Quality of Life and Depressive symptoms at T1 (N = 63) and T2
(N = 40)
T1

T2

Perceived Stress

S (< 0.001**)

S (< 0.001**)

Salivary Cortisol AM

NS (0.103)
in univariate analysis
(N = 57)

NS (0.570)
in univariate analysis
(N = 38)

Salivary Cortisol PM

NS (0.451)
in univariate analysis
(N = 54)

NS (0.055)
in univariate analysis
(N = 38)

Burden

S (< 0.001**)

S (0.031*)

Health-Related Quality of Life

S (< 0.001**)

S (0.023*)
in univariate analysis

Depressive Symptoms

S (0.002**)

S (0.002**)

Note. S = significant; NS = nonsignificant; *p < 0.05, two-tailed, **p < 0.01, two-tailed.

Repeated-measures sensitivity analysis for Aims 1, 2 and 3. Separate bivariate
linear mixed models with repeated measures of each dependent variable (perceived stress,
salivary cortisol, burden, HRQOL and depressive symptoms) were computed to further
explore the overall effects of uncertainty or covariates on repeated measures of each
dependent variable.
Sensitivity analysis revealed that uncertainty was associated with repeated
measures of perceived stress, burden, HRQOL and depressive symptoms. Uncertainty,
however, was not associated with repeated measures of salivary cortisol either on waking
or in the evening. The interactions between uncertainty and time were not associated with
repeated measures of perceived stress, salivary cortisol either on waking or in the evening,

103

burden, HRQOL or depressive symptoms.
The majority of covariates that remained in the final stepwise regression model at
either at T1 and T2 were associated with repeated measures of each dependent variable.
Stroke-survivor communication ability, which was associated with perceived stress at T1,
was not significantly associated with repeated measures of perceived stress although it
approached significance (p = 0.062). The relationship to the stroke survivor associated
with salivary cortisol on waking at T2 was not significantly associated with repeated
measures of salivary cortisol on waking (p = 0.064), but did approach significance. With
these few exceptions, the results from the regression analysis at each time point were
consistent with the findings from bivariate linear mixed models with repeated measures
of each dependent variable.
Time was not associated with repeated measures of perceived stress, salivary
cortisol on waking or in the evening or depressive symptoms. Time, however, was
associated with repeated measures of burden and HRQOL. In other words, perceived
stress, salivary cortisol on waking or in the evening and depressive symptoms did not
change, whereas caregivers demonstrated greater burden and poorer HRQOL by 6 weeks
poststroke. With the exception of the effect of time on burden, these results were
consistent with the findings from the paired t-tests using subjects with complete data at
both time points (N = 40). The paired t-test showed that, although not statistically
significant, the differences between T1 and T2 for burden in that smaller sample
approached significance at p = 0.068.
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Aim 4: Explore at each time point the mediator effect of stress (perceived stress
and physiological stress) on the relationship between uncertainty and psychological
outcomes (burden, HRQOL and depressive symptoms).
At each time point, perceived stress and salivary cortisol will mediate the
relationship between uncertainty and
H6: burden,
H7: HRQOL and
H8: depressive symptoms.
Mediator effect of perceived stress on the relationship between uncertainty
and burden. At T1, uncertainty was a significant determinant of burden (β = 0.44,
t = 5.14, p < 0.001) and of perceived stress (β = 0.26, t = 5.70, p < 0.001). When
uncertainty and perceived stress were simultaneously regressed on burden, while
controlling for perceived level of preparedness for caregiving and caregiver comorbidity,
these four variables together explained 47% of the variance in burden; perceived stress
remained a significant determinant (β = 0.43, t = 2.10, p = 0.040), and the significant
relationship of uncertainty to burden was reduced (β = 0.23, t = 2.92, p = 0.005),
indicating a partial mediator effect.
Uncertainty (p = 0.031) and coping capacity (p = 0.006) were significant factors
influencing burden at T2. Coping capacity mediated the relationship between uncertainty
and stress; thus, coping capacity was excluded to test this aim, that is, the mediating
effect of perceived stress in the relationship between uncertainty and burden. At T2,
uncertainty was a significant determinant of burden (β = 0.44, t = 4.54, p < 0.001) and of
perceived stress (β = 0.23, t = 3.76, p = 0.001). When uncertainty and perceived stress
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were simultaneously regressed on burden, these two variables together explained 54% of
the variance in burden; perceived stress remained a significant determinant (β = 0.86,
t = 3.78, p = 0.001), and the significant relationship of uncertainty to burden was reduced
(β = 0.24, t = 2.56, p = 0.015), indicating a partial mediator effect.
Mediator effect of perceived stress on the relationship between uncertainty
and health-related quality of life. At T1, uncertainty was a significant determinant of
HRQOL (β = 0.029, t = 4.15, p < 0.001) and of perceived stress (β = 0.26, t = 5.70,
p < 0.001). When uncertainty and perceived stress were simultaneously regressed on
HRQOL, while controlling for caregiver comorbidity and coping capacity, these four
variables together explained 55% of the variance in HRQOL; perceived stress was not a
significant determinant (β = 0.017, t = 1.91, p = 0.062), and the significant relationship of
uncertainty to HRQOL remained (β = 0.014, t = 2.85, p = 0.006), indicating no mediator
effect.
At T2, uncertainty was a significant determinant of HRQOL (β = 0.02, t = 2.37
p = 0.023) and of perceived stress (β = 0.23, t = 3.76, p = 0.001). When uncertainty and
perceived stress were simultaneously regressed on HRQOL, the two variables explained
26% of the variance in HRQOL; perceived stress remained a significant determinant
(β = 0.06, t = 2.58, p = 0.014), whereas uncertainty was no longer a significant
determinant (β = 0.01, t = 0.67, p = 0.505), indicating a full mediator effect.
Mediator effect of perceived stress on the relationship between uncertainty
and depressive symptoms. At T1, uncertainty was a significant determinant of
depressive symptoms (β = 0.14, t = 4.67, p < 0.001) and perceived stress (β = 0.26,
t = 5.70, p < 0.001). When uncertainty and perceived stress were simultaneously
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regressed on depressive symptoms, while controlling for coping capacity and caregiver
race, these four independent variables together explained 46% of the variance in
depressive symptoms; perceived stress remained a significant determinant (β = 0.19,
t = 3.11, p = 0.003), and the significant relationship of uncertainty to depressive
symptoms was attenuated (β = 0.08, t = 2.17, p = 0.034), indicating a partial mediator
effect.
At T2, uncertainty was a significant determinant of depressive symptoms
(β = 0.12, t = 3.25, p = 0.002) and of perceived stress (β = 0.23, t = 3.76, p = 0.001).
When uncertainty and perceived stress were simultaneously regressed on depressive
symptoms, these two variables together explained 62% of the variance in depressive
symptoms; perceived stress remained a significant determinant (β = 0.41, t = 7.48,
p < 0.001), and the significant relationship of uncertainty to depressive symptoms became
nonsignificant (β = 0.02, t = 0.70, p = 0.489), indicating a full mediator effect.
Mediator effect of salivary cortisol on the relationship between uncertainty
and psychological outcomes (burden, HRQOL and depressive symptoms). At neither
time point—T1 or T2 —was uncertainty a significant determinant of salivary cortisol on
either waking (p = 0.103 at T1 and p = 0.570 at T2) or in the evening (p = 0.451 at T1
and p = 0.055 at T2). Thus, there were no mediating effects of salivary cortisol on waking
or in the evening on the relationship of uncertainty to psychological outcomes (burden,
HRQOL and depressive symptoms).
Summary for Aim 4. Table 28 summarizes mediator effects of perceived stress
on each relationship between uncertainty, burden, HRQOL and depressive symptoms.
There was a partial mediator effect of perceived stress on the relationship between
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uncertainty and burden, while controlling for perceived level of preparedness for
caregiving and caregiver comorbidity at T1 and in univariate regression analysis without
controlling for covariates at T2. There were, however, no mediating effects of salivary
cortisol on waking or in the evening on the relationship of uncertainty to burden at either
T1 or T2. Thus, Hypothesis 6 (that at each time point, perceived stress and salivary
cortisol would each mediate the relationship between uncertainty and burden) was
partially supported.
There was no mediator effect of perceived stress on the relationship between
uncertainty and HRQOL at T1. By T2, there was a full mediator effect of perceived stress
on the relationship of uncertainty to HRQOL in univariate regression analysis without
controlling for covariates. Prior to testing the mediator effect of perceived stress on the
relationship between uncertainty and HRQOL, the association between uncertainty and
HRQOL, however, was not strong. There were, however, no mediating effects of salivary
cortisol on waking or in the evening on the relationship of uncertainty to HRQOL at
either T1 or T2. Thus, Hypothesis 7 (that at each time point, perceived stress and salivary
cortisol would mediate the relationship between uncertainty and HRQOL) was partially
supported.
There was a partial mediator effect of perceived stress on the relationship between
uncertainty and depressive symptoms, while controlling for caregiver coping capacity
and race at T1 and a full mediator effect of perceived stress on the relationship of
uncertainty to depressive symptoms in univariate regression analysis without controlling
for covariates at T2. There were, however, no mediating effects of salivary cortisol on
waking or in the evening on the relationship of uncertainty to depressive symptoms at
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both T1 and T2. Thus, Hypothesis 8 (that at each time point, perceived stress and salivary
cortisol would mediate the relationship between uncertainty and depressive symptoms)
was partially supported.
Table 28
Mediator Effects of Perceived Stress on the Relationship between Uncertainty, Burden,
Health-Related Quality of Life and Depressive Symptoms at T1 (N = 63) and T2 (N = 40)
T1

T2 (in univariate analysis)

Burden

Partial Mediation

Partial Mediation

Health-Related Quality of Life

No Mediation

Full Mediation

Depressive Symptoms

Partial Mediation

Full Mediation
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CHAPTER 5: DISCUSSION
Introduction
I examined the effect of uncertainty on caregiver perceived and physiological
stress and psychological outcomes (burden, health-related quality of life [HRQOL] and
depressive symptoms) within the first 2 weeks (baseline) following a sudden health event
(i.e., stroke) in a family member and again 4 weeks later (~6 weeks poststroke). In
addition, I examined whether perceived or physiological stress influenced the relationship
between uncertainty and psychological outcomes at each time point. This final chapter (a)
summarizes principal findings, (b) discusses the meaning of study results and their
relationship to existing literature, (c) identifies the strengths and limitations of the study,
(d) specifies implications for clinical practice and health policy and (e) makes
recommendations for future research.
Summary of Principal Findings
To the best of my knowledge, I believe I am the first to investigate the effect of
uncertainty on perceived and physiological stress, burden, HRQOL or depressive
symptoms in caregivers of stroke survivors in the very early phase poststroke. In addition,
I explored the mediator effect of stress on the relationship between uncertainty and
psychological outcome. Greater uncertainty was significantly associated with higher
perceived stress in caregivers of stroke survivors, both immediately following the stroke
and at 6 weeks poststroke. Uncertainty was not a significant predictor of physiological
stress, however, at either time point. Greater uncertainty was significantly associated with
greater burden, poorer HRQOL and greater depressive symptoms at both observations.
By 6 weeks poststroke, however, uncertainty was significantly associated with poorer
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HRQOL only in univariate analysis, indicating that the importance of uncertainty to
HRQOL had waned. In addition, perceived stress partially mediated the relationship
between uncertainty and depressive symptoms at baseline, and at 6 weeks poststroke it
fully mediated that relationship; patients with greater uncertainty had more depressive
symptoms as perceived stress levels increased. At both observations, perceived stress
partially mediated the relationship between uncertainty and burden.
Comparison with Findings in Existing Literature
Uncertainty. The present study revealed that the level of uncertainty in caregivers
of stroke survivors was consistent from baseline (Mean [M] ± Standard Deviation [SD]:
84.13 ± 19.93, N = 63) to 6 weeks poststroke (M ± SD: 85.23 ± 23.94, N = 40); further, in
the 40 caregivers with complete data at both time points, there was no statistically
significant difference in level of uncertainty. The level was higher than that previously
reported for several populations of family caregivers for persons living with, for example,
dementia, prostate cancer and myocardial infarction (Mishel, 1997b). In addition,
Mitchell and Courtney (2004) reported that average caregiver uncertainty levels, when a
family member transferred from intensive care, ranged from 76.24 to 78.93. Nauser’s
(2010) study of uncertainty in caregivers for patients with heart failure, using only a 30item version of the Perception of Uncertainty in Illness Scale for Family Member, also
reported proportionally lower uncertainty scores than in the caregivers of stroke survivors
in the present study. These findings suggest that caregivers of stroke survivors may have
somewhat greater uncertainty. The average duration of providing care for patients with
heart failure in the Nauser study was approximately 4 years, whereas the sampling
interval for caregiving after stroke in the present study was shorter (within 2 weeks
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poststroke to around 6 weeks poststroke). Caregivers of new stroke survivors must adjust
to an altered relationship with their family member and also take on new responsibilities
as informal caregivers; they may have great uncertainty in making meaning of their
stroke survivors’ potential health outcomes and their own new caregiver role.
Characteristics of caregivers or their stroke survivors that influence uncertainty in
caregivers for stroke survivors have not been well documented in the existing literature.
Although not the aim of the present study, it was notable that several of these were found
related to uncertainty: caregiver coping capacity, caregiver health status, perceived
quality of relationship with the stroke survivor and stroke-survivor functional status at
both observations; and caregiver social support and stroke-survivor health-insurance type
at baseline and caregiver age and relationship to the stroke survivor at 6 weeks poststroke.
These observations add to the body of knowledge about factors that may influence
caregiver uncertainty.
Stress.
Perceived stress. In this study, caregiver perceived stress was consistent from
baseline (M ± SD: 24.21 ± 9.55, N = 63) to 6 weeks poststroke (M ± SD: 24.47 ± 10.74,
N = 40), regardless of the current posthospital placement of the patient (rehabilitation
hospital, nursing facility or other). By comparison, the mean perceived stress-scale levels
in a probability sample of the United States (N = 2,355) was 19.62 (± 7.49; B. Cohen &
Williamson, 1988) and 16.22 (±8.73) in caregivers of older adults with heart failure
(Schwarz & Dunphy, 2003). Average perceived stress levels in caregivers of stroke
survivors in the present study were higher than those reported in these other studies,
suggesting that stroke-survivor caregivers are at high risk for the development of stress112

related morbidity as found in the existing literature.
The finding that greater uncertainty was associated with higher perceived stress in
caregivers of stroke survivors is supported by studies on uncertainty in other populations.
Shannon and Lee (2008) reported that a mother’s uncertainty about infant HIV serostatus
was correlated with her perceived stress. In their study, however, there was no adjustment
for other factors that may have influenced perceived stress, whereas in the present study,
uncertainty was a main predictor for perceived stress when adjusting for other caregiver
and stroke-survivor characteristics, both at baseline and at 6 weeks poststroke. These
results indicate that caregiver uncertainty is likely a key factor associated with stress
during the first 6 weeks of caregiving.
Previous research identified several factors affecting perceived stress: caregiver
gender, age, health status, time since beginning to provide care for stroke survivors,
coping strategies/capacity, social support, preparedness for caregiving, stroke-survivor
functional status and severity of stroke (Ostwald et al., 2009). With the exception of
coping capacity and social support, none of these factors was supported in the present
study. One possible reason for these differences may be that the time period we explored,
the first 6 weeks of caregiving, represents only a relatively early period of caregiving,
whereas Ostwald et al. (2009) investigated perceived stress in caregivers on hospital
discharge and then up to 12 months postdischarge. Another possibility affecting
differences in study outcomes is the larger sample size in the Ostwald et al. study, which
included 159 stroke survivors and their caregivers.
In the present study, in addition to uncertainty, factors associated with perceived
stress were caregiver coping capacity and stroke survivor’s inability to communicate at
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baseline and social support and stroke survivor’s income at 6 weeks poststroke. Of stroke
survivors, 43% were unable to communicate verbally. Other researchers have reported
that communication loss or aphasia was the most upsetting factor to caregivers and was
related strongly to caregiver burden (Bakas, Kroenke, et al., 2006; Vincent et al., 2009).
When stroke survivors were in the acute stage, their caregivers experienced stress from
the stroke survivor’s inability to communicate. At 6 weeks poststroke, caregivers
reported significantly less perceived social support from family, friends and significant
others compared to baseline. Although stroke survivors had recovered much function,
other issues such as economic strain and reduction in perceived social support surfaced as
important aspects affecting caregiver perceived stress. In addition, although caregivers
spent significant time in caregiving during the first 6 weeks of caregiving, this factor did
not affect perceived stress. Time spent per day in caregiving was consistent from 8.59
(± 6.64, N = 63) at baseline to 7.60 (± 6.59, N = 40) at 6 weeks poststroke. Tooth et al.
(2005) reported that caregivers of stroke survivors spent approximately 4.6 hours per day
at 6 months poststroke and approximately 3.6 hours per day at 12 months to assist
patients with daily activities.
Poorer caregiver coping capacity was associated with higher perceived stress at
baseline and mediated the relationship between uncertainty and stress at 6 weeks
poststroke; it is noteworthy that coping capacity consistently influenced perceived stress
during the first 6 weeks of caregiving. Even with a relatively small sample size at 6
weeks poststroke, uncertainty and coping capacity remained significant predictors of
perceived stress. After the stroke survivor’s discharge from the hospital, caregivers with
greater uncertainty experienced higher levels of perceived stress, which may have
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contributed to difficulty adjusting to their new role. Those with higher coping capacity at
6 weeks poststroke, however, had lower perceived stress.
Physiological stress. No studies investigating the relationship between
uncertainty and physiological stress response were found in the current literature. In the
present study, uncertainty was not a predictor of physiological stress at either time point.
There was, however, a significant correlation between caregiver uncertainty and evening
salivary-cortisol level at 6 weeks poststroke. Although caregivers were uncertain
regarding the outcomes of the stroke and their new caregiver role at baseline, there was
no measurable influence on physiological stress in the first few days after the stroke.
Their greater uncertainty by 6 weeks poststroke, however, may have influenced their
physiological regulatory mechanisms. At that same observation point, there was also a
significant correlation between perceived stress and salivary-cortisol level in the evening,
whereas this relationship was not significant at baseline. One possible explanation is that
while physiologic homeostasis may have been maintained even in the face of perceived
stress at baseline, the body’s failure to compensate longer term led to a physiological
stress response by 6 weeks poststroke.
In addition, acute stress response, which would be represented by an increase in
salivary cortisol among caregivers of stroke survivors, may be more likely to be detected
in salivary cortisol in the evening. Woods et al. (2008) also reported that cortisol
dysregulation for residents with advanced dementia is more likely to be detected in the
evening. In the present study, salivary-cortisol levels on waking, however, were not
correlated with uncertainty or perceived stress at either time point. A 12-month selfmanagement intervention in patients with irritable bowel syndrome, including cognitive115

behavioral strategies, reduced perceived stress over time, but did not diminish urinary
salivary cortisol in the morning (Deechakawan, Cain, Jarrett, Burr, & Heitkemper, 2013).
In the present study, the mean salivary-cortisol levels on waking and in the
evening at each time point were in normal ranges, based on the salivary cortisol expected
ranges provided by the enzyme-linked immuno sorbent assay kit manufacturer, although
salivary-cortisol levels in a few participants were above or below normal ranges. Further
exploration is required with a larger sample size. One study reporting salivary-cortisol
levels in female caregivers of stroke survivors found that younger age was associated
with lower levels of cortisol on waking and 30 minutes postwaking (Saban et al., 2012).
In the present study, at baseline, older caregiver age was associated with elevated
salivary-cortisol level on waking, and experiencing other life events was associated with
a lower salivary-cortisol level on waking; these significant associations had, however,
disappeared by 6 weeks poststroke. Instead, at the second time point, a spousal
relationship with stroke survivors was associated with elevated waking levels of salivary
cortisol. The inconsistency found for study variables that were related to salivary-cortisol
levels (correlations and associations) at both time points—and either on waking or in the
evening—in the present study is puzzling and warrants further research on salivary
cortisol with repeated measures in a larger sample to better understand the mixed results.
Saban et al. (2012) reported that salivary-cortisol levels were lower across the day
in caregivers with higher versus lower depressive-symptom scores. Another study
reported that patients with relapsed major depression had higher cortisol levels than
patients in stable remission (Zobel et al., 2001). At 6 weeks poststroke in the present
study, having greater depressive symptoms was correlated with elevated salivary-cortisol
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level in the evening, but not with the levels on waking at either time period. The present
study measured salivary-cortisol levels at two time points during the first 6 weeks of
caregiving, whereas Saban et al. (2012) measured them at approximately 8 months of
caregiving. One possible explanation for these differences may be that when caregivers
initially are exposed to stressors, e.g., within 2 weeks poststroke, their physiologic
homeostasis may have been maintained, as suggested previously. By 6 weeks poststroke,
as in the present study, stressors had induced an increase in hypothalamic-pituitaryadrenal (HPA)-axis activity, which caused elevated cortisol level. By 8 months poststroke,
however, HPA-axis activity may have decreased or overadjusted, resulting in lower
levels of cortisol (Fries, Hesse, Hellhammer, & Hellhammer, 2005; Saban et al., 2012).
Another difference between the present study and that of Saban et al. (2012) is
gender differences in the study samples; the present study included both male and female
caregivers, whereas their study was limited to women. The present study, however, found
no significant gender differences for salivary-cortisol levels. Women with irritable-bowel
syndrome had slightly higher urinary cortisol levels than did men; however, this
difference was not statistically significant (Deechakawan et al., 2013). Thus, gender
differences between study samples would not likely be a reason affecting the relationship
between salivary-cortisol levels and depressive symptoms.
Psychological outcomes.
Burden. In this study, caregivers reported mild to moderate burden on average
during the first 6 weeks of caregiving; this observation is consistent with results of a
study by Bugge et al. (1999) in which caregivers experienced “strain” at least 1 month
poststroke. In the present study, 14% to 20% of caregivers experienced burden at
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moderate-to-severe or severe levels. One possible reason for the inconsistent findings
between the present study and the study by Tooth et al. (2005), in which 44% caregivers
reported considerable burden at 6 months and 42% reported burden at 12 months
poststroke, may be the effect of time on burden. I studied caregiver burden during the
first 6 weeks of caregiving whereas Tooth et al. studied burden from 6 months to 12
months poststroke; the experience of burden may be cumulative and worsen over time
and certainly burden in caregivers is reported to be at much higher levels at 1 year. Some
studies reported that caregiver burden continued to increase from 2 months to 6 months
(Ilse et al., 2008) or from 1 month to 6 months (Blake et al. 2003; Bugge et al., 1999).
Two other studies, however, reported that burden of caregivers decreased over time, that
is, baseline to 6 months (McCullagh et al., 2005; Vincent et al., 2009). Additional studies
that encompass multiple measurements over longer periods from the stroke event to
several years, as well as inclusion of comparable risk factors and measures, are required
to understand the mixed results in the existing literature.
No previous studies were found that explored the direct relationship between
uncertainty and burden in caregivers. In a study of caregivers for patients with
Parkinson’s disease, Sanders-Dewey et al. (2001) reported that uncertainty was a
significant factor affecting psychological distress. In the present study, uncertainty was a
significant predictor for burden. I found that burden in caregivers increased slightly from
baseline (within 2 weeks poststroke) to 6 weeks poststroke, although there was no
statistical difference based on paired t-tests in the smaller sample of those who completed
the study. In addition, at both observations, perceived stress partially mediated the
relationship between uncertainty and burden. Although the mediator effect of perceived
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stress on the relationship between uncertainty and burden was weak, this result suggests
that caregiver uncertainty may lead to a stressful caregiving situation, which eventually
induces greater burden.
Uncertainty, perceived level of preparedness for caregiving and caregiver
comorbidity at baseline, and uncertainty and caregiving coping capacity at 6 weeks
poststroke were significant factors influencing burden in the present study. The findings
that caregiver comorbidity was associated with burden at baseline and that coping
capacity was associated with burden 6 weeks poststroke are supported by other studies
(Cameron & Gignac, 2008; Van Puymbroeck & Rittman, 2005). Ostwald et al. (2009)
reported that preparedness for caregiving influenced perceived stress in caregivers for
stroke survivors. The significant effect of perceived level of preparedness for caregiving
on burden found in the present study, however, has not been shown in previous studies.
Another interesting finding in the present study was that perceived level of preparedness
for caregiving was associated with burden only at baseline; further, there was no
significant difference in perceived level of preparedness for caregiving at baseline and 6
weeks poststroke (from M ± SD: 2.21 ± 1.11, N = 63 to M ± SD: 2.25 ± 1.01, N = 40 on
scale of 1 [excellent] to 4 [poor]), suggesting that although there was greater uncertainty
among caregivers, time in caregiving experience did not affect sense of preparedness and
average preparedness level did not improve. Perceived level of preparedness for
caregiving may be an important factor in acute stages of stroke, such as within the first 2
weeks poststroke, but over time, other factors such as uncertainty and coping capacity
may be more important influences on burden than preparedness for caregiving. This
factor warrants further exploration.
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Health-related quality of life. Northouse et al. (2002) reported that uncertainty
was associated with mental health dimensions of HRQOL (while adjusting for caregiver
and patient characteristics) in caregivers for persons with recurrent breast cancer. In the
present study, uncertainty was associated with HRQOL at baseline. By 6 weeks
poststroke, uncertainty had lost its significant association with HRQOL, while adjusting
for other caregiver and stroke-survivor characteristics, although there was a significant
association in univariate regression analysis. The study by Northouse et al. (2002) was a
cross-sectional study with a sample of 189. In the present study, only 40 caregivers
remained at 6 weeks poststroke to explore the relationship between uncertainty and
HRQOL. Our dissimilar result could, thus, be related to the limited sample size; at 6
weeks poststroke, the 40 remaining caregivers, on average, had significantly poorer
HRQOL and poorer health status than they had at baseline (based on a paired t-test with
the sample of 40 caregivers), whereas uncertainty levels among these remaining
caregivers was consistent over time. Another possibility is that a relativity lower
reliability and fewer items (only 5) of the EQ5D instrument used to measure HRQOL
may have impeded the detection of the effect of uncertainty on HRQOL. Although
caregiver HRQOL and health status each declined from baseline to 6 weeks poststroke,
other factors, including caregiver coping capacity and comorbidity, appeared to have a
stronger influence on HRQOL than did uncertainty at 6 weeks poststroke. Neither age of
caregiver nor that of stroke survivor influenced HRQOL or health status in caregivers in
the short time period of the present study; it should be noted, however, that 30% of
caregivers were aged 65 years or older, placing them at higher longer term risk for
morbidity and mortality from caregiving.
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Our finding of a continuous effect of caregiver coping capacity and comorbidity
on HRQOL over time does support results of previous studies (Morimoto et al., 2003;
Visser-Meily et al., 2009). McCullagh et al. (2005) revealed that increasing caregiver age
and male gender were associated with their poorer quality of life, whereas these same
caregiver characteristics were not associated with HRQOL in the present study. Possible
explanations for this difference may include the variation between studies in operational
definitions and measures for quality of life and HRQOL. The McCullagh et al. study used
EQ-Visual-Analog Scale (VAS) to measure quality of life, whereas the present study
used EQ5D to measure HRQOL. In addition, caregivers in this sample were much
younger (M ± SD: 56.92 ± 13.81 years) compared to those in the study by McCullagh et
al. (2005; M ± SD: 65.7 ± 12.5 years).
One of the noteworthy findings of the present study is that caregiver HRQOL,
health status and comorbidity each got worse, even while stroke-survivor functional
status improved. Caregiving outcomes in stroke survivors is reported to be related to
physical and psychological health as well as related morbidities (Anderson et al., 1995;
Bauer et al., 2000; Berg et al., 2005; Blake et al., 2003; Burman, 2001; Forsberg-Warleby
et al., 2002; McCullagh et al., 2005; Pierce et al., 2006; White et al., 2003). Stroke has a
sudden onset. Thus, while caregivers were trying to adjust to their new caregiver role in
the early weeks of caregiving, their own health status had already begun to deteriorate,
underscoring the importance of monitoring caregivers during this critical period.
Perceived stress mediated the relationship between uncertainty and HRQOL at 6
weeks poststroke but not at baseline. This relationship is limited to univariate regression
analysis without adjusting for other caregiver and stroke-survivor characteristics. In
121

addition, prior to testing the mediator effect, the association between uncertainty and
HRQOL was not strong. This result, however, may be clinically meaningful. Uncertainty
was associated with HRQOL in patients with cancer and their caregivers (Northouse et al.,
2002) and patients with gynecological cancer (Padilla, Mishel, & Grant, 1992).
Compared to noncaregivers, caregivers of patients with Alzheimer’s disease had elevated
allostatic load (measures of blood pressure, BMI, total/HDL, HDL cholesterol, plasma
norepinephrine and epinephrine; Roepke et al., 2011). Uncertainty in caregivers of stroke
survivors during the early weeks is likely a key factor associated with caregiver stress,
leading to poorer HRQOL.
Depressive symptoms. Although in the present study caregivers, on average,
reported mild levels of depressive symptoms, approximately 30% of caregivers had
moderate, moderate-to-severe or severe depressive symptoms. This finding is consistent
with previous reports that as many as 23% to 33% of caregivers experience depression
during an 18-month poststroke follow-up period (Berg et al., 2005; Blake et al., 2003),
yet is nearly twice as high as the 18% of caregivers with moderate, moderate-to-severe or
severe depressive symptoms reported in the Bakas, Kroenke, et al. study (2006).
The finding of a significant effect of uncertainty on depressive symptoms is
consistent with earlier findings of a correlation between uncertainty and depression in
caregivers for persons with Parkinson’s disease (Sanders-Dewey et al., 2001). In that
study, however, other predictors that may influence caregiver depression were not
analyzed, whereas in this study, uncertainty, caregiver coping capacity and race were
each found to be associated with depressive symptoms at baseline. At 6 weeks poststroke,
uncertainty and the covariate number of close friends and relatives were entered in the
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multivariate stepwise regression model, but number of close friends and relatives did not
remain in the final model. Thus, uncertainty itself was related to depressive symptoms. In
the existing literature, a number of factors were found to influence depressive symptoms
but mixed results between studies also have been reported. One result of the present study,
that caregiver race and coping capacity were associated with depressive symptoms at
baseline, is supported a study by Van Puymbroeck et al. (2008). Caregiver race was no
longer associated with depressive symptoms at 6 weeks poststroke, but coping capacity
mediated the relationship between uncertainty and depressive symptoms.
Although uncertainty and coping capacity were each significant predictors for
depressive symptoms in caregivers for stroke survivors, over time the effect of coping
capacity on depressive symptoms proved stronger than that of uncertainty. Caregivers
may have mixed emotions about their caregiving situation because they may have daily
caregiving tasks that disturb their own lifestyles or jobs. Chumbler, Rittman, and Wu
(2008) reported that higher coping capacity was associated with lower levels of
depression in caregivers of stroke survivors across 2 years of follow-up. They suggested
that caregivers be encouraged to cope with their situations by finding meaning in
caregiving rather than by focusing on negative demands or burden, and that this strategy
may prevent depressive symptoms (Chumbler et al., 2008).
The current findings show that the degree of influence of perceived stress in the
relationship between uncertainty and depressive symptoms was strengthened at 6 weeks
poststroke. In other words, patients with greater uncertainty had greater depressive
symptoms as perceived stress levels increased. In patients with multiple sclerosis,
uncertainty about the illness was an important mediator of the relationship between the
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present state of the illness and depression (Kroencke, Denney, & Lynch, 2001). Perceived
stress as a mediator of the relationship between uncertainty and depressive symptoms is
not clear in the current literature. Caregivers of stroke survivors may experience stress
because they are not certain of the extent to which stroke survivors will worsen or
recover, as well as how involved they will need to be in longer term care for the stroke
survivor and the commensurate impacts on employment, economics, family life and so on.
This uncertainty is highly associated with stress, which eventually leads to greater
depressive symptoms. Stress-management behavioral therapy has been shown to decrease
the prevalence of depression in patients with early-stage breast cancer (Antoni et al.,
2001). Cognitive-behavioral therapies, including stress management related to
uncertainty, may have utility in decreasing depressive symptoms in caregivers of stroke
survivors as well.
Strengths of This Study
The present study exhibits several strengths. First, the prospective longitudinal
design captured the effects of uncertainty on perceived and physiological stress, burden,
HRQOL and depressive symptoms at two time points within the first 6 weeks poststroke:
within 2 weeks poststroke and again at ~6 weeks poststroke. In addition, this is the first
study to examine the role of uncertainty on these outcomes in caregivers of stroke
survivors or to investigate caregiver experiences in the very early period poststroke. By
including physiologic measures of stress, the early time period of caregiving was further
illuminated. Although the follow-up period was relatively short, I was able to examine
the influence of uncertainty on outcomes at each time point. As there was no intervention
for caregivers between baseline and 6 weeks poststroke, I, thus, observed the “natural
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history” of this relationship. The effects of uncertainty on perceived stress, burden,
HRQOL and depressive symptoms were consistently important over time and explained a
large amount of their variance. Different caregiver and stroke-survivor characteristics,
however, affected outcomes at each time point: when stroke survivors were still in the
hospital (baseline) and at 6 weeks poststroke (after discharge). These results are clinically
meaningful because they facilitate the ability to target factors and key time points for
potential intervention.
Second, I used multiple statistical methods to confirm the validity of the findings.
I used either a parametric or nonparametric method for bivariate analysis based on
distributions of the variables (Pearson’ correlation vs. Spearman’s correlation, two
sample t-test vs. Mann-Whitney U test and analysis of variance [ANOVA] vs. KruskalWallis test). The results from paired t-tests used to examine changes from baseline to 6
weeks poststroke in continuous variables among 40 participants were compared with
those of Wilcoxon Signed ranks test. In addition, as sensitivity analyses, separate
bivariate linear mixed models with repeated measures of each dependent variable to
compare the effects of uncertainty or covariates were computed to affirm confidence in
the results in the present study. The findings from the bivariate linear mixed models were
very similar to those resulting from the conservative statistical analyses used to test the
hypotheses, thereby increasing my confidence in the results.
Limitations of This Study
This study has some limitations that should be acknowledged. First,
generalizability is potentially limited because of the study’s design, convenience
sampling, single geographic region and relatively small sample size. For instance, the
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present study did not include age/gender-matched noncaregivers or caregivers of persons
with other conditions as control subjects. The literature on caregivers for patients with
dementia, for example, indicates that they have elevated levels of salivary cortisol across
the day and higher stress than do noncaregivers (Gallagher-Thompson et al., 2006). It
would be difficult, however, to compare measures such as caregiver uncertainty or
burden between caregivers and noncaregivers or even among those caring for persons
with other conditions with nonacute onset; examining differences in perceived stress,
salivary cortisol, HRQOL and depressive symptoms between caregivers for stroke
survivors and either of these other groups, however, would increase current knowledge of
stroke-survivor caregivers.
Furthermore, caregivers who did not agree to participate in the study or who were
lost to follow up at 6 weeks poststroke may have had more caregiving responsibilities and
higher stress levels. The main reason given for declining to participate in the study was
“feeling overwhelmed with their current situation.” Some study participants who
withdrew from the study expressed they could not continue to participate due to their
caregiving situation and/or personal problems. Thus, there is a possibility that some
caregivers with greater uncertainty or more severe levels of stress were not included in
the present study. By 6 weeks poststroke, 13 stroke survivors had died and their caregiver
data were excluded in analyses for that observation. Another 10 caregivers were lost to
follow up or withdrew from the study. The majority of the baseline values in caregiver
and stroke-survivor characteristics between these 23 caregivers who were not included in
the data analysis at 6 weeks poststroke and 40 caregivers who completed the study were
similar, pointing to overall homogeneity in the sample. The 40 caregivers who completed
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the study, however, did report less social support at baseline than did the 23 who were
excluded in the data analysis at 6 weeks poststroke; the sample of 40 caregivers at 6
weeks poststroke also contained a slightly larger proportion of non-White participants.
Although these two differences were statistically significant, they are not believed to be
clinically meaningful; however, there is a possibility that the findings at 6 weeks
poststroke could be influenced by characteristics in the retained sample.
Second, the time period for follow up was limited. Extending the follow-up period
to include multiple time points over a longer period of time after caregivers assume their
caregiver role is required to further examine how uncertainty may change “naturally” and
to determine its effect on long-term perceived stress, diurnal salivary cortisol and
psychological outcomes. Still, the study results shed light on a previously unexplored
period in the development of untoward caregiver outcomes.
Third, there is the possibility that participants were noncompliant with the
protocol for saliva collection. Although caregivers were taught self-collection of saliva in
a personal demonstration at baseline, I was unable to verify whether they actually
followed directions. For example, some salivary-cortisol levels in the evening were
higher than those on waking, an unusual finding that held even after reanalysis. It is
possible that caregivers mislabeled the sample vials with an incorrect time of day.
Salivary-cortisol levels in a few participants were similar between on waking and in the
evening. A possible interpretation for these flatter salivary slope patterns in a few
caregivers could be depression. Stroke-survivor caregivers with depression were found to
have lower salivary levels across the day than did caregivers without depression (Saban
et al., 2012).
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Fourth, due to the small sample size and limited power in the present study, I
chose as covariates to enter into the multivariate stepwise regression models for testing
Aims 1, 2 and 3 only caregiver and stroke-survivor characteristics that were identified
from bivariate analysis on the basis of a p-value less than or equal to 0.05. There is a
possibility that some covariates that were not significant in the bivariate analysis could
have been important factors affecting outcomes in a multivariate analysis. Because of the
mediation effects between uncertainty and covariates, testing the mediator effect of
perceived stress on the relationship between uncertainty and psychological outcomes
including burden, HRQOL and depressive symptoms at 6 weeks poststroke was limited
to univariate regression analysis. With a larger sample size, many more covariates could
be controlled to better examine any mediating effect of stress on the relationship between
uncertainty and psychological outcomes including burden, HRQOL and depressive
symptoms.
Finally, although not proposed for this study, sophisticated methods such as
mixed models with repeated-measures analysis would be statistically more powerful
because this analysis accounts for missing data if the data are missing at random. No
previous studies, however, had examined the effect of uncertainty on perceived and
physiological stress, burden, HRQOL and depressive symptoms in caregivers of stroke
survivors. Therefore, as the first step, it was important in this study to explore whether
uncertainty, as well as other caregiver and stroke-survivor characteristics, affect these
outcomes at each time point—while stroke survivors are in the hospital and after
discharge to home, rehabilitation hospitals or nursing facilities—using participants with
complete data at each time point. Conducting separate regression analyses with complete
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data at each time point in the present study was, thus, appropriate for the aims of the
present study. Further, existing longitudinal studies on caregivers of stroke survivors
have used a separate regression analysis to reveal factors that affected outcomes at each
time point (Bugge et al., 1999; McCullagh et al., 2005; Tooth et al., 2005). Hence, my
design permits important comparisons with existing reports and also fills gaps to
contribute importantly to a story about the evolution of caregiver outcomes, including
burden, over time.
Further, in the present study, there was no intervention for caregivers between
baseline and 6 weeks poststroke. In a natural environment without any intervention and in
the absence of previous study results, it is difficult to hypothesize whether perceived and
physiological stress, burden, HRQOL and depressive symptoms change significantly or
remain consistent over time. The paired t-tests using data from participants with complete
datasets (N = 40) in the present study showed that perceived stress, salivary cortisol,
burden and depressive symptoms were consistent from baseline to 6 weeks poststroke,
whereas bivariate linear mixed models with repeated measures of each dependent
variable using the entire available sample (63 at baseline, 53 [40 participants who
completed the study and 13 participants whose stroke survivor died after baseline data
collection] at 6 weeks poststroke) revealed that caregivers had greater burden and poorer
HRQOL at 6 weeks poststroke compared to baseline. The difference from baseline to 6
weeks poststroke for burden based on the paired t-test in the present study approached
statistical significance (p = 0.068), suggesting lack of power due to the small sample size
at 6 weeks poststroke (N = 40). Using a larger sample size in future studies may reveal
significant differences from baseline to 6 weeks poststroke. With a few exceptions (2
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covariates [stroke-survivor communication ability for perceived stress at baseline and
relationship to the stroke survivor for salivary cortisol on waking at 6 weeks poststroke]
that approached significance in bivariate linear mixed models with repeated measures),
the results from the regression analysis at each time point were consistent with the
findings from bivariate linear mixed models with repeated measures of each dependent
variable, adding further support for the study findings.
Implications for Clinical Practice and Health Policy
The findings from the current study have several implications for clinical practice
with caregivers of stroke survivors. First, healthcare providers in neuroscience must
become sensitized to caregiver uncertainty in the early period of caregiving. It is
important for clinicians to help caregivers identify specific areas where they are uncertain
(e.g., re: stroke-survivor outcome, the recovery process or caregiver role) and provide
appropriate support. Using uncertainty as a predictor may help identify caregivers at risk
for stress, burden, poor HRQOL or depressive symptoms—that is, those in need of
additional support. In addition, the present study revealed that by 6 weeks poststroke,
caregivers with greater uncertainty had greater depressive symptoms as perceived stress
levels increased. Acting on these critical insights has the potential to improve clinical
outcomes. Using early detection of uncertainty as a trigger to initiate caregiver
intervention in the early period of caregiving, such as consultation or stress-management
behavioral therapy, may lead to decreased depressive symptoms and reduced morbidity
and mortality in this population.
Second, greater caregiver involvement in discharge planning for stroke
survivors—by providing anticipatory guidance and information about care needs and care
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options and enhancing caregiver preparedness—may also help reduce early uncertainty,
support decision making in care planning and attenuate stress in the complex and oftenalienating healthcare-delivery system during a critical period. Caregivers for patients with
heart failure have better caregiving experiences and health outcomes when they are
involved in hospital-discharge planning (Bull, Hansen, & Gross, 2000). The results from
the present study indicated that caregiver uncertainty remained consistent from within 2
weeks poststroke to 6 weeks poststroke. Stroke-survivor functional status was correlated
with uncertainty at both times in the present study. Stroke survivors who were discharged
directly to home with their caregivers had had less severe strokes and fewer
complications, but at 6 weeks poststroke, there was no difference in caregiver uncertainty
regardless of posthospital discharge placement (i.e., rehabilitation hospital, nursing
facility or homes) of the stroke survivor. Involvement in discharge planning, especially
for stroke survivors who will be discharged directly home, could immeasurably help
caregivers adjust to their new caregiver role, increase preparedness for caregiving and
reduce their uncertainty. In the present study, less preparedness for caregiving in
caregivers was associated with greater burden at baseline. In a related study (Ostwald et
al., 2009), spousal caregivers who reframed their situation and prepared for caregiving
had lower stress throughout the year after discharge.
Third, policymakers need to make better informed investments in caregivers to
effectively reduce healthcare costs. The majority of new or recurring strokes occurs
among the older population (Stephenson, 2001). The U.S. 65 years and older population
comprised 35 million people in 2000 and will increase to 71 million by 2030 (U.S.
Census Bureau, 2004); thus, it is expected that the numbers of caregivers for older adults
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with stroke will increase commensurately. A policy improving informal family
caregiving, especially for caregivers of stroke survivors, could result in cost savings in
the formal long-term-care system. For example, in the present study, it was noted that
caregivers reported lowered social support at 6 weeks poststroke compared to baseline.
Social support (including instrumental and informational as well as emotional and
companionship support) is an important buffer known to decrease stress in stroke
survivors and their caregivers (Glass, Matchar, Belyea, & Feussner, 1993; Jonsson,
Lindgren, Hallstrom, Norrving, & Lindgren, 2005; Ostwald et al., 2009; Pierce et al.,
2004; Secrest, 2000). Efforts to enhance social support and discharge planning for stroke
survivors and for their caregivers, as well as provide direct interventions for caregivers
such as consultation or stress-management behavioral therapy, may prevent stress-related
health problems in caregivers, decrease their burden and depressive symptoms and
eventually reduce their healthcare costs by preventing or forestalling untoward outcomes.
Therefore, provision of these services as a covered benefit under Medicare/Medicaid and
other health insurances should be seriously considered.
Recommendations for Future Research
Replication studies are required that use a larger sample size in which many
factors that have been viewed in previous studies as influencing outcomes can be
successfully controlled. These include perceived stress, salivary cortisol, burden,
HRQOL and depressive symptoms. Longitudinal designs that encompass longer periods
(from the initial stroke event to several years poststroke) and multiple time points are also
needed. Because of the relatively small sample size in the present study, it was difficult to
examine the influence on outcomes of variables that changed over time. Such studies,
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which can better employ multilevel mixed linear-regression analyses and explore the
effects of time, interactions between time and uncertainty and interactions between time
and other covariates, will further elucidate the overall effects of uncertainty on short- and
long-term outcomes for caregivers. In the present study, salivary-cortisol levels were
measured on waking and in the evening to decrease data-collection burden in caregivers.
Longitudinal studies with saliva collection on waking, 30 minutes postawakening,
afternoon and evening (4 measures per day) over 2 consecutive days at each
measurement point would provide greater reliability and validity of the measure (Saban et
al., 2012; Woods et al., 2008). Such longitudinal studies may reveal diurnal variation in
salivary cortisol when caregivers for stroke survivors experience chronic stress. Further
investigation is required to verify whether, over time, cortisol levels increase, similar to
those in caregivers for patients with dementia (Bauer et al., 2000; Da Roza Davis &
Cowen, 2001; de Vugt et al., 2005; Vedhara et al., 1999) or lower, similar to those in a
previous study of caregivers for stroke survivors (Saban et al., 2012). In addition, daily
self-reported stress reflecting how study participants feel when collecting saliva would
enhance an interpretation regarding the finding of lack of correlation between perceived
stress and salivary cortisol in the present study.
Future intervention studies that incorporate components of uncertainty into a
problem-solving approach are required. In one study, social problem-solving telephone
interventions with family caregivers of stroke survivors after hospital discharge enhanced
mental health, caregiver preparedness and social functioning, and decreased depression,
although there was no effect on burden (Grant, Elliott, Weaver, Bartolucci, & Giger,
2002). The steps for problem-solving therapy suggested by Grant et al. (2002) are to
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(a) identify and define the problem, (b) decide what needs to be accomplished and list
possible solutions to the problems, (c) choose and test best solution(s) and (d) evaluate
outcomes of problem solving. Applying similar steps with caregivers to identify and
define uncertainty for the individual; find possible solutions to resolve uncertainty;
choose, test and evaluate the best problem-solving solutions and evaluate outcomes may
increase effective communication between caregivers and healthcare providers to resolve
uncertainty and enhance caregiver outcomes including stress, burden, HRQOL and
depressive symptoms.
Conclusions
The purpose of the present study was to examine the effect of uncertainty on
perceived and physiological stress, burden, HRQOL and depressive symptoms in
caregivers of stroke survivors within 2 weeks and 6 weeks poststroke. The results of
these analyses indicate that greater uncertainty was associated with higher perceived
stress immediately following the stroke and also at 6 weeks poststroke. Uncertainty,
however, was not a significant predictor of physiological stress at either time point.
Overall, greater uncertainty was associated with greater burden, poorer HRQOL and
greater depressive symptoms at both times. By 6 weeks poststroke, however, the
influence of uncertainty on HRQOL had diminished. In addition, at 6 weeks poststroke,
perceived stress fully mediated the relationship between uncertainty and depressive
symptoms and mediated the effect of uncertainty on HRQOL. Prior to testing the
mediator effect of perceived stress on the relationship between uncertainty and HRQOL,
however, the association between uncertainty and HRQOL was not strong. At both times,
perceived stress partially mediated the relationship between uncertainty and burden.
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Healthcare providers in neuroscience must become sensitized to caregiver uncertainty in
the early period of caregiving, helping them identify specific areas where they are
uncertain (e.g., stroke-survivor outcome, the recovery process and/or caregiver role) and
provide appropriate support. Further research on the observed rapid decline in caregiver
health is warranted, and studies of the effect of uncertainty on long-term caregiving
would be useful to explore its consequences over time.

135

APPENDIX A. SOCIODEMOGRAPHICS OF CAREGIVERS
Date: _____________________________________
Identification Number: ________________________
1.
2.
3.
4.
5.
6.

7.
8.

9.
10.

11.
12.
13.
14.

15.

16.

17.

Age: _____(years)
Gender: a) Male b) Female
Race/Ethnicity:
a) Caucasian b) African American c) Asian d) Latino/Hispanic e) Other:
Native Language: a) English b) Spanish c) Other:
Relationship to the stroke survivor:
a) Spouse b) Child c) Grandchild d) Sibling e) Friend f) Other:
Perceived quality of relationship with the stroke survivor
on a scale of 1 = excellent, 4 = poor
1
2
3
4
Duration of caregiving for the stroke survivor: prior to stroke _____days
since stroke _____days
Time spent caring per day:
prior to stroke _____hours
since stroke _____hours
(It included time spent with stroke survivors in a hospital.)
Length of time since the stroke survivor was diagnosed with stroke: _____days
Perceived level of preparedness for caregiving
On a scale of 1 = well prepared, 4 = not at all prepared
1
2
3
4
Your (caregiver) insurance including Medicare/Medicaid:
a) Private insurance b) Medicare c) Medicaid d) No Insurance e) Other:
Number of close friends and relatives: _____
Distance between the hospital (or facility) and your home:
_____miles or not applicable _____
Education (highest level of education completed):
a) Less than high school b) High school c) Vocational training d) College
e) Postgraduate
Employment Status:
a) Full-time work b) Part-time work c) Homemaker d) Unemployed e) Retired
f) Leave of Absence
Considering how well your household lives on its income, financially, would you
say you are:
a) Comfortable, have more than enough to make ends meet
b) Adequate, have enough to make ends meet
c) Do Not have enough to make ends meet
Other life events in the past 3 months: e.g., death, moving, retirement, marriage
a) Yes, specify _____________ b) No
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Sociodemographics of Caregivers for the Second Interview
Date: _____________________________________
Identification Number: ________________________
1.

Perceived quality of relationship with the stroke survivor
on a scale of 1=excellent, 4=poor
1
2
3
4

2.

Duration of caregiving for the stroke survivor: since stroke _____days

3.

Time spent caring per day:
since stroke _____hours
(It includes time spent with your loved one with stroke in a hospital, rehabilitation
center or nursing home.)

4.

Length of time since the stroke survivor was diagnosed with stroke: _____days

5.

Perceived level of preparedness for caregiving
On a scale of 1= well prepared and 4 = not at all prepared
1
2
3
4

6.

Distance between the hospital or facility (rehabilitation center or nursing home)
and your home: ____miles or N/A _____

7.

Other life events since the first interview: e.g., death, moving, retirement, marriage
a) Yes, specify _____________ b) No
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APPENDIX B. MISHEL UNCERTAINTY IN ILLNESS SCALE—FAMILY
MEMBER FORM

Date: _____________________________________
Identification Number: ________________________
INSTRUCTIONS:
Please read each statement. Take your time and think about what each statement
says. Then place a “X” under the column that most closely measures how you
are feeling about your family member TODAY. If you agree with a statement,
then you would mark under either “Strongly Agree” or “Agree”. If you
disagree with a statement, then mark under either “Strongly Disagree”
or “Disagree”. If you are undecided about how you feel about him /her, then
mark under “Undecided” for that statement. Please respond to every statement.
1.

I don’t know what is wrong with him/her.
Strongly Agree
(5)
_______

2.

Disagree
(2)
______

Strongly Disagree
(1)
______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

I am unsure if his/her illness is getting better or worse.
Strongly Agree
(5)
_______

4.

Undecided
(3)
______

I have a lot of questions without answers.
Strongly Agree
(5)
_______

3.

Agree
(4)
______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

It is unclear how bad his/her pain will be.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______
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5. The explanations they give about him/her seem hazy to me.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

6. The purpose of each treatment for him/her is clear to me.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

7. I do not know when to expect things will be done to him/her.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

8. His/her symptoms continue to change unpredictably.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

9. I understand everything explained to me.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

10. The doctors say things to me that could have many meanings.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

11. I can predict how long his/her illness will last.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______
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12. His/her treatment is too complex to figure out.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

13. It is difficult to know if the treatment or medications he/she is getting are
helping.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

14. There are so many different types of staff; it’s unclear who is responsible for
what.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

15. Because of the unpredictability of his/her illness, I cannot plan for the future.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

16. The course of his/her illness keeps changing. He/she has good and bad days.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

17. It’s vague to me how I will manage the care of him/her after he/she leaves the
hospital.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

18. It is not clear what is going to happen to him/her.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______
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Disagree
(2)
______

Strongly Disagree
(1)
______

19. I usually know if he /she is going to have a good or bad day.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

20. The results of his/her test are inconsistent.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

21. The effectiveness of the treatment is undetermined.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

22. It is difficult to determine how long it will be before I can care for him/her by
myself.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

23. I can generally predict the course of his/her illness.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

24. Because of the treatment, what he/she can do and cannot do keeps changing.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

25. I ‘m certain they will not find anything else wrong with him/her.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______
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Disagree
(2)
______

Strongly Disagree
(1)
______

26. They have not given him/her a specific diagnosis.
Strongly Agree
(5)
_______

Agree
(4)
______

Undecided
(3)
______

Disagree
(2)
______

Strongly Disagree
(1)
______

27. His/her physical distress is predictable; I know when it is going to get better or
worse.
Strongly Agree
(5)

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

_______

______

______

______

______

28. His/her diagnosis is definite and will not change.
Strongly Agree
(5)

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

_______

______

______

______

______

29. I can depend on the nurses to be there when I need them.
Strongly Agree
(5)

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

_______

______

______

______

______

30. The seriousness of his/her illness has been determined.
Strongly Agree
(5)

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

_______

______

______

______

______

31. The doctors and nurses use everyday language so I can understand what they
are saying.
Strongly Agree
(5)

Agree
(4)

Undecided
(3)

Disagree
(2)

Strongly Disagree
(1)

_______

______

______

______

______
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APPENDIX C. PERCEIVED STRESS SCALE
Date: _____________________________________
Identification Number: ________________________
The questions in this scale ask you about your
feelings and thoughts in the past day (24 hours). In
each case, you will be asked to indicate by circling
how often you felt or thought a certain way.
1. In the past day, how often have you been upset
because of something that happened unexpectedly?
2. In the past day, how often have you felt that you
were unable to control the important things in your
life?
3. In the past day, how often have you felt nervous
and “stressed”?
4. In the past day, how often have you dealt
successfully with irritating life hassles?
5. In the past day, how often have you felt that you
were effectively coping with important changes that
were occurring in your life?
6. In the past day, how often have you felt confident
about your ability to handle your personal problems?
7. In the past day, how often have you felt that
things were going your way?
8. In the past day, how often have you found that
you could not cope with all the things that you had
to do?
9. In the past day, how often have you been able to
control irritations in your life?
10. In the past day, how often have you felt that you
were on top of things?
11. In the past day, how often have you been
angered because of things that happened that were
outside of your control?
12. In the past day, how often have you found
yourself thinking about things that you have to
accomplish?
13. In the past day, how often have you been able to
control the way you spend your time?
14. In the past day, how often have you felt
difficulties were piling up so high that you could not
overcome them?

143

0=
Never

1=
Almost
Never

2=
Sometimes

3=
Fairly
Often

4=
Very
Often

APPENDIX D. SALIVA COLLECTION INSTRUCTIONS
Supplies Needed: Swab, cap, storage tube and sample ID labels.
1.
2.
3.
4.
5.
6.
7.
8.

Do not eat food or drink liquid for 30 minutes before collecting saliva.
Do not brush your teeth for 30 minutes before collecting saliva.
Do not smoke for 60 minutes before collecting saliva.
Do not have any major dental work within 3 days before collecting saliva.
Using pre-prepared label, mark date and time.
Wash your hands.
Remove the oral swab from the tube (see the picture). .
Put the oral swab under the tongue for 1 full minute. The oral swab can be
moved around in the mouth to take advantage of saliva pooling under the
tongue. This may help increase collection volume. If after 1 full minute the
oral swab appears dry, then repeat the process.
9. Return the oral swab into tube insert and replace the cap.
10. Place the label on the storage tube.
11. Wash your hands.
12. After collecting each sample, please mark the time below.
(Dates will be marked on the form ahead time for you).
13. Place all two tubes in a plastic sealed bag and place in the freezer overnight.
14. After collecting samples, the research team members will pick up the samples.
Schedule for Salivary Cortisol Sampling
Collect 2 salivary samples per day after the first interview.
First Samples
Date:
Waking
9 pm
Actual Time:
Actual Time:
Collect 2 salivary samples per day before or after the second interview (1 month after the
first interview).
Second Samples (1 month after the first interview)
Date:
Waking
9 pm
Actual Time:
Actual Time:
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SAMPLE PREPARATION
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APPENDIX E. ZARIT BURDEN INTERVIEW
Date: _____________________________________
Identification Number: ________________________

Please circle the response the best describes how you feel.
Quite
Sometimes Frequently

Nearly
Always

Never

Rarely

1. Do you feel that your relative asks for
more help than he/she needs?

0

1

2

3

4

2. Do you feel that because of the time
you spend with your relative that you
don’t have enough time for yourself?

0

1

2

3

4

3. Do you feel stressed between caring for
your relative and trying to meet other
responsibilities for your family or work?

0

1

2

3

4

4. Do you feel embarrassed over your
relative’s behavior?

0

1

2

3

4

5. Do you feel angry when you are
around your relative?

0

1

2

3

4

6. Do you feel that your relative currently
affects our relationships with other family
members or friends in a negative way?

0

1

2

3

4

7. Are you afraid what the future holds
for your relative?

0

1

2

3

4

8. Do you feel your relative is dependent
on you?

0

1

2

3

4

9. Do you feel strained when you are
around your relative?

0

1

2

3

4

10. Do you feel your health has suffered
because of your involvement with your
relative?

0

1

2

3

4

11. Do you feel that you don’t have as
much privacy as you would like because
of your relative?

0

1

2

3

4

12. Do you feel that your social life has
suffered because you are caring for your
relative?

0

1

2

3

4

13. Do you feel uncomfortable about
having friends over because of your
relative?

0

1

2

3

4

146

Quite
Sometimes Frequently

Nearly
Always

Never

Rarely

14. Do you feel that your relative seems
to expect you to take care of him/her as if
you were the only one he/she could
depend on?

0

1

2

3

4

15. Do you feel that you don’t have
enough money to take care of your
relative in addition to the rest of your
expenses?

0

1

2

3

4

16. Do you feel that you will be unable to
take care of your relative much longer?

0

1

2

3

4

17. Do you feel you have lost control of
your life since your relative’s illness?

0

1

2

3

4

18. Do you wish you could leave the care
of your relative to someone else?

0

1

2

3

4

19. Do you feel uncertain about what to
do about your relative?

0

1

2

3

4

20. Do you feel you should be doing
more for your relative?

0

1

2

3

4

21. Do you feel you could do a better job
in caring for your relative?

0

1

2

3

4

22. Overall, how burdened do you feel in
caring for your relative?

0

1

2

3

4

© 1983 Steven Zarit
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APPENDIX F. EUROQOL
Date: _____________________________________
Identification Number: ________________________
A. EQ5D
By placing a checkmark in one box in each group below, please indicate which
statements best describe your own health state today.
Mobility
I have no problems in walking about
I have some problems in walking about
I am confined to bed





Self-Care
I have no problems with self-care
I have some problems washing or dressing myself
I am unable to wash or dress myself





Usual Activities (e.g. work, study, housework, family or
leisure activities)
I have no problems with performing my usual activities
I have some problems with performing my usual activities
I am unable to perform my usual activities





Pain/Discomfort
I have no pain or discomfort
I have moderate pain or discomfort
I have extreme pain or discomfort





Anxiety/Depression
I am not anxious or depressed
I am moderately anxious or depressed
I am extremely anxious or depressed
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B. EuroQol-VAS (visual-analog scale)
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APPENDIX G. PATIENT HEALTH QUESTIONNAIRE
Date: _____________________________________
Identification Number: ________________________

Not
at
all

Over the last 2 weeks, how often have you been
bothered by any of the following problems?

Several
days

More
than half
the days

Nearly
every
day

1. Little interest or pleasure in doing things.
2. Feeling down, depressed, or hopeless.
3. Trouble falling or staying asleep, or sleeping too
much.
4. Feeling tired or having little energy.
5. Poor appetite or overeating.
6. Feeling bad about yourself – or that you are a failure
or have let yourself or your family down.
7. Trouble concentrating on things, such as reading the
newspaper or watching television.
8. Moving or speaking so slowly that other people could
have noticed. Or the opposite – being so fidgety or
restless that you have been moving around a lot more
than usual.
9. Thoughts that you would be better off dead or of
hurting yourself in some way.

10. If you checked off any problem on this questionnaire so far, how difficult have these
problems made it for you to do your work, take care of things at home, or get along
with other people?
Not difficult at all
_______

Somewhat difficult
_______

Very difficult
_______
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Extremely difficult
_______

APPENDIX H. CUMULATIVE ILLNESS RATING SCALE

Date: _____________________________________
Identification Number: ________________________
0: No problem
1: Current mild problem or past significant problem
2: Moderate disability or morbidity / requires “first line” therapy
3: Severe / constant significant disability / “uncontrollable” chronic problems
4: Extremely severe / immediate treatment required / end organ failure / severe
impairment of function
Score
Notes: Conditions, treatments, etc.
1:

Heart ………………………..

2:

Vascular ……………...……..
2a: Hypertension ……….…

3:

Hematopoieric …..…………

4:

Respiratory ……………..…

5:

Eyes, ears, nose, throat,
and larynx ………..…..

6:

Upper gastrointestinal……...

7:

Lower gastrointestinal……..

8:

Liver and biliary ……..……

9:

Renal …………………..…..

10: Genito-urinary …………...
11: Musculo-skeletal /
integument ………..…..
12: Neurological ………………
13: Endocrine/metabolic
and breast……………..….
14: Psychiatric …………………
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APPENDIX I. SHORT-FORM VERSION OF SENSE OF COHERENCE

Date: _____________________________________
Identification Number: ________________________
Here is a series of questions relating to various aspects of your lives. Each question has
seven possible answers. Please mark the number, which expresses your answer, with
number 1 and 7 being the extreme answers. If the words under 1 are right for you, circle
1: if the words under 7 are right for you, circle 7. If you feel differently, circle the number
which best expresses your feeling. Please give only one answer to each question.
1. Do you have feeling that you don’t really care about what goes on around you?
1
2
very seldom
or never

3

4

5

6

7
very often

2. Has it happened in the past that you were surprised by the behavior of people whom
you thought you knew well?
1
2
never happened

3

4

5

6

7
always happened

3. Has it happened that people whom you counted on disappointed you?
1
2
never happened

3

4

5

6

7
always happened

4

5

6

7
very clear
goals and purpose

6

7
very seldom or
never

4. Until now your life has had:
1
2
no clear goals
or purpose at all

3

5. Do you have the feeling that you’re being treated unfairly?
1
2
very often

3

4

5

6. Do you have the feeling that you are in an unfamiliar situation and don’t know what to
do?
1
2
very often

3

4

5
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6

7
very seldom or
never

7. Doing the thing you do every day is:
1
2
a source of deep
pleasure and
satisfaction

3

4

5

6

7
a source of
pain and
boredom

5

6

7
very seldom or
never

8. Do you have very mixed-up feelings and ideas?
1
2
very often

3

4

9. Does it happen that you have feelings inside you would rather not feel?
1
2
very often

3

4

5

6

7
very seldom or
never

10. Many people – even those with a strong character – sometimes feel like sad sacks
(losers) in certain situations. How often have you felt this way in the past?
1
never

2

3

4

5

6

7
very often

6

7

11. When something happened, have you generally found that:
1
2
you overestimated
or underestimated
its importance

3

4

5

you saw
things in the
right proportion

12. How often do you have the feeling that there’s little meaning in the things you do in
your daily life?
1
2
very often

3

4

5

6

7
very seldom or
never

13. How often do you have feelings that you’re not sure you can keep under control?
1
2
very often

3

4

5
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6

7
very seldom or
never

APPENDIX J. MULTIDIMENSIONAL SCALE OF PERCEIVED SOCIAL
SUPPORT
Date: _____________________________________
Identification Number: ________________________
I am going to read several statements about how much help you receive from others.
Please use the following scale to indicate how much you agree or disagree with each
statement. The responses range from very strongly disagree to very strongly agree,
with neither agree nor disagree in the middle. You can answer with either a number or
the words.
very
strongly
disagree

strongly
disagree

mildly
disagree

1

2

3

neutral

mildly
agree

strongly
agree

very
strongly
agree

4

5

6

7

1

2

3

4

5

6

7

1. There is a special person who is around when I am in need.

○

○

○

○

○

○

○

2. There is a special person with whom I can share my joys and sorrows.

○

○

○

○

○

○

○

3. My family really tries to help me.

○

○

○

○

○

○

○

4. I get the emotional help and support I need from my family.

○

○

○

○

○

○

○

5. I have a special person who is a real source of comfort to me.

○

○

○

○

○

○

○

6. My friends really try to help me.

○

○

○

○

○

○

○

7. I can count on my friends when things go wrong.

○

○

○

○

○

○

○

8. I can talk about my problems with my family.

○

○

○

○

○

○

○

9. I have friends with whom I can share my joys and sorrows.

○

○

○

○

○

○

○

10. There is a special person in my life who cares about my feelings.

○

○

○

○

○

○

○

11. My family is willing to help me make decisions.

○

○

○

○

○

○

○

12. I can talk about my problems with my friends.

○

○

○

○

○

○

○
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APPENDIX K. SOCIODEMOGRAPHICS OF STROKE SURVIVORS

Date: _____________________________________
Identification Number: ________________________
1.
2.
3.
4.

5.

6.

7.
8.

Age: _____(years)
Gender: a) Male b) Female
Race/Ethnicity:
a) Caucasian b) African American c) Asian d) Latino/Hispanic e) Other:
Education (highest level of education completed):
a) Less than high school b) High school c) Vocational training d) College
e) Postgraduate
Employment Status:
a) Full-time work b) Part-time work c) Homemaker d) Unemployed e) Retired
f) Leave of Absence
Considering how well your household lives on its income, financially, would
you say you are:
a) Comfortable, have more than enough to make ends meet
b) Adequate, have enough to make ends meet
c) Do Not have enough to make ends meet
Insurance including Medicare/Medicaid:
a) Private insurance b) Medicare c) Medicaid d) No Insurance e) Other:
Time since admission to hospital _____days
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Sociodemographics of Stroke Survivors for the Second Interview
Date: _____________________________________
Identification Number: ________________________
1.

A facility or home where a stroke survivor was initially placed after hospital
discharge
a) Rehabilitation center b) Nursing Home c) Home d) Other: _____
Time since admission to facility _____ days
Or
Time since discharge to home _____ days

2.

A facility or home where a stroke survivor is now currently placed
a) Rehabilitation center b) Nursing Home c) Home d) Other: _____
Time since admission to facility _____ days
Or
Time since discharge to home _____ days

3.

Duration of rehabilitation including Inpatient _____ days
Outpatient _____ days

156

APPENDIX L. NIH STROKE SCALE & DESCRIPTION OF STROKE
Date: _____________________________________
Identification Number: ________________________
Instructions

Scale definition

Score

1a. Level of Consciousness: The investigator must
choose a response, even if a full evaluation is
prevented by such obstacles as an endotracheal tube,
language barrier, orotracheal trauma/bandages. A 3 is
scored only if the patient makes no movement (other
than reflexive posturing) in response to noxious
stimulation.

0 = Alert; keenly responsive.
1 = Not alert, but arousable by minor
stimulation to obey, answer, or
respond.
2 = Not alert, requires repeated
stimulation to attend, or is obtunded
and requires strong or painful
stimulation to make movements (not
stereotyped).
3 = Responds only with reflex motor
or autonomic effects or totally
unresponsive, flaccid, areflexic.

1b. LOC Questions: The patient is asked the month
and his/her age. The answer must be correct—there is
no partial credit for being close. Aphasic and stuporous
patients who do not comprehend the questions will
score 2. Patients unable to speak because of
endotracheal intubation, orotracheal trauma, severe
dysarthria from any cause, language barrier or any
other problem not secondary to aphasia are given a 1. It
is important that only the initial answer be graded and
that the examiner not “help” the patient with verbal or
non-verbal cues.

0 = Answers both questions correctly.
1 = Answers one question correctly.
2 = Answers neither question
correctly.

1c. LOC Commands: The patient is asked to open and
close the eyes and then to grip and release the nonparetic hand. Substitute another one step command if
the hands cannot be used. Credit is given if an
unequivocal attempt is made but not completed due to
weakness. If the patient does not respond to command,
the task should be demonstrated to them (pantomime)
and score the result (i.e., follows none, one or two
commands). Patients with trauma, amputation, or other
physical impediments should be given suitable onestep commands. Only the first attempt is scored.

0 = Performs both tasks correctly.
1 = Performs one task correctly.
2 = Performs neither task correctly.

Table continues
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Instructions

Scale definition

Score

2. Best Gaze: Only horizontal eye movements will be
tested. Voluntary or reflexive (oculocephalic) eye
movements will be scored but caloric testing is not
done. If the patient has a conjugate deviation of the
eyes that can be overcome by voluntary or reflexive
activity, the score will be 1. If a patient has an isolated
peripheral nerve paresis (CN III, IV or VI) score a 1.
Gaze is testable in all aphasic patients. Patients with
ocular trauma, bandages, pre-existing blindness or
other disorder of visual acuity or fields should be tested
with reflexive movements and a choice made by the
investigator. Establishing eye contact and then moving
about the patient from side to side will occasionally
clarify the presence of a partial gaze palsy.

0 = Normal
1 = Partial gaze palsy. This score is
given when gaze is abnormal in one or
both eyes, but where forced deviation
or total gaze paresis are not present.
2 = Forced deviation, or total gaze
paresis not overcome by the
oculocephalic maneuver.

3. Visual: Visual fields (upper and lower quadrants)
are tested by confrontation, using finger counting or
visual threat as appropriate. Patient must be
encouraged, but if they look at the side of the moving
fingers appropriately, this can be scored as normal. If
there is unilateral blindness or enucleation, visual fields
in the remaining eye are scored. Score 1 only if a clearcut asymmetry, including quadrantanopia is found. If
patient is blind from any cause score 3. Double
simultaneous stimulation is performed at this point. If
there is extinction patient receives a 1 and the results
are used to answer question 11.

0 = No visual loss
1 = Partial hemianopia
2 = Complete hemianopia
3 = Bilateral hemianopia (blind
including cortical blindness)

4. Facial Palsy: Ask, or use pantomime to encourage
the patient to show teeth or raise eyebrows and close
eyes. Score symmetry of grimace in response to
noxious stimuli in the poorly responsive or noncomprehending patient. If facial trauma/bandages,
orotracheal tube, tape or other physical barrier obscures
the face, these should be removed to the extent
possible.

0 = Normal symmetrical movement
1 = Minor paralysis (flattened
nasolabial fold, asymmetry on smiling)
2 = Partial paralysis (total or near total
paralysis of lower face)
3 = Complete paralysis of one or both
sides (absence of facial movement in
the upper and lower face)
Table continues
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Instructions

Scale definition

Score

5 & 6. Motor Arm and Leg: The limb is placed in the
appropriate position: extend the arms (palms down) 90
degrees (if sitting) or 45 degrees (if supine) and the leg
30 degrees (always tested supine). Drift is scored if the
arm falls before 10 seconds or the leg before 5 seconds.
The aphasic patient is encouraged using urgency in the
voice and pantomime but not noxious stimulation.
Each limb is tested in turn, beginning with the nonparetic arm. Only in the case of amputation or joint
fusion at the shoulder or hip may the score be “9” and
the examiner must clearly write the explanation for
scoring as a “9”.

0 = No drift, limb holds 90 (or 45)
degrees for full 10 seconds.
1 = Drift, Limb holds 90 (or 45)
degrees, but drifts down before full 10
seconds; does not hit bed or other
support.
2 = Some effort against gravity, limb
cannot get to or maintain (if cued) 90
(or 45) degrees, drifts down to bed, but
has some effort against gravity.
3 = No effort against gravity, limb
falls.
4 = No movement
9 = Amputation, joint fusion, explain
______________________
5a. Left Arm
5b. Right Arm
0 = No drift, leg holds 30 degrees
position for full 5 seconds.
1 = Drift, leg falls by the end of the 5
second period but does not hit bed.
2 = Some effort against gravity; leg
falls to bed by 5 seconds, but has some
effort against gravity.
3 = No effort against gravity, leg falls
to bed immediately.
4 = No movement
9 = Amputation, joint fusion, explain
______________________
6a. Left Leg
6b. Right Leg

7. Limb Ataxia: This item is aimed at finding
evidence of a unilateral cerebellar lesion. Test with
eyes open. In case of visual defect, insure testing is
done in intact visual field. The finger-nose-finger and
heel-shin tests are performed on both sides, and ataxia
is scored only if present out of proportion to weakness.
Ataxia is absent in the patient who cannot understand
or is paralyzed. Only in the case of amputation or joint
fusion may the item be scored “9”, and the examiner
must clearly write the explanation for not scoring. In
case of blindness test by touching nose from extended
arm position.

0 = Absent
1 = Present in one limb
2 = Present in two limbs
If present, is ataxia in
Right arm 1 = Yes 2 = No
9 = amputation or joint fusion, explain
___________________
Left arm 1 = Yes 2 = No
9 = amputation or joint fusion, explain
___________________
Right leg 1 = Yes 2 = No
9 = amputation or joint fusion, explain
___________________
Left leg 1 = Yes 2 = No
9 = amputation or joint fusion, explain
___________________
Table continues
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Instructions

Scale definition

Score

8. Sensory: Sensation or grimace to pin prick when
tested, or withdrawal from noxious stimulus in the
obtunded or aphasic patient. Only sensory loss
attributed to stroke is scored as abnormal and the
examiner should test as many body areas [arms (not
hands), legs, trunk, face] as needed to accurately check
for hemisensory loss. A score of 2, “severe or total,”
should only be given when a severe or total loss of
sensation can be clearly demonstrated. Stuporous and
aphasic patients will therefore probably score 1 or 0.
The patient with brain stem stroke who has bilateral
loss of sensation is scored 2. If the patient does not
respond and is quadriplegic score 2. Patients in coma
(item 1a=3) are arbitrarily given a 2 on this item.

0 = Normal; no sensory loss.
1 = Mild to moderate sensory loss;
patient feels pinprick is less sharp or is
dull on the affected side; or there is a
loss of superficial pain with pinprick
but patient is aware he/she is being
touched.
2 = Severe to total sensory loss; patient
is not aware of being touched in the
face, arm, and leg.

9. Best Language: A great deal of information about
comprehension will be obtained during the preceding
sections of the examination. The patient is asked to
describe what is happening in the attached picture, to
name the items on the attached naming sheet, and to
read from the attached list of sentences.
Comprehension is judged from responses here as well
as to all of the commands in the preceding general
neurological exam. If visual loss interferes with the
tests, ask the patient to identify objects placed in the
hand, repeat, and produce speech. The intubated patient
should be asked to write. The patient in coma (question
1a=3) will arbitrarily score 3 on this item. The
examiner must choose a score in the patient with stupor
or limited cooperation but a score of 3 should be used
only if the patient is mute and follows no one step
commands.

0 = No aphasia, normal
1 = Mild to moderate aphasia; some
obvious loss of fluency or facility of
comprehension, without significant
limitation on ideas expressed or form
of expression. Reduction of speech
and/or comprehension, however,
makes conversation about provided
material difficult or impossible. For
example in conversation about
provided materials examiner can
identify picture or naming card from
patient’s response.
2 = Severe aphasia; all communication
is through fragmentary expression;
great need for inference, questioning,
and guessing by the listener. Range of
information that can be exchanged is
limited; listener carries burden of
communication. Examiner cannot
identify materials provided from
patient response.
3 = Mute, global aphasia; no usable
speech or auditory comprehension.

10. Dysarthria: If patient is thought to be normal an
adequate sample of speech must be obtained by asking
patient to read or repeat words from the attached list. If
the patient has severe aphasia, the clarity of articulation
of spontaneous speech can be rated. Only if the patient
is intubated or has other physical barrier to producing
speech, may the item be scored “9”, and the examiner
must clearly write an explanation for not scoring. Do
not tell the patient why he/she is being tested.

0 = Normal
1 = Mild to moderate; patient slurs at
least some words and, at worst, can be
understood with some difficulty.
2 = Severe; patient’s speech is so
slurred as to be unintelligible in the
absence of or out of proportion to any
dysphasia, or is mute/anarthric.
9 = Intubated or other physical barrier,
explain
Table continues
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Instructions

Scale definition

11. Extinction and Inattention (formerly Neglect):
Sufficient information to identify neglect may be
obtained during the prior testing. If the patient has a
severe visual loss preventing visual double
simultaneous stimulation, and the cutaneous stimuli are
normal, the score is normal. If the patient has aphasia
but does appear to attend to both sides, the score is
normal. The presence of visual spatial neglect or
anosagnosia may also be taken as evidence of
abnormality. Since the abnormality is scored only if
present, the item is never untestable.

0 = No abnormality.
1 = Visual, tactile, auditory, spatial, or
personal inattention or extinction to
bilateral simultaneous stimulation in
one of the sensory modalities.
2 = Profound hemi-inattention or
hemi-inattention to more than one
modality. Does not recognize own
hand or orients to only one side of
space.

Score

Description of Stroke
1.

2.

3.
4.

Type of stroke:
a) Ischemic ______ b) Intracerebral Hemorrhage ______
c) Subarachnoid Hemorrhage ______
d) Unclassified ______
Area of stroke:
a) Right______ b) Left ______ c) Cerebellar ______ d) Brain Stem ______
e) Other ______ f ) Unclassified ______
Communication disability: a) Yes ______ b) No ______ c) Unclassified ______
Time poststroke: ______ days
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APPENDIX M. BARTHEL INDEX
Date: _____________________________________
Identification Number: ________________________
Instructions: Choose the scoring point for the statement that most closely corresponds to
the patient’s current level of ability for each of following 10 items. Record actual, not
potential, functioning.
Activity Score
FEEDING
0 = unable
5 = needs help cutting, spreading butter, etc., or requires modified diet
10 = independent
BATHING
0 = dependent
5 = independent (or in shower)
GROOMING
0 = needs to help with personal care
5 = independent face/hair/teeth/shaving (implements provided)
DRESSING
0 = dependent
5 = needs help but can do about half unaided
10 = independent (including buttons, zips, laces, etc.)
BOWELS
0 = incontinent (or needs to be given enemas)
5 = occasional accident
10 = continent
BLADDER
0 = incontinent, or catheterized and unable to manage alone
5 = occasional accident
10 = continent
TOILET USE
0 = dependent
5 = needs some help, but can do something alone
10 = independent (on and off, dressing, wiping)
TRANSFERS (BED TO CHAIR AND BACK)
0 = unable, no sitting balance
5 = major help (one or two people, physical), can sit
10 = minor help (verbal or physical)
15 = independent
MOBILITY (ON LEVEL SURFACES)
0 = immobile or < 50 yards
5 = wheelchair independent, including corners, > 50 yards
10 = walks with help of one person (verbal or physical) > 50 yards
15 = independent (but may use any aid; for example, stick) > 50 yards
STAIRS
0 = unable
5 = needs help (verbal, physical, carrying aid)
10 = independent
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Scores

APPENDIX N. CONSENT CAPACITY GUIDE FOR CAREGIVERS
Identification Number: ________________________
Interviewer: I am going to ask you some true/false questions now.
Before each statement state: True or False read statement

Correct

1) The goal of this study is to describe caregiver experience in response to a loved
one’s health event. (T)

Yes

No

2) If I do not participate in this study, my relative or friend’s medical care will still
be provided. (T)

Yes

No

3) If I participate in this study, it will cost me a lot of money. (F)

Yes

No

4) I can decide I do not want to participate at any time. (T)

Yes

No

5) If I participate, I will have to answer questions about how I am feeling and
collect saliva samples to measure level of stress. (T)

Yes

No

Assessment: _______________________________________________________
__________________________________________________________________
Considering the risks and benefits we have discussed, what have you decided about
participating in this study?
____to participate ___not to participatewhy?:________________________________________
A subject must have a perfect score of 5 for being eligible to provide informed consent
for this study. If a subject gets a lower score, the information on the items missed may be
repeated, and the specific question/s asked again. This may be done for a total of 3 trials.
If a subject fails to obtain a score of 5 after 3 such attempts, he/she is not eligible to
participate in the study.
____Does____Does not demonstrate adequate decision-making capacity.
________________________ ___________________________ ________
Printed name of assessor
Signature of assessor
Date
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APPENDIX O. MACCAT-CR RECORD FORM FOR STROKE SURVIVORS
Understanding (Each item is rated 2–0)
Understanding Rating
2: Subject recalls the content of the item and offers a fairly clear version of it.
1: Subject shows some recollection of the item content, but describes it in a way that
renders understanding uncertain, even after the interviewer has made efforts to obtain
clarification from the subject.
0: Subject (a) does not recall the content of the item, or (b) describes it in a way that is
clearly inaccurate, or (c) describes it in a way that seriously distorts its meaning, even
after the interviewer has made efforts to obtain clarification from the subject, or offers a
response that is unrelated to the question or is unintelligible.
1. Nature of project
Description and Interview Questions: “The purpose of the research project is to
learn more about the experience of caregivers of older adults with stroke in the
first 6 weeks of caregiving. You are being asked to participate in this study
because you have been diagnosed with stroke and your family caregiver is
participating in the study. The entire study is expected to be completed within one
year. Your agreement to allow us to review your hospital records will be a onetime permission to get information about your health and stroke. You will not be
asked to do anything. A member of the research team will review your hospital
medical record to get selected information about your health, type of stroke, and
severity of stroke.” Can you tell me your understanding of what I just said? [If
subject fails to mention spontaneously, ask:]
a) What is the purpose of the research project I described to you?
Expected Answer: To learn more about the experience of caregivers of older
adults with stroke in the first 6 weeks of caregiving.
b) How long will the research project last?
Expected Answer: The entire study is expected to be completed within one
year. My agreement to allow us to review my hospital records will be a onetime permission to get information about my health and stroke.
c) What sorts of things will be done with people who agree to be in the study?
Expected Answer: I will not be asked to do anything. A member of the
research team will review my hospital medical record to get selected
information about my health and stroke.
Score
a) _______________
b) _______________
c) _______________
Subtotal: _______________
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2. Primary purpose is research
Description and Interview Questions: “It is important for you to understand that
the project in which you have been asked to participate is a research project. This
study is not treatment. The main purpose of the study is to help researchers figure
out caregiver experiences in response to a loved one’s stroke.” Can you tell me
your understanding of what I just said?
Expected Answer: The project in which I have been asked to participate is for
research, and not treatment/care.
Score
Subtotal: _______________
3. Effects on individualized care
Description and Interview Questions:
a) “If you do not choose to participate in the research study, your medical care
will still be provided.” Can you tell me your understanding of what I just said?
Expected Answer: If I do not participate in this study, my medical care will
still be provided.
b) “What will you be asked to do if you agree to participate in this research
project?”
Expected Answer: If I participate in this study, a member of the research
team will review my hospital record. I will not need to do anything.
Score
a) _______________
b) _______________
Subtotal: _______________
4. Benefits and risks/discomfort
Description and Interview Questions: “No major risks are anticipated from this
study and your privacy and confidentiality will be protected. An identification
code number will be assigned to you and the number, and not your name, will be
used to identify all the information. There is no benefit to you. This study will
guide future research and promote improved clinical practice and education for
caregivers of survivors.” Can you tell me your understanding of what I just said?
[If subject fails to mention spontaneously, ask:]
a) What are the risks?
Expected Answer: No major risks are anticipated from this study.
165

b) Will confidentially be maintained and your privacy be protected?
Expected Answer: My privacy and confidentiality will be protected. An
identification code number will be assigned to me.
c) How will you benefit from the study?
Expected Answer: There is no benefit to me.
c) Will this study guide future research and promote improved clinical practice
and education for caregivers of survivors?
Expected Answer: This study will guide future research and promote
improved clinical practice and education for caregivers of survivors.
Score
a) _______________
b) _______________
c) _______________
d) _______________
Subtotal: _______________
5. Ability to withdraw
Description and Interview Questions: “No one has to be in this study. People
who agree to be in this research project can change their minds at any time. You
can leave the study before the study ends. Nothing will happen to you, if you
decide not to be in the study.” Can you tell me your understanding of what I just
said?
Expected Answer: If I change my mind, I can withdraw at any time.
Score
Subtotal: _______________
Total Understanding Score (22–0): _______________
Appreciation (Each item is rated 2–0)
1. Object not personal benefit
Interview Questions: Earlier, we discussed benefits and risks of participation in
this study. Do you believe that you have been asked to be in this study primarily
for your personal benefit? [If yes, then:] What makes you believe that this is the
reason you were asked?
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Rating
2: Subject acknowledges that he or she is being recruited for a valid reason
unrelated to potential benefit from being in the study (e.g., because he or she has
had a stroke and has a caregiver who is willing to participate).
1: Subject acknowledges being recruited for reasons both related to and unrelated
to potential personal benefit. Or, subject maintains being recruited for a reason
related to only to potential personal benefit, but has a plausible explanation for
why this is the case.
0: Subject maintains he or she is being recruited for a reason related only to
potential personal benefit, but does not have a plausible explanation for why this
is the case. Or, subject offers response that is unrelated to the question or
unintelligible.
Score: _______________
2. Withdrawal possible
Interview Questions: What do you believe would happen if you decided not to
be in this study?
Expected Answer: If I do not participate in this study, my medical care will still
be provided.
Rating
2: Subject acknowledges that failure to participate or later withdrawal will not
adversely affect him or her (in particular, in the context of a treatment setting, that
subject can continue to receive ordinary care, assuming that this in the case).
1: Subjects is uncertain whether failure to participate or later withdraw will
adversely affect him or her. Or, subject believes failure to participate or later
withdrawal will adversely affect him or her and has a plausible explanation for
why this is the case.
0: Subject believes failure to participate or later withdrawal will adversely affect
him or her and dose not have a plausible explanation for why this is the case. Or,
subject offers response that is unrelated to the question or unintelligible.
Score: _______________
Total Appreciation Score (4–0): _______________
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Reasoning (Each item is rated 2–0)
1. Consequential reasoning
Interview Question: Do you think that you are more likely to want to participate
in the study or not participate in the study?
Expected Answer: Yes or No.
Rating
2: Subject states a choice.
1: Subject states more than one choice, seems ambivalent.
0: Subject does not state a choice.
Score: _______________
2. Comparative reasoning
Interview Question: Tell me what it is that makes that your [option named by
patient] better than [option not chosen by patient]?
Rating
2: Subject offers at least one statement in the form of a comparison at least two
options, with the comparison including a statement of at least one specific
difference. For example: “I’d prefer not to take part in the study, because I am not
comfortable someone who is not involved in my care to see my medical record.”
1: Subject makes comparison statement, but does not include a statement of a
specific consequence. For example, “It will be better if I stay out of the study”.
0: Subject makes no comparative statements.
Score: _______________
3. Generating consequences
Description and Interview Questions: “If you agree to participate in this
research project, a member of the research team will review your hospital record.
You will not be asked to do anything.” What are some ways that participating in
the study could affect your everyday activities?
Expected Answer: My participation will not affect my everyday activities.
Rating
2: Subject recalls the content of the item and offers a fairly clear version of it.
1: Subject shows some recollection of the item content, but describes it in a way
that renders understanding uncertain, even after the interviewer has made efforts
to obtain clarification from the subject.
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0: Subject (a) does not recall the content of the item; or (b) describes it in a way
that is clearly inaccurate, or (c) describe it in a way that seriously distorts its
meaning, even after the interviewer has made efforts to obtain clarification from
the subjects; or offers a response that is unrelated to the question or unintelligible.
Score: _______________
4. Logical consistency of choice
There are no specific questions. The interviewer will determine whether
participant’s statements have been consistently logical, thus, signifying ability to
provide informed consent.
Rating
2: Subject’s final choice (in Expressing a Choice) follows logically from the
subject’s own reasoning, as explained by the subject in response to the three
previous subparts.
1: It is not clear whether the choice follows logically from the subject’s own
reasoning.
0: Subject’s choice clearly does not follow logically form subject’s own reasoning.
Score: _______________
Total Reasoning Score (8–0): _______________
Expressing a Choice (Rate 2–0)
Description and Interview Questions: “As you know, you have been invited to
participate in a research project to describe caregiver experience in response a
loved one’s health event, that is, a stroke.” Do you think you are more likely to
want to participate or not to want to participate?
Expected Answer: Yes, I would like to participate in the study. Or, no, I would
not like to participate in this study.
Rating
2: Subject states a choice.
1: Subject states more than one choice, seems ambivalent.
0: Subject does not state a choice.
Score: _______________
Total Expressing a Choice Score (2–0): _______________
Total Scores (0–36): _______________ (Cut off score: 13)
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APPENDIX P. UNIVERSITY OF PENNSYLVANIA INFORMED CONSENT
FORM (CAREGIVERS)

Title of the Research Study: The effect of early uncertainty on caregiver stress and
psychological outcomes: The case of stroke survivor caregivers
Protocol Number: 813927
Principal Investigator: Lois K. Evans, PhD, RN, FAAN,
van Ameringen Professor in Nursing Excellence, University of Pennsylvania School of
Nursing, 418 Curie Boulevard, Room 419, Philadelphia, PA, 19104-4217, Telephone:
215-898-2140. Email: evans@nursing.upenn.edu
Co-investigator: Eeeseung Byun, MSN, RN, ACNP-BC, Doctoral Student, University of
Pennsylvania School of Nursing, 418 Curie Boulevard, Room 310H, Philadelphia, PA,
19104-4217, Telephone: 215-746-4454. Email: eeeseung@nursing.upenn.edu
Emergency Contact: (name, address, phone and email) Eeeseung Byun, MSN, RN,
ACNP-BC, Telephone: 215-746-4454. Email: eeeseung@nursing.upenn.edu

You are being asked to take part in a research study. This is not a form of treatment or
therapy. It is not supposed to detect a disease or find something wrong. Your
participation is voluntary which means you can choose whether or not to participate. If
you decide to participate or not to participate, there will be no loss of benefits to which
you are otherwise entitled. Before you make a decision, you will need to know the
purpose of the study, the possible risks and benefits of being in the study and what you
will have to do if you decide to participate. As the researcher, I will talk with you about
the study and give you this consent form to read. You do not have to make a decision
now; you can take the consent form home and share it with your family, friends, or
family doctor and family.
If you do not understand what you are reading, do not sign it. Please ask me, the
researcher, to explain anything you do not understand, including any language contained
in this form. If you decide to participate, you will be asked to sign this form and a copy
will be given to you. Keep this form; in it you will find contact information and answers
to questions about the study. You may ask to have this form read to you.

What is the purpose of the study?
The purpose of the study is to learn more about the feelings and experiences of caregivers
of older adults with stroke in the first 6 weeks of caregiving. The study is a doctoral
dissertation in the School of Nursing, University of Pennsylvania.
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Why was I asked to participate in the study?
You are being asked to join this study because you (a) are a family member or friend of
an older adult (age 65 or older) who was diagnosed with new or recurrent stroke within
the past 2 weeks, (b) expect to be the primary caregiver for this older adult with stroke,
(c) can communicate in English, (d) are able to demonstrate capacity for informed
consent and (e) are age 21or older.
How long will I be in the study? How many other people will be in the study?
If you decide to participate in the study, you will be involved for about four weeks. You
will be interviewed in-person two times: within two weeks after the older person’s stroke
while they are still in the hospital and again four weeks later. This will take about 40–50
minutes for the first interview and 30–40 minutes for the second interview.
On a day following each interview, you will be also asked to collect your saliva (spit)
using a sponge that you will place in your mouth for one minute twice in the same day.
Collecting and labeling each saliva (spit) sample will take up to 5 minutes.
With the permission from your older adult with stroke, we will also review their hospital
medical record to get information about his/her health, the type of stroke he/she has had
and the severity of his/her stroke.
You will be one of 230 participants (115 caregivers and 115 stroke survivors) in the study.
The entire study is expected to be completed within one year.
Where will the study take place?
Depending on your preference, you will be interviewed for the first time at hospital, your
home, or another convenient location. For the second interview [four weeks later] you
can be interviewed at home or another convenient location.
You will collect your own saliva (spit) sample at home.
What will I be asked to do?
You will be asked to respond to questions asked by the researcher who will read the
questions aloud and record your answers. You will be given a written copy of the
questions to view at the same time. This will take about 40–50 minutes for the first
interview and 30–40 minutes for the second interview. The interview questions include
information about you (for example, your age, gender, education, caregiving experience);
questions about your feelings of uncertainty, stress, depression and caregiving burden, as
well as your quality of life, health, ways of coping, and social support. You will be also
asked about your older adults’ functional status and characteristics (for example, age,
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gender, education). If any of the information is missing, you will be re-contacted by
investigator over the phone in an attempt to complete the information.
You will be also asked to collect your saliva (spit) to assess your biologic stress level
(salivary cortisol) using a sponge that you will place in your mouth for one minute twice
in the same day: 1) within 2 weeks after stroke and 2) 4 weeks after the first interview.
Collecting each saliva sample will take up to 5 minutes. You will place the samples in a
plastic bag and keep them in your freezer overnight. The researcher will pick up the
saliva samples or you will place the bag in a pre-paid FedEx clinical envelope and mail it
to the researcher.
What are the risks?
No major risks are expected from this study. You, however, may become tired while
answering the interview questions or you may feel upset discussing your experience in
taking care of your older adult family member/friend with a stroke. If you become tired,
you may stop and complete the interview later. If you experience uncomfortable feelings
and upset during the interview, you may take a break in the interview. The investigator is
prepared to be sensitive and respectful if you decide not to participate or not to answer
some of the questions. You may withdraw from the study at any time. You will not be
asked to answer any questions that you do not wish to answer. To protect your privacy, a
quiet place will be provided for an interview that is held in the hospital or another
healthcare facility, with permission of the facility.
If you feel severely distressed during the hospital-based interview at the hospital, the
investigator will contact a hospital-based psychiatric counseling service for your
assistance. If you should develop this response during the interview at your home or other
location, the investigator will help you contact emergency psychiatric services for your
assistance.
All information including completed interview tools and coded computerized information
will be cared for in a manner to protect your privacy and confidentiality. An
identification code number will be assigned to you, and will be used to identify all the
information you provide so that your name will not be placed at risk for identification. To
ensure confidentiality, all research information will be kept in a locked filing cabinet in a
secure area at the University of Pennsylvania School of Nursing and only the researchers
will be allowed to see your personal data. In addition, all information in computerized
files will be stored using a special protection tool specifically for research studies. No
individual identifying information will be made public in any presentations or
publications of the results of this study.
How will I benefit from the study?
There is no benefit to you. Your participation could help us understand the caregiving
experience for older family members or friends with stroke, however, which can benefit
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you indirectly. This study will guide future research and promote improved clinical
practice and education for caregivers of stroke survivors. You may feel satisfaction from
having had the opportunity to participate in the study and contribute to increased
knowledge in science.
What other choices do I have?
Your alternative to being in the study is to not be in the study.
What happens if I do not choose to join the research study?
You may choose to join the study or you may choose not to join the study. Your
participation is voluntary.
If you choose not to join the research study, you will lose no benefits or advantages that
are now coming to you, or would come to you in the future. Neither will this decision
affect the care for your older family member or friend with stroke. His or her health care
providers will not be upset with your decision either way.
When is the study over? Can I leave the study before it ends?
The study is expected to end after all participants have completed all interviews and
provided saliva samples. Your role in the study is complete after your second interview
and return of the second set of saliva samples. The overall study may be stopped without
your consent for the following reasons:
o The investigators, the sponsor or the Office of Regulatory Affairs at the
University of Pennsylvania can stop the study anytime
You have the right to drop out of the study at any time during your participation. There is
no loss of benefits to which you are otherwise entitled if you decide to do so. Withdrawal
will not interfere with your future care.
If you no longer wish to be in the research study, please contact Eeeseung Byun at 215746-4454 and talk with her directly or leave a message regarding your wish to voluntarily
withdraw from the study.
How will confidentiality be maintained and my privacy be protected?
The researcher will make every effort to keep all the information you share during the
study strictly confidential, as required by law. The Institutional Review Board (IRB) at
the University of Pennsylvania is responsible for protecting the rights and welfare of
research volunteers like you. The IRB has access to study information. Any forms you
sign where you can be identified by name will be kept in a locked drawer in a safe area at
the University of Pennsylvania School of Nursing. These forms will be kept confidential.
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All these forms will be destroyed when the study is over.
Will I have to pay for anything?
There are no costs associated with participating in the study.
Will I be paid for being in this study?
You will receive a $10 gift card upon completion of the quantitative interview and
collection of saliva samples for each of two times: 1) within 2 weeks after stroke and 2) 4
weeks after the first interview (a total maximum value of $20).
Who can I call with questions, complaints or if I’m concerned about my rights as a
research subject?
If you have questions, concerns or complaints regarding your participation in this
research study or if you have any questions about your rights as a research subject, you
should speak with the Principal Investigator listed on page one of this form. If a she or
the researcher cannot be reached or you want to talk to someone other than those working
on the study, you may contact the Office of Regulatory Affairs with any question,
concerns or complaints at the University of Pennsylvania by calling (215) 898-2614.
When you sign this form, you are agreeing to take part in this research study. This means
that you have read the consent form, your questions have been answered, and you have
decided to volunteer. Your signature also means that you are permitting the University of
Pennsylvania to use your personal health information collected about you for research
purposes within our institution. You are also allowing the University of Pennsylvania to
disclose that personal health information to outside organizations or people involved with
the operations of this study. If you have any questions or there is something you do not
understand, please ask. You will receive a copy of this consent form.
________________________________________
Signature of Participant

__________________
Date

________________________________________
Print Name of Participant

__________________
Date

________________________________________
Signature of Investigator

__________________
Date

________________________________________
Print Name of Investigator

__________________
Date
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APPENDIX Q. UNIVERSITY OF PENNSYLVANIA INFORMED CONSENT
AND HIPAA AUTHORIZATION FORM (STROKE SURVIVORS)

Title of the Research Study: The effect of early uncertainty on caregiver stress and
psychological outcomes: The case of stroke survivor caregivers
Protocol Number: 813927
Principal Investigator: Lois K. Evans, PhD, RN, FAAN,
van Ameringen Professor in Nursing Excellence, University of Pennsylvania School of
Nursing, 418 Curie Boulevard, Room 419, Philadelphia PA 19104-4217, Telephone: 215898-2140. Email: evans@nursing.upenn.edu
Co-investigator: Eeeseung Byun, MSN, RN, ACNP-BC, Doctoral Student, University of
Pennsylvania School of Nursing, 418 Curie Boulevard, Room 310H, Philadelphia, PA,
19104-4217, Telephone: 215-746-4454. Email: eeeseung@nursing.upenn.edu
Emergency Contact: Eeeseung Byun, MSN, RN, ACNP-BC, Telephone: 215-746-4454.
Email: eeeseung@nursing.upenn.edu

You are being asked help with a research study by allowing us to see your hospital
medical record information. This is not a form of treatment or therapy. It is not supposed
to detect a disease or find something wrong. Your agreement is voluntary which means
you can choose whether or not to allow us to see your hospital medical record. If you
decide not to allow us to see your hospital medical record, there will be no loss of
benefits to which you are otherwise entitled. Before you make a decision you will need to
know the purpose of the research study, the possible risks and benefits of sharing your
hospital medical record information and what you will have to do if you agree. The
researcher is going to talk with you about the study and give you this consent form to
read. You do not have to make a decision now; you can keep the consent form
and discuss it with your family, friends and health care providers.
If you do not understand what you are reading, do not sign it. Please ask the researcher to
explain anything you do not understand, including any language contained in this form. If
you decide allow us to use your hospital medical record information, you will be asked to
sign this form and a copy will be given to you. Keep this form; in it you will find contact
information and answers to questions about the study. You may ask to have this form
read to you.
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What is the purpose of the study?
The purpose of the study is to learn more about the experience of caregivers of older
adults with stroke in the first 6 weeks of caregiving. This is a doctoral dissertation study
being conducted at the School of Nursing, University of Pennsylvania.
Why was I asked to participate in the study?
You are being asked to allow us to see your hospital medical record because (a) your
family or friend caregiver is participating in the study, (b) you have been diagnosed with
new or recurrent stroke, (c) you are within the first 2 weeks after having had the stroke,
(d) you are age 65 or older, and (e) you can communicate in English.
How long will I be in the study? How many other people will be in the study?
The entire study is expected to be completed within one year. Your agreement to allow us
to review your hospital medical record will be a one time to get information about your
health, the type of stroke you have had and the severity of your stroke.
You will be one of 230 participants (115 caregivers and 115 stroke survivors) in the study.
Where will the study take place?
If you agree, the researcher will review your hospital medical record at the hospital.
What will I be asked to do?
You will not be asked to do anything. The researcher will review your hospital medical
record to get selected information about your health, type of stroke and severity of stroke.
What are the risks?
No major risks are anticipated from this study.
The form onto which the information from your hospital medical record is written and the
computerized file will be handled and processed in a way to protect your privacy and
confidentiality. An identification code number will be assigned to your caregiver who is
participating in the study, and will be used to identify all the information including the
information from your hospital medical record. No personal names will be attached in
order to prevent your identification. To ensure confidentiality, all research information
will be kept in a locked filing cabinet in a secure area at University of Pennsylvania
School of Nursing and only the investigator will be allowed to access the information. In
addition, all computerized information will be stored using a special secure tool for
research studies. No individual identifying information will be shared in scientific
presentations or published papers in which study results are presented.
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How will I benefit from the study?
There is no benefit to you. Your agreement to allow us see your hospital medical record
could help us understand the caregiving experience for older adults with stroke, however,
which can benefit you indirectly. This study will guide future research and promote
improved clinical practice and education for caregivers of stroke survivors. You may feel
satisfaction from having had the opportunity to participate in the study and contribute to
increased knowledge in science.
What other choices do I have?
Your alternative to agreeing to allow the researcher to review your hospital medical
record is to not agree.
What happens if I do not choose to join the research study?
You may choose to allow the researcher to review your hospital medical record or you
may choose not to. Your participation is voluntary.
If you choose not to allow the researcher to review your hospital medical record, you will
lose no benefits or advantages that are now coming to you, or would come to you in the
future, nor will it affect the care you receive at the hospital. Your health care providers
will not be upset with your decision.
When is the study over? Can I leave the study before it ends?
Your hospital medical record will be reviewed only once while you are still in the
hospital to get information about your health, the type of stroke you have had and the
severity of your stroke. No further information regarding your medical condition will be
collected. The entire study with 230 participants (115 caregivers and 115 stroke
survivors) is expected to end after all the information from caregivers and the stroke
survivors for whom they care has been collected. The study may be stopped at any time
without consent of the caregiver participants by the researchers, the sponsor or the Office
of Regulatory Affairs at the University of Pennsylvania.
You have the right to ask that your hospital medical record information be removed from
the research study at any time during your caregiver participation. There is no loss of
benefits to which you are otherwise entitled if you decide to do so. Withdrawal will not
interfere with your future care.
If you no longer wish your hospital medical record information to be included in the
study, please contact Eeeseung Byun at 215-746-4454 and talk with her directly or leave
a message regarding your wish.
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How will confidentiality be maintained and my privacy be protected?
The research team will make every effort to keep all the information we review from
your hospital medical record for this study strictly confidential, as required by law. The
Institutional Review Board (IRB) at the University of Pennsylvania is responsible for
protecting the rights and welfare of research volunteers like you. The IRB has access to
study information. Any forms you sign where you can be identified by name will be kept
in a locked drawer in secure area at the University of Pennsylvania School of Nursing.
These forms will be kept confidential. All of these forms will be destroyed when the
study is over.
Will I have to pay for anything?
There are no costs associated with allowing the researcher to review your hospital
medical record.
Will I be paid for being in this study?
Your caregiver who is participating in the study will receive a gift card for each of the
two times s/he is interviewed.
Who can see or use my information? How will my personal information be
protected?
A federal regulation known as the Privacy Rule gives you certain rights concerning the
privacy of your health information. The Privacy Rule was issued under a law called the
Health Insurance Portability and Accountability Act of 1996 (HIPAA). Researchers
covered by this regulation are required to get your permission to use and share with
others any health information that could identify you. If you sign this informed consent
form, you are giving permission for the use and disclosure of your health information for
purposes of this research study. You do not have to give this permission. We will do our
best to make sure that the personal information from your hospital medical record will be
kept private. However, we cannot guarantee total privacy. Your personal information
may be given out if required by law. If information from this study is published or
presented at scientific meetings, your name and other personal information will not be
used.
What information about me may be collected, used or shared with others?
The study team will record the information regarding your health, type and severity of
stroke on study forms. Your name will not appear on the study forms. Instead, subject
identification number assigned to your caregiver will be written on your forms.
Representatives from the groups identified below may need to look at your hospital
medical records to make sure that the information on the study forms is correct or that the
study was conducted properly. Reviews like that will take place at the study center or
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where the hospital medical records are stored and can take place after the study is over.
Why is my information being used?
Your information will be used to:
 do the research
 oversee the research
 to see if the research was done right.
Who may use and share information about me?
The following individuals may use or share your information for this research study:
 The principal investigator (researcher) for the study and her faculty mentor
 Other authorized personnel at University of Pennsylvania
Who, outside of the School of Medicine, might receive my information?
Your personal health information may be shared with the following people or groups:
 University of Pennsylvania School of Nursing
 The institutional review board (ethics committee) that approved this study and
any other committees responsible for overseeing the research
 Government health agencies in the US or other countries.
Representatives from these groups may receive information from your caregiver’s study
forms or may review your medical records (as described above) or both. Once your
personal health information is disclosed to others outside the School of Medicine, it may
no longer be covered by federal privacy protection regulations. The Principal Investigator
or study staff will inform you if there are any additions to the list above during your
active participation in the trial. Any additions will be subject to University of
Pennsylvania procedures developed to protect your privacy.
How long may the School of Medicine use or disclose my personal health
information?
Your authorization for use of your personal health information for this specific study
does not expire. Your personal health information may be held in a research database.
However, the School of Medicine may not re-use or re-disclose information collected in
this study for a purpose other than this study unless:
 You have given written authorization
 The University of Pennsylvania’s Institutional Review Board grants
permission
 As permitted by law
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Can I change my mind about giving permission for use of my information?
Yes. You may withdraw or take away your permission to disclose and use your health
information. You do this by contacting Eeeseung Byun at 215-746-4454 and talking with
her directly or leaving a message regarding your wish to voluntarily withdraw from the
study. If you withdraw your permission, your information will not be used.
What if I decide not to give permission to use and give out my health information?
You will be given a copy of this Research Subject HIPAA Authorization describing your
confidentiality and privacy rights for this study. By signing this document you are
permitting the School of Nursing to use and disclose personal health information
collected about you for research purposes as described above.
How will confidentiality be maintained and my privacy be protected?
The researcher will make every effort to keep all the information you give us during the
study strictly confidential, as required by law. The Institutional Review Board (IRB) at
the University of Pennsylvania is responsible for protecting the rights and welfare of
research volunteers. Your personal information may be shared with others if required by
law. The IRB has access to study information.
Since this is a study about your caregiver, we will assign an identification number to your
caregiver when consents are obtained. All related data we collect about you from your
hospital medical record will carry that code rather than your name, social security number
or hospital record number. The researcher who collects the information will have access
to private information about you as an individual. All information will be stored in a
locked office in a locked cabinet. Any forms you sign where you can be identified by
name will be kept in a locked drawer in a locked office. These forms will be kept
confidential. All the documents will be destroyed when the study is over.
Who can I call with questions, complaints or if I’m concerned about my rights as a
research subject?
If you have questions, concerns or complaints regarding sharing your personal
information as part of this research study or if you have any questions about your rights
in sharing such information, you should speak with the Principal Investigator listed on the
first page of this form. If she or the researcher cannot be reached or you want to talk to
someone other than those working on the study, you may contact the Office of
Regulatory Affairs with any question, concerns or complaints at the University of
Pennsylvania by calling (215) 898-2614.
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When you sign this form, you are agreeing to allow us to see your hospital medical
record. This means that you have read the consent form, your questions have been
answered, and you have decided to volunteer. Your signature also means that you are
permitting the University of Pennsylvania to use your personal health information
collected about you for research purposes within our institution. You are also allowing
the University of Pennsylvania to disclose that personal health information to outside
organizations or people involved with the operations of this study. If you have any
questions or there is something you do not understand, please ask. You will receive a
copy of this consent form.
________________________________________
Signature of Participant

__________________
Date

________________________________________
Print Name of Participant

__________________
Date

________________________________________
Signature of Surrogate
If surrogate signs this form

__________________
Date

________________________________________
Print Name of Surrogate
If surrogate signs this form

__________________
Date

________________________________________
Signature of Investigator

__________________
Date

________________________________________
Print Name of Investigator

__________________
Date
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APPENDIX R. PATIENT AGREEMENT FORM
AGREEMENT TO PARTICIPATE IN RESEARCH
[Experience of caregivers for older adults with stroke]
My name is Eeeseung Byun. I am a graduate student at the School of Nursing, University
of Pennsylvania. I am studying the experience of caregivers for older adults with stroke.
I am talking with you today because I am trying to learn more about the experience of
caregivers for older adults with stroke in the first 6 weeks of caregiving, and your
family/friend caregiver has agreed to be a join in this study.
If you agree, I will see your hospital medical record to get information about your health,
the type of stroke you have had, and severity of the stroke. You will not need to do
anything.
No major risks are expected from your allowing me to look at your hospital medical
record as part of this study.
The form onto which the information from your hospital medical record will be written
and the computerized research file will be handled and kept safely in a way to protect
your privacy.
There is no benefit to you. Having being able to use your health information could help
us understand the caregiving experience for older adults with stroke, however, which can
benefit you indirectly.
Please talk this over with your family, friend or health care providers before you decide
whether or not to agree. We will also ask your family or friend to give their permission to
allow us to look at your hospital medical record. But even if your family or friend says
“yes,” you can still decide not to allow it.
If you don’t want your medical record information to be used in this study, you do not
have to agree. Remember, sharing this information is up to you and no one will be mad if
you don’t want to participate or even if you change your mind later and want to stop.
You can ask any questions that you have about this study. If you have a question later
that you didn’t think of now, you can call me (215-746-4454) or ask me the next time you
see me.
Signing your name below means that you agree to for your hospital medical record
information to be used in this study. You and your family or friend caregiver will be
given a copy of this form after you sign it.
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________________________________________
Signature of Participant

__________________
Date

________________________________________
Print Name of Participant

__________________
Date

________________________________________
Signature of Investigator

__________________
Date

________________________________________
Print Name of Investigator

__________________
Date

Contact Information: Eeeseung Byun, MSN, RN, ACNP-BC, Doctoral Student,
University of Pennsylvania School of Nursing, 418 Curie Boulevard, Room 310H,
Philadelphia, PA, 19104-4217, Telephone: 215-746-4454. Email:
eeeseung@nursing.upenn.edu
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APPENDIX S. THOMAS JEFFERSON UNIVERSITY INFORMED CONSENT
DOCUMENT FOR HUMAN-SUBJECTS RESEARCH (CAREGIVERS)

Department:

Nursing

Principal Investigator:
Meg Bourbonniere, PhD, RN
Telephone: 215-503-6122
Co-Investigator(s): Lois Evans, PhD, RN, FAAN
Telephone: 215-898-2140
Co-Investigator(s): Eeeseung Byun, PhD(c), MSN, RN, ACNP-BC
Telephone: 215-746-4454
Nursing Study Title: The effect of early uncertainty on caregiver stress and
psychological outcomes: The case of stroke survivor caregivers
Lay Study Title:

Experience of Caregivers for Older Adults with Stroke

What Is Informed Consent?
You are being asked to take part in a nursing research study. As required by federal
regulations, this research study has been reviewed and approved by an Institutional
Review Board (IRB), a University committee that reviews, approves and monitors
research involving humans. Before you can make a knowledgeable decision about
whether to participate, you should understand the possible risks and benefits related to
this study. This process of learning and thinking about a study before you make a
decision is known as informed consent and includes:
 Receiving detailed information about this research study;
 Being asked to read, sign and date this consent form, once you understand the
study and have decided to participate. If you don’t understand something
about the study or if you have questions, you should ask for an explanation
before signing this form;
 Being given a copy of the signed and dated consent form to keep for your own
records.
What is the purpose of this study?
The purpose of the study is to learn more about the feelings and experiences of caregivers
of older adults with stroke in the first 6 weeks of caregiving. The study is a doctoral
dissertation in the School of Nursing, University of Pennsylvania.
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Why was I asked to participate in the study?
You are being asked to join this study because you (a) are a family member or friend of
an older adult (age 65 or older) who was diagnosed with new or another stroke within the
past 2 weeks, (b) expect to be the primary caregiver for this older adult with stroke,
(c) can communicate in English, (d) are able to demonstrate an understanding of the
informed consent and (e) are age 21or older.
How many individuals will participate in the study and how long will the study last?
230 participants (115 caregivers and 115 stroke survivors) from the Thomas Jefferson
University Hospitals and University of Pennsylvania Health System will participate in the
study. We hope to enroll at least 130 participants (65 caregivers and 65 stroke survivors)
at Jefferson. Your involvement in the study will last about 6 weeks. The entire study will
take about 12 months to complete.
What will I have to do during the study?
You will be asked to respond to questions asked by the researcher who will read the
questions aloud and record your answers. You will be given a written copy of the
questions to view at the same time. This will take about 40–50 minutes for the first
interview and 30–40 minutes for the second interview. The interview questions include
information about you (for example, your age, sex, education, caregiving experience);
questions about your feelings of uncertainty, stress, depression and caregiving burden, as
well as your quality of life, health, ways of coping, and social support. You will be also
asked about your older adults’ functional status and characteristics (for example, age, sex,
education). If any of the information is missing, you will be re-contacted by the
investigator over the phone in an attempt to complete the information.
You will also be asked to collect your saliva (spit) to assess your biologic stress by
measuring a substance in saliva (salivary cortisol) using a sponge that you will place in
your mouth for one minute twice in the same day: 1) within 2 weeks after stroke and 2) 4
weeks after the first interview. Collecting each saliva sample will take up to 5 minutes.
You will place the samples in a plastic bag and keep them in your freezer overnight. The
researcher will pick up the saliva samples or you will place the bag in a pre-paid FedEx
clinical envelope and mail it to the researcher.
What are the risks or discomforts involved?
No major risks are expected from this study. You may become tired while answering the
interview questions or you may feel upset discussing your experience in taking care of
your older adult family member/friend with a stroke. If you become tired, you may stop
and complete the interview later. If you experience uncomfortable feelings and upset
during the interview, you may take a break in the interview. The investigator is prepared
to be sensitive and respectful if you decide not to participate or not to answer some of the
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questions. You may withdraw from the study at any time. You will not be asked to
answer any questions that you do not wish to answer. To protect your privacy, a quiet
place will be provided for an interview that is held in the hospital or another healthcare
facility, with permission of the facility.
If you feel severely distressed during the interview at the hospital, and if you agree, the
investigator will contact a hospital-based psychiatric counseling service for your
assistance. If you should develop this response during the interview at your home or other
location, the investigator will help you contact emergency psychiatric services for your
assistance.
Are there alternatives to being in the study?
Your alternative to being in the study is to not be in the study.
How will privacy and confidentiality (identity) be protected?
All information including completed interview results and coded computerized
information will be cared for in a manner to protect your privacy and confidentiality. An
identification code number will be assigned to you, and will be used to identify all the
information you provide so that your name will not be placed at risk for identification. To
ensure confidentiality, all research information will be kept in a locked filing cabinet in a
secure area at the University of Pennsylvania School of Nursing and only the researchers
will be allowed to see your personal data. In addition, all information in computerized
files will be stored using a special protection program specifically for research studies.
No individual identifying information will be made public in any presentations or
publications of the results of this study.
The researcher will make every effort to keep all the information you share during the
study strictly confidential, as required by law. The Institutional Review Board (IRB) is
responsible for protecting the rights and welfare of research volunteers like you. The IRB
has access to study information. Any forms you sign where you can be identified by
name will be kept separate from your questionnaires in a locked drawer in a safe area at
the University of Pennsylvania School of Nursing. These forms will be kept confidential.
All these forms will be destroyed when the study is over.
The information from this study may be published in scientific journals or presented at
scientific meetings but you will not be personally identified in these publications and
presentations.
Will I benefit from being in this study?
There is no benefit to you. Your participation could help us understand the caregiving
experience for older family members or friends with stroke, however, which can benefit
you indirectly. We hope this study will guide future research and promote improved
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clinical practice and education for caregivers of stroke survivors. You may feel
satisfaction from having had the opportunity to participate in the study and contribute to
increased knowledge in science.
Will I be paid for being in this study?
You will receive a $10 gift card upon completion of the quantitative interview and
collection of saliva samples for each of two times: 1) within 2 weeks after stroke and 2) 4
weeks after the first interview (a total maximum value of $20).
Will I be told about any new findings?
You will not receive the study results or other data about the study. However, this study
will guide future research and promote improved clinical practice and education for
caregivers of stroke survivors.
Are there costs related to being in this study?
There are no costs associated with participating in the study.
Can I be removed from the study or quit the study?
Your decision to participate in this research study is entirely voluntary. You have been
told what being in this study will involve, including the possible risks and benefits.
Your participation in this research project may be terminated by the researcher for any
reason.
You may refuse to participate in this investigation or withdraw consent and quit this
study without penalty and without affecting the care for your older family member or
friend with stroke at the Thomas Jefferson University. His or her health care providers
will not be upset with your decision either way. If you no longer wish to be in the
research study, please contact Eeeseung Byun at 215-746-4454 (or Dr. Meg
Bourbonniere at 215-503-6122) and talk with her directly or leave a message regarding
your wish to voluntarily withdraw from the study.
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CONTACT INFORMATION

Telephone number for questions
about your rights as a research
participant

The Jefferson Institutional
Review Board

For questions, concerns or
complaints about the research, or
if you suspect a research-related
injury

The Principal Investigator,
Dr. Meg Bourbonniere
Co-investigators,
Dr. Lois Evans
Eeeseung Byun

If you have difficulty contacting
the study staff

Call the Jefferson Office of
Human Research

215-503-8966

215-503-6122
215-898-2140
215-746-4454
215-503-0203

If you want more information about the Jefferson Institutional Review Board or
Jefferson’s Human Research Protection Program, please visit our website at
http://www.jefferson.edu/human_research/irb/index.cfm.
Non-Waiver of Legal Rights Statement
By your agreement to participate in this study, and by signing this consent form,
you are not waiving any of your legal rights.
In order to be in this research study, you must sign this consent form.
You affirm that you have read this consent form. You have been told that you will
receive a copy.
Signatures:
________________________________________
Your Name (Please print or type)

__________________
Date

________________________________________
Your Signature

__________________
Date

________________________________________
Name of Person Conducting Consent Interview

__________________
Date

________________________________________
Signature of Person Conducting Consent Interview

__________________
Date

______________________________________
Signature of Principal Investigator or Co-Investigator

__________________
Date
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APPENDIX T. THOMAS JEFFERSON UNIVERSITY INFORMED CONSENT
DOCUMENT FOR HUMAN-SUBJECTS RESEARCH (STROKE SURVIVORS)

Department:

Nursing

Principal Investigator:
Meg Bourbonniere, PhD, RN
Telephone: 215-503-6122
Co-Investigator(s): Lois Evans, PhD, RN, FAAN
Telephone: 215-898-2140
Co-Investigator(s): Eeeseung Byun, PhD(c), MSN, RN, ACNP-BC
Telephone: 215-746-4454
Nursing Study Title: The effect of early uncertainty on caregiver stress and
psychological outcomes: The case of stroke survivor caregivers
Lay Study Title:

Experience of Caregivers for Older Adults with Stroke

What Is Informed Consent?
You are being asked to take part in a nursing research study. As required by federal
regulations, this research study has been reviewed and approved by an Institutional
Review Board (IRB), a University committee that reviews, approves and monitors
research involving humans. Before you can make a knowledgeable decision about
whether to participate, you should understand the possible risks and benefits related to
this study. This process of learning and thinking about a study before you make a
decision is known as informed consent and includes:
 Receiving detailed information about this research study;
 Being asked to read, sign and date this consent form, once you understand the
study and have decided to participate. If you don’t understand something
about the study or if you have questions, you should ask for an explanation
before signing this form;
 Being given a copy of the signed and dated consent form to keep for your own
records.
What is the purpose of this study?
The purpose of the study is to learn more about the feelings and experiences of caregivers
of older adults with stroke in the first 6 weeks of caregiving. The study is a doctoral
dissertation in the School of Nursing, University of Pennsylvania.
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Why was I asked to participate in the study?
You are being asked to allow us to see your hospital medical record because (a) your
family or friend caregiver is participating in the study, (b) you have been diagnosed with
new or another stroke, (c) you are within the first 2 weeks after having had the stroke, (d)
you are age 65 or older, and (e) you can communicate in English.
How many individuals will participate in the study and how long will the study last?
230 participants (115 caregivers and 115 stroke survivors) from the Thomas Jefferson
University Hospitals and University of Pennsylvania Health System will participate in the
study. We hope to enroll at least 130 participants (65 caregivers and 65 stroke survivors)
at Jefferson. Your involvement in the study will last about 6 weeks. The entire study will
take about 12 months to complete.
What will I have to do during the study?
You will not be asked to do anything. The researcher will review your hospital medical
record to get selected information about your health, type of stroke and severity of stroke.
What are the risks or discomforts involved?
No major risks are anticipated from this study.
Are there alternatives to being in the study?
Your alternative to agreeing to allow the researcher to review your hospital medical
record is to not agree.
How will privacy and confidentiality (identity) be protected?
The form onto which the information from your hospital medical record is written and the
computerized file will be handled and processed in a way to protect your privacy and
confidentiality. An identification code number will be assigned to your caregiver who is
participating in the study, and will be used to identify all the information including the
information from your hospital medical record. No personal names will be attached in
order to prevent your identification. To ensure confidentiality, all research information
will be kept in a locked filing cabinet in a secure area at University of Pennsylvania
School of Nursing and only the investigator will be allowed to access the information. In
addition, all computerized information will be stored using a special secure program for
research studies. No individual identifying information will be shared in scientific
presentations or published papers in which study results are presented.
Federal regulations require that certain information about individuals be kept confidential.
This information is called “protected health information” (PHI). PHI includes
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information that identifies you personally such as name, address and social security
number, or any medical or mental health record, or test result, that may have this sort of
information on it. The laws state that you may see and review your TJU or Thomas
Jefferson University Hospital medical records at any time.
If you sign this informed consent form, you are giving permission for the use and
disclosure of your PHI for purposes of this research study. You do not have to give this
permission. The following individuals or entities may have access to your PHI and by
law must protect it. These include investigators listed on this consent form and other
personnel of Thomas Jefferson University and Thomas Jefferson University Hospitals,
Inc. involved in this specific study, the University’s Division of Human Subjects
Protection and the Institutional Review Board (IRB). It may also be provided to other
people or groups as follows:
 Authorized personnel at University of Pennsylvania.

Your PHI may also be shared with the following entities that, while not obligated by law
to protect PHI, will protect it to the best of their ability:
 University of Pennsylvania School of Nursing
 University of Pennsylvania Institutional review board (ethics committee) that
approved this study and any other committees responsible for overseeing the
research
 Government health agencies in the US or other countries
 Any person or agency required by law.
The following information will be provided to the study sponsor and other entities noted
above:
Your health, the type of stroke you have had and the severity of your stroke.
The information from this study may be published in scientific journals or presented at
scientific meetings but you will not be personally identified in these publications and
presentations.
You may withdraw or take away your permission to disclose and use your PHI. You do
this by contacting Eeeseung Byun at 215-746-4454 (or Dr. Meg Bourbonniere at 215503-6122) and talking with her directly or leaving a message regarding your wish to
voluntarily withdraw from the study. If you withdraw your permission, your information
will not be used.
Will I benefit from being in this study?
There is no benefit to you. Your agreement to allow us see your hospital medical record
could help us understand the caregiving experience for older adults with stroke, however,
191

which can benefit you indirectly. We hope this study will guide future research and
promote improved clinical practice and education for caregivers of stroke survivors. You
may feel satisfaction from having had the opportunity to participate in the study and
contribute to increased knowledge in science.
Will I be paid for being in this study?
Your caregiver who is participating in the study will receive a gift card for each of the
two times s/he is interviewed.
Will I be told about any new findings?
You will not receive the study results or other data about the study. However, this study
will guide future research and promote improved clinical practice and education for
caregivers of stroke survivors.
Are there costs related to being in this study?
There are no costs associated with participating in the study.
Can I be removed from the study or quit the study?
You may choose to allow the researcher to review your hospital medical record or you
may choose not to. Your participation is voluntary.
If you choose not to allow the researcher to review your hospital medical record, you will
lose no benefits or advantages that are now coming to you, or would come to you in the
future, nor will it affect the care you receive at the hospital. Your health care providers
will not be upset with your decision.
You may withdraw or take away your permission to disclose and use your hospital record
by contacting Eeeseung Byun at 215-746-4454 (or Dr. Meg Bourbonniere at 215-5036122) and talking with her directly or leaving a message regarding your wish to
voluntarily withdraw from the study.
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CONTACT INFORMATION

Telephone number for questions
about your rights as a research
participant

The Jefferson Institutional
Review Board

For questions, concerns or
complaints about the research, or
if you suspect a research-related
injury

The Principal Investigator,
Dr. Meg Bourbonniere
Co-investigators,
Dr. Lois Evans
Eeeseung Byun

If you have difficulty contacting
the study staff

Call the Jefferson Office of
Human Research

215-503-8966

215-503-6122
215-898-2140
215-746-4454
215-503-0203

If you want more information about the Jefferson Institutional Review Board or
Jefferson’s Human Research Protection Program, please visit our website at
http://www.jefferson.edu/human_research/irb/index.cfm.
Non-Waiver of Legal Rights Statement
By your agreement to participate in this study, and by signing this consent form,
you are not waiving any of your legal rights.
In order to be in this research study, you must sign this consent form.
You affirm that you have read this consent form. You have been told that you will
receive a copy.
Signatures:
________________________________________
Your Name (Please print or type)

__________________
Date

________________________________________
Your Signature

__________________
Date

________________________________________
Name of Person Conducting Consent Interview

__________________
Date

________________________________________
Signature of Person Conducting Consent Interview

__________________
Date

________________________________________
Signature of Principal Investigator or Co-Investigator

__________________
Date
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APPENDIX U. THOMAS JEFFERSON UNIVERSITY SURROGATE CONSENT
FOR A RESEARCH PROTOCOL
Department:

Nursing

Principal Investigator:
Meg Bourbonniere, PhD, RN
Telephone: 215-503-6122
Co-Investigator(s): Lois Evans, PhD, RN, FAAN
Telephone: 215-898-2140
Co-Investigator(s): Eeeseung Byun, PhD(c), MSN, RN, ACNP-BC
Telephone: 215-746-4454
Nursing Study Title: The effect of early uncertainty on caregiver stress and
psychological outcomes: The case of stroke survivor caregivers
Lay Study Title:

Experience of Caregivers for Older Adults with Stroke

Name of Subject: ____________________________________________________________________________
COMPLETE SECTIONS “A,” “B” AND “C” BELOW.

A.

REASON FOR SURROGATE CONSENT:

______ The subject is unable to give informed consent.
 Reason for Subject’s Inability To Give Informed Consent:1
_______________________________________________________________
_______________________________________________________________
B.

SURROGATE INFORMATION:

______ COURT ORDER AUTHORIZING GUARDIAN CONSENT
Date of Order: ___________ Name of Guardian: _______________________________
______ POWER OF ATTORNEY

Name: ___________________________________

1 Examples of evidence to consider include indications in the medical record concerning whether the subject was
oriented times three, whether the subject was alert and communicating with others, whether the subject was able to
write messages on paper, and whether the subject was able to adequately respond to questioning regarding his or her
participation in the research. Other considerations include the subject’s baseline cognitive status and the administration
of medications that might impair mental capacity.
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______ SPOUSE

Name: _______________________________________________

______ PARENT

Name: _______________________________________________

______ ADULT CHILD

Name: _________________________________________

______ ADULT BROTHER/SISTER

Name: ______________________________

______ OTHER ADULT RELATIVE

Name:______________________________
Relationship:_________________________

C.

PATIENT’S ASSENT TO PARTICIPATE:

______ The subject’s assent to inclusion in the study was sought and obtained.
______ The subject’s assent to inclusion in the study was sought and denied.
______ The subject’s assent was not sought.
 Reason for Subject’s Inability to
Assent:_________________________________________________________
_______________________________________________________________
_______________________________________________________________

Signatures:
————————————————(Date)
Surrogate’s Signature
————————————————(Date)
Name of Person Conducting Consent Interview
————————————————(Date)
Signature of Person Conducting Consent Interview
————————————————(Date)
Signature of Principal Investigator or
Co-Investigator
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APPENDIX V. RECRUITMENT SCRIPT
Hello, my name is ____, and I am a nurse here at the University of Pennsylvania. I am
also a PhD student in the School of Nursing (I am Research Assistant in the School of
Nursing). I am working with Dr. XX and the nurses here on the unit, and we are worried
about the amount of stress that families have/experience when their loved one has had a
stroke. So our project is to learn more about family caregiver stress.
Could I talk with you for a few minutes now about the project? [If this is not a good time
for you, would you mind my coming back later? etc….].
The study is about feelings and experiences when taking care of, or helping care for, an
older family member in the first few weeks after stroke, when they first begin to provide
care for their loved ones.
I am going to give you a general picture of the study. There are several survey questions
that I will ask you or read to you. Answering the questions will take a maximum of 40–50
minutes. Questions are related to how members of the family feel and what they
experience from their caregiving.
The next day after the interview, we will ask you collect your saliva on a cotton sponge
that we will provide and collect from you. The saliva will be used to measure the stress
level of family caregivers. Then, one month later, we will meet with you for the second
interview and again ask you to collect your saliva.
Let me explain how to collect your salvia. You will collect saliva after waking up and
then around 9 pm before you go to bed. Basically, each time you will put a cotton sponge
under your tongue for a minute, take it out and place it in the tube we will give you, and
then keep it in a plastic bag in your freezer overnight. The research team will pick up the
two tubes or arrange a time and place to pick them up from you. We provide a $10 gift
certificate for the first interview and saliva collection and another $10 one month later for
the second interview and saliva collection.
Would you like to participate in this study?
{If the person indicates that they do not wish to collect saliva}: If you are not
comfortable collecting your saliva, we can do only the survey questions. Would you be
able to do only the survey questions? {If the person indicates they are too busy to meet us
for the second interview}: If you are too busy to meet for the second interview, we can
give you a copy of the survey questions to take home and then we can do the second
interview over the phone while you are reading the questions and answering them at the
same time.
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APPENDIX W. PHONE SCRIPT TEMPLATE
Hello, my name is ____, and I am a nurse at the University of Pennsylvania. I am also a
research assistant in the School of Nursing. I am working with Dr. Meg Bourbonniere
and the nurses here on the unit at the Thomas Jefferson University Hospital, and we are
interested in studying the amount of stress that families have/experience when their loved
one has had a stroke. So our project is to learn more about family caregiver stress.
Is this good time to talk with you? If you do not have time now, can I call you back later?
The study is about feelings and experiences when taking care of, or helping care for, an
older family member in the first few weeks after stroke, when they first begin to provide
care for their loved ones.
I am going to give you a general picture of the study. There are several survey questions
that I will ask you or read to you. Answering the questions will take up to 40–50 minutes.
Questions are related to how members of the family feel and what they experience from
their caregiving.
The next day after the interview, we will ask you collect your saliva on a cotton sponge
that we will provide and collect from you. The saliva will be used to measure chemicals
that indicate your stress level as a family caregiver. Then, one month later, we will meet
with you for the second interview and again ask you to collect your saliva for a repeat of
the test.
Let me explain how to collect your salvia. You will collect saliva after waking up and
then around 9 pm before you go to bed. Basically, each time you will put a cotton sponge
under your tongue for a minute, take it out and place it in the tube we will give you, and
then keep it in a plastic bag in your freezer overnight. The research team will arrange a
time and place to pick up the saliva samples from you or you will place the bag in a prepaid FedEx clinical envelope and mail it to the researcher.
We provide a $10 gift certificate for the first interview and saliva collection and another
$10 one month later for the second interview and saliva collection.
Your participation in this study is entirely voluntary, and you can refuse to participate or
stop your participation at any time without penalty or loss of benefits to which you are
otherwise entitled, and without affecting your loved one or their care at Jefferson.
Would you like to participate in this study?
{If the person indicates that they do not wish to collect saliva}: If you are not
comfortable collecting your saliva, we can do only the survey questions. Would you be
able to do only the survey questions? {If the person indicates they are too busy to meet us
for the second interview}: If you are too busy to meet for the second interview, we can
197

give you a copy of the survey questions to take home and then we can do the second
interview over the phone while you are reading the questions and answering them at the
same time.
(If no) Thank you for your time. I won’t call you again.
(If yes) When would be good time for you to meet?
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APPENDIX X. FLYER

Care to change the world.TM
School of Nursing
Claire M. Fagin Hall
418 Curie Boulevard
Philadelphia, PA 19104 - 4217

Research Study Seeks Family Caregivers
for Older Adults with Stroke
You May be Eligible if You:
1. Are a family member or friend of an older adult (age 65
or older) who had a stroke or brain hemorrhage within
the past 2 weeks.
2. Expect to be the primary caregiver for the older adult
with a stroke or brain hemorrhage.
3. Can communicate in English.
4. Are age 21 or over.
Qualified Participants will:
1. Take part in two interviews about caregiving and collect
samples of saliva.
Participants will be compensated with gift cards worth up to
$20 for their time and effort.
For more information about this study call 215-746-4454.
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